<?xml version="1.0" encoding="utf-8"?><!DOCTYPE html><html lang="EN" xml:lang="en" xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops"><head><meta http-equiv="default-style" content="text/html; charset=utf-8"/><title>Cancer Medicine (Oncology)</title><link rel="stylesheet" type="text/css" href="../../Style/Elsevier_eBook.css"/><link rel="stylesheet" type="text/css" media="only screen" href="../../Style/media.css"/></head><body><span role="doc-pagebreak" epub:type="pagebreak" aria-label="745" id="pagebreak_745"/><section xmlns:epub="http://www.idpf.org/2007/ops" role="doc-chapter" epub:type="chapter" id="CH0019"><h1 class="chaptitle" epub:type="title" id="B9780443107795000191">Chapter 19: Cancer Medicine (Oncology)</h1><nav role="doc-toc" epub:type="toc"><p class="chapoutlhd" id="outline0010"/><div class="outlchap"><ol><li class="chapoutl1" id="u0160"><a href="../B9780443107795000191/CH0019_745-792_B9780443107795000191.xhtml#s0010" id="p0190"><b>Introduction</b></a></li><li class="chapoutl1" id="u0165"><a href="../B9780443107795000191/CH0019_745-792_B9780443107795000191.xhtml#s0020" id="p0195"><b>Carcinogenesis</b></a></li><li class="chapoutl1" id="u0170"><a href="../B9780443107795000191/CH0019_745-792_B9780443107795000191.xhtml#s0045" id="p0200"><b>Classification of Cancerous Tumors</b></a></li><li class="chapoutl1" id="u0175"><a href="../B9780443107795000191/CH0019_745-792_B9780443107795000191.xhtml#s0065" id="p0205"><b>Pathologic Descriptions</b></a></li><li class="chapoutl1" id="u0180"><a href="../B9780443107795000191/CH0019_745-792_B9780443107795000191.xhtml#s0080" id="p0210"><b>Grading and Staging Systems</b></a></li><li class="chapoutl1" id="u0185"><a href="../B9780443107795000191/CH0019_745-792_B9780443107795000191.xhtml#s0085" id="p0215"><b>Cancer Treatment</b></a></li><li class="chapoutl1" id="u0190"><a href="../B9780443107795000191/CH0019_745-792_B9780443107795000191.xhtml#b0020" id="p0220"><b>Vocabulary</b></a></li><li class="chapoutl1" id="u0195"><a href="../B9780443107795000191/CH0019_745-792_B9780443107795000191.xhtml#b0025" id="p0225"><b>Terminology</b></a></li><li class="chapoutl1" id="u0200"><a href="../B9780443107795000191/CH0019_745-792_B9780443107795000191.xhtml#s0125" id="p0230"><b>Laboratory Tests</b></a></li><li class="chapoutl1" id="u0205"><a href="../B9780443107795000191/CH0019_745-792_B9780443107795000191.xhtml#s0130" id="p0235"><b>Clinical Procedures</b></a></li><li class="chapoutl1" id="u0210"><a href="../B9780443107795000191/CH0019_745-792_B9780443107795000191.xhtml#b0045" id="p0240"><b>Abbreviations</b></a></li><li class="chapoutl1" id="u0215"><a href="../B9780443107795000191/CH0019_745-792_B9780443107795000191.xhtml#b0050" id="p0245"><b>In Person: Radiotherapy</b></a></li><li class="chapoutl1" id="u0220"><a href="../B9780443107795000191/CH0019_745-792_B9780443107795000191.xhtml#b0055" id="p0250"><b>Practical Applications</b></a></li><li class="chapoutl1" id="u0225"><a href="../B9780443107795000191/CH0019_745-792_B9780443107795000191.xhtml#em0010" id="p0255"><b>Exercises</b></a></li><li class="chapoutl1" id="u0230"><a href="../B9780443107795000191/CH0019_745-792_B9780443107795000191.xhtml#exma0010" id="p0260"><b>Answers to Exercises</b></a></li><li class="chapoutl1" id="u0235"><a href="../B9780443107795000191/CH0019_745-792_B9780443107795000191.xhtml#b0060" id="p0265"><b>Pronunciation of Terms</b></a></li><li class="chapoutl1" id="u0240"><a href="../B9780443107795000191/CH0019_745-792_B9780443107795000191.xhtml#b0065" id="p0270"><b>Review Sheet</b></a></li></ol></div></nav><div class="objoutlhd"><a id="cesectitle0010"/>Chapter Goals</div><div class="objoutl"><div id="p0155"/><div><div id="ulist0085"><div id="u0135"><div class="objbulllist" id="p0160">• Identify medical terms that describe the growth and spread of tumors.</div></div><div id="u0140"><div class="objbulllist" id="p0165">• Recognize terms related to the causes, diagnosis, and treatment of cancer.</div></div><div id="u0145"><div class="objbulllist" id="p0170">• Review how tumors are classified and described by pathologists.</div></div><div id="u0150"><div class="objbulllist" id="p0175">• Describe x-ray studies, laboratory tests, and other procedures used by physicians for determining the presence and extent of spread (staging) of tumors.</div></div><div id="u0155"><div class="objbulllist" id="p0180">• Apply your new knowledge to understanding medical terms in their proper contexts, such as medical reports and records.</div></div></div></div></div><section><div id="p0275"/><div><div class="pageavoid"><figure class="fig" id="f0080"><img src="../../IMAGES/B9780443107795000191/main.assets/co19-9780443107795.jpg" alt="image"/><figcaption class='figleg'></figcaption></figure></div></div><div class="textfl"><span role="doc-pagebreak" epub:type="pagebreak" aria-label="746" id="pagebreak_746"/><a id="pg746"/></div><section><a id="s0010"/><h2 class="h1hd" id="cesectitle0020">Introduction</h2><div class="textfl" id="p0280">Cancer is a disease caused by abnormal and excessive growth of cells in the body. It may arise in any tissue and appear at any time of life, although cancer occurs most frequently in older people. Cancer cells accumulate as growths called malignant tumors that compress, invade, and ultimately destroy the surrounding normal tissue. In addition to their local growth, cancerous cells spread throughout the body by way of the bloodstream or lymphatic vessels. In some patients, the spread of cancers from their site of origin to distant organs occurs early in the course of tumor growth and ultimately results in death.</div><div class="text" id="p0285">Although nearly two thirds of all patients who develop cancer are cured of their disease, about 600,000 people die of cancer in the United States each year. Lung cancers, followed by breast and colorectal cancers, are the most common causes of cancer death for women, whereas lung, colorectal, and prostate cancers are the leading causes of death due to cancer in men. This chapter explores the terminology related to this common and often fatal group of diseases.</div></section><section><a id="s0015"/><h2 class="h1hd" id="cesectitle0025">Characteristics of Tumors</h2><div class="textfl" id="p0290"><b>Tumors (neoplasms)</b> are new growths that arise from normal tissue. They may be either <b>malignant</b> (capable of invasion and spread to surrounding or more distant sites) or <b>benign</b> (noninvasive and not spreading to other sites). There are several differences between benign and malignant tumors. Some of these differences are:</div><div><ul class="ce_list" id="olist0015"><li class="numlist" id="p0295"><a id="o0030"/>1. Benign tumors <b>grow slowly,</b> and malignant tumor cells <b>multiply rapidly.</b></li><li class="numlist" id="p0300"><a id="o0035"/>2. Benign tumors are often <b>encapsulated</b> (contained within a fibrous capsule or cover) so that the tumor cells do not invade the surrounding tissue. Malignant tumors characteristically are <b>invasive</b> and <b>infiltrative,</b> extending into neighboring normal tissue.</li><li class="numlist" id="p0305"><a id="o0040"/>3. Benign tumors are composed of organized and specialized <b>(differentiated)</b> cells that closely resemble the normal, mature tissue from which they are derived. For example, <span role="doc-pagebreak" epub:type="pagebreak" aria-label="747" id="pagebreak_747"/><a id="pg747"/>benign tumors derived from epithelial cells that line the wall of the gastrointestinal tract look very much like their normal counterparts. Malignant tumors are composed of cancerous cells that resemble primitive cells and lack the capacity to perform mature cell functions. This characteristic of malignant tumors is called <b>anaplasia.</b> Anaplasia (ana- means backward and -plasia means growth) indicates that the cancerous cells are <b>dedifferentiated,</b> or <b>undifferentiated</b> (reverting to a less specialized state), in contrast with the normal, differentiated tissue of their origin. Anaplastic cells lack an orderly arrangement. Thus, tumor cells vary in size and shape and are piled one on top of the other in a disorganized fashion. The nuclei in these cells are large and <b>hyperchromatic</b> (stain excessively with dyes that recognize genetic material, DNA).</li><li><div class="pageavoid"><figure class="fig" id="f0010"><img src="../../IMAGES/B9780443107795000191/main.assets/f19-01-9780443107795.jpg" alt="image" aria-describedby="LD02"/><figcaption class='figleg'><a id="cap0010"/><a id="fspara0010"/><span class="fignum"><a href="#Bf0010">FIGURE 19-1</a></span> <b>A, Photomicrograph of normal skeletal muscle cells (fibers).</b> Note the orderly arrangement and the long, narrow, threadlike shape of the cells. There are many nuclei per cell and many cross striations. <b>B, Anaplastic tumor cells of the skeletal muscle (rhabdomyosarcoma).</b> Note the variation in size and shape of the nuclei (pleomorphism; pleo = many, morph/o = shape), hyperchromatic (intensely staining) nuclei, and large tumor cells (which may possess more than one nucleus). <span class="figcredit"><b>A,</b> from Thibodeau GA, Patton KT: <i>Anatomy &amp; Physiology,</i> ed 6, St. Louis, 2007, Elsevier/Mosby. <b>B,</b> Courtesy Trace Worrell, MD, Department of Pathology, University of Texas Southwestern Medical School, Dallas.</span></figcaption></figure><p class="sr-only" id="LD02">A) A photomicrograph shows labels of cross-striations of muscle cell, nuclei of muscle cell, and muscle fiber. B) A micrograph shows two huge pink stained cell containing numerous blue-stained cells; all vary in shape and size.</p></div></li><li><div class="pageavoid"><figure class="fig" id="f0015"><img src="../../IMAGES/B9780443107795000191/main.assets/f19-02-9780443107795.jpg" alt="An extracted liver shows white patches varying size on the surface of liver on a black background."/><figcaption class='figleg'><a id="cap0015"/><a id="fspara0015"/><span class="fignum"><a href="#Bf0015">FIGURE 19-2</a></span> A liver studded with metastatic cancer. <span class="figcredit">From Kumar V et al: <i>Robbins Basic Pathology,</i> ed 8, Philadelphia, 2010, Elsevier/Saunders.</span></figcaption></figure></div></li><li class="unnumlist" id="p0310"><a id="u0245"/><a href="#f0010" id="Bf0010">Figure 19-1A and B</a> shows normal skeletal muscle and anaplastic malignant muscle tumor cells.</li><li class="numlist" id="p0315"><a id="o0045"/>4. Cells from benign tumors do not spread or <b>metastasize</b> to form secondary tumor masses in distant places in the body. Cells from malignant tumors, however, can detach themselves from the primary tumor site, penetrate a blood vessel or lymphatic vessel, travel through the bloodstream or lymphatic system, and establish a new tumor site at a distant tissue, such as the lung, liver, or bone marrow. The secondary growth is called a <b>metastasis.</b> <a href="#f0015" id="Bf0015">Figure 19-2</a> shows metastatic tumors within the liver.</li></ul></div><div class="text" id="p0320"><a href="#f0020" id="Bf0020">Figure 19-3</a> reviews the differences between benign and malignant tumors.<span role="doc-pagebreak" epub:type="pagebreak" aria-label="748" id="pagebreak_748"/><a id="pg748"/></div><div class="pageavoid"><figure class="fig" id="f0020"><img src="../../IMAGES/B9780443107795000191/main.assets/f19-03-9780443107795.jpg" alt="image" aria-describedby="LD04"/><figcaption class='figleg'><a id="cap0020"/><a id="fspara0020"/><span class="fignum"><a href="#Bf0020">FIGURE 19-3</a></span> Differences between benign and malignant tumors.</figcaption></figure><p class="sr-only" id="LD04">A flow diagram compares two types of tumors (neoplasms) as follows: Benign: Slowly growing; encapsulated and noninvasive; well-differentiated; and nonmetastatic. Malignant: Rapidly multiplying; invasive and infiltrative; anaplastic and undifferentiated; and metastatic.</p></div></section><section><a id="s0020"/><hgroup><h2 class="h1hd" id="cesectitle0030">Carcinogenesis</h2><p class="h2after1" id="cesectitle0035">What Causes Cancer?</p></hgroup><section><a id="s0025"/><div class="textfl" id="p0325">The causes of transformation from a normal cell to a cancerous one <b>(carcinogenesis)</b> are only partly understood. What is clear is that malignant transformation results from damage to the genetic material, or <b>DNA (deoxyribonucleic acid),</b> of the cell. Strands of DNA in the cell nucleus form <b>chromosomes,</b> which become readily visible under a microscope when a cell is preparing to divide into two (daughter) cells. In order to understand what causes cancer, it is necessary to learn more about DNA and its functions in a normal cell.</div><div class="text" id="p0330">DNA has two main functions in a normal cell. First, DNA controls the production of new cells (cell division). When a cell divides, the DNA material in each chromosome copies itself so that exactly the same DNA is passed to the two new daughter cells that are formed. This process of cell division is called <b>mitosis</b> (<a href="#f0025" id="Bf0025">Figure 19-4A</a>).</div><div class="text" id="p0335">Second, DNA controls the production of new proteins (<b>protein synthesis</b>) in the cell. Each DNA piece, or <b>gene</b>, contains the code for making a single protein. That protein carries out an important specific function in the cell. There are 20,000 to 25,000 human protein-coding genes. Genes are composed of an arrangement of units called <b>nucleotides</b> (containing a sugar, phosphate, and a base, such as adenine, guanine, thymine, or cytosine). DNA (as a string of coded nucleotides) sends a molecular message outside the nucleus to the cytoplasm of the cell, directing the synthesis of specific proteins (such as hormones and enzymes) essential for normal cell function and growth. This message is transmitted in the following way: In the nucleus, the coded message with instructions for making a specific protein is copied from DNA onto another molecule called <b>RNA (ribonucleic acid).</b> Then RNA travels from the nucleus to the cytoplasm of the cell, carrying the coded message that directs the formation of specific proteins (<a href="#f0025">Figure 19-4B</a>).<span role="doc-pagebreak" epub:type="pagebreak" aria-label="749" id="pagebreak_749"/><a id="pg749"/></div><div class="pageavoid"><figure class="fig" id="f0025"><img src="../../IMAGES/B9780443107795000191/main.assets/f19-04-9780443107795.jpg" alt="image" aria-describedby="LD05"/><figcaption class='figleg'><a id="cap0025"/><a id="fspara0025"/><span class="fignum"><a href="#Bf0025">FIGURE 19-4</a></span> <b>Two functions controlled by DNA. A, Mitosis</b> (process of cell division). <b>B, Protein synthesis</b> (creating new proteins for cellular growth). <b>RNA,</b> which is a product of DNA, is vital to this function.</figcaption></figure><p class="sr-only" id="LD05">Two functions of DNA are: A) Mitosis where DNA copies itself to generate two identical daughter cells. B) Protein synthesis: Coded message is copied from DNA to RNA, and further, RNA takes code message to cytoplasm where proteins are made according to the RNA code.</p></div><div class="text" id="p0340">When a cell becomes malignant, however, the processes of mitosis and protein synthesis are disturbed. Cancer cells reproduce almost continuously, and abnormal proteins are made. Malignant cells are <b>anaplastic</b>; that is, their DNA stops making normal codes that allow the cells to carry on the function of differentiating mature cells. Instead, new signals lead to malignant growth and spread of tumor cells.</div><div class="text" id="p0345">Various kinds of damage to DNA result in malignancy. DNA damage may be caused by toxic chemicals, sunlight, tobacco smoke, and viruses. The specific damage usually involves changes in the cell’s DNA codes, creating abnormal genes with changes called <b>mutations</b>. Mutations interfere with the accurate synthesis of new proteins and can be passed on to new cells during cell division.</div><div class="text" id="p0350">Although most DNA changes, or mutations, lead to higher-than-normal rates of growth, some mutations found in cancer cells actually prevent the cells from dying. In recent years, scientists have recognized that in some types of cancers, the normal blueprints that direct aging or damaged cells to die are missing. Normal cells undergo spontaneous disintegration by a process known as <b>apoptosis,</b> or programmed cell death. Some cancer cells have lost elements of this program and thus can live indefinitely.</div></section><section><a id="s0030"/><h3 class="h2hd" id="cesectitle0040">Environmental Agents</h3><div class="textfl" id="p0355">Agents from the environment, such as chemicals, drugs, tobacco smoke, radiation, and viruses, can cause damage to DNA and thus produce cancer. These environmental agents are called <b>carcinogens.</b></div><div class="text" id="p0360"><b>Chemical carcinogens</b> are found in a variety of products and drugs, including <b>hydrocarbons</b>—in cigarette, cigar, and pipe smoke and automobile exhaust—insecticides, dyes, industrial chemicals, asbestos as in insulation, and hormones. Hormones such as estrogens can cause cancer by stimulating growth of cells in the lining of the uterus or in milk glands of the breast.</div><div class="text" id="p0365"><b>Radiation,</b> whatever its source—sunlight, x-rays, radioactive substances—consists of waves of energy. This energy causes DNA damage and mutations that lead to cancer. Leukemia used to be an occupational hazard of radiologists, who were routinely exposed to x-rays. There is a high incidence of leukemia and other cancers among survivors of atomic bomb explosions, as at Hiroshima and Nagasaki. Ultraviolet radiation in sunlight can cause skin cancer, especially in persons with lightly pigmented, or fair, skin.</div><div class="text" id="p0370">Some <b>viruses</b> are carcinogenic. For example, the human T cell leukemia virus (HTLV1) causes a form of leukemia in adults. Kaposi sarcoma is caused by another virus, herpesvirus type 8. Other viruses are known to cause cervical cancer (human papillomavirus or HPV) and liver cancer (hepatitis B and C viruses). See <a href="#t0010" id="Bt0010">Table 19-1</a>.<span role="doc-pagebreak" epub:type="pagebreak" aria-label="750" id="pagebreak_750"/><a id="pg750"/></div><div class="pageavoid"><p class="tnum"><a href="#Bt0010">TABLE 19-1</a></p><div class="big_device"><table id="t0010" class="tbody"><caption class="ttitle"><a id="tspara0010"/>ENVIRONMENTAL CARCINOGENS</caption><tbody><tr><th scope="row" class="tb"><b>Chemicals</b></th><td class="tb"><ol id="ulist0010"><li class="tbulllist" id="p0010">• asbestos in insulation</li><li class="tbulllist" id="p0015">• dyes and industrial chemicals</li><li class="tbulllist" id="p0020">• hormones</li><li class="tbulllist" id="p0025">• hydrocarbons</li><li class="tbulllist" id="p0030">• insecticides</li></ol></td></tr><tr><th scope="row" class="tb"><b>Radiation</b></th><td class="tb"><ol id="ulist0015"><li class="tbulllist" id="p0035">• sunlight (ultraviolet rays)</li><li class="tbulllist" id="p0040">• x-rays</li><li class="tbulllist" id="p0045">• radioactive substances</li></ol></td></tr><tr><th scope="row" class="tb"><b>Viruses</b></th><td class="tb"><ol id="ulist0020"><li class="tbulllist" id="p0050">• human T cell leukemia virus (HTLV1)</li><li class="tbulllist" id="p0055">• human papillomavirus (HPV)</li><li class="tbulllist" id="p0060">• hepatitis B and C viruses</li></ol></td></tr></tbody></table></div>

</div></section><section><a id="s0035"/><h3 class="h2hd" id="cesectitle0045">Oncogenes</h3><div class="textfl" id="p0375">Oncogenes are pieces of normal DNA that, when activated by a mutation, can convert a normal cell to a cancerous cell. Some examples of oncogenes are <i><b>ras</b></i> (colon cancer), <i><b>myc</b></i> (lymphoma), and <i><b>abl</b></i> (chronic myeloid leukemia or CML).</div><div class="text" id="p0380">In chronic myeloid leukemia, the gene <i>abl</i> is activated to become an oncogene when two different chromosomes switch locations. This mutation is called a <b>translocation.</b> What happens is that the gene <i>abl</i> on chromosome 9 moves to a new location next to a gene called <i>bcr</i> on chromosome 22, (see <a href="#f0030" id="Bf0030">Figure 19-5</a>). When <b>bcr</b> (<b>b</b>reakpoint <b>c</b>luster <b>r</b>egion) and <b>abl</b> are near each other, they cause the production of an abnormal protein that makes the leukocyte divide and causes a malignancy (chronic myeloid leukemia). The new chromosome formed from the translocation is called the <b>Philadelphia chromosome</b> (it was discovered in 1970 in Philadelphia). Other gene translocations are found in lung cancers.</div></section><section><a id="s0040"/><h3 class="h2hd" id="cesectitle0050">Heredity</h3><div class="textfl" id="p0385">Cancer also may be caused by transmission of DNA mutations that are associated with cancer susceptibility. These mutations are found in the DNA of the parental egg or sperm cells and are passed from generation to generation. Although most cancers result from chance mutations in body cells during a person’s lifetime, examples of known inherited cancers are <b>retinoblastoma</b> (tumor of the retina of the eye), <b>adenomatous polyposis coli</b> <span role="doc-pagebreak" epub:type="pagebreak" aria-label="751" id="pagebreak_751"/><a id="pg751"/><b>syndrome</b> (premalignant polyps that grow in the colon and rectum), and certain forms of colon, breast, and kidney cancer.</div><div class="pageavoid"><figure class="fig" id="f0030"><img src="../../IMAGES/B9780443107795000191/main.assets/f19-05-9780443107795.jpg" alt="Diagram shows changes brought in normal chromosome 0, which after translocation result in production of abnormal protein."/><figcaption class='figleg'><a id="cap0030"/><a id="fspara0030"/><span class="fignum"><a href="#Bf0030">FIGURE 19-5</a></span> <b>Oncogene translocation resulting in the Philadelphia chromosome.</b> Notice the translocation of the <i>abl</i> gene from the long arm of chromosome 9 to the long arm of chromosome 22 (next to the <i>bcr</i> gene). This results in a combination <b><i>bcr-abl</i> oncogene</b>, which produces an abnormal protein, leading to chronic myeloid leukemia.</figcaption></figure></div><div class="pageavoid"><p class="tnum"><a href="#Bt0015">TABLE 19-2</a></p><table id="t0015" class="tbody"><caption class="ttitle"><a id="tspara0015"/>EXAMPLES OF GENES IMPLICATED IN HEREDITARY CANCERS</caption><thead><tr><th scope="col" class="tcolhd1">CANCER</th><th scope="col" class="tcolhd1">GENE</th><th scope="col" class="tcolhd1">CHROMOSOMAL LOCATION<a href="#tn0010" role="doc-noteref" epub:type="noteref" id="ctn0010">∗</a></th></tr></thead><tbody><tr><th scope="row" class="tb">Breast; ovarian</th><td class="tb"><i>BRCA1</i></td><td class="tb_calign">17q21</td></tr><tr><th scope="row" class="tb">Breast; ovarian</th><td class="tb"><i>BRCA2</i></td><td class="tb_calign">3q12-13</td></tr><tr><th scope="row" class="tb">Li-Fraumeni syndrome (multiple cancers)</th><td class="tb"><i>TP53</i></td><td class="tb_calign">17p13</td></tr><tr><th scope="row" class="tb">Polyposis coli syndrome</th><td class="tb"><i>APC</i></td><td class="tb_calign">5q21</td></tr><tr><th scope="row" class="tb">Renal cell carcinoma</th><td class="tb"><i>VHL</i></td><td class="tb_calign">3p21-26</td></tr><tr><th scope="row" class="tb">Retinoblastoma</th><td class="tb"><i>RB1</i></td><td class="tb_calign">13q14</td></tr><tr><th scope="row" class="tb">Wilms tumor</th><td class="tb"><i>WT1</i></td><td class="tb_calign">11p13</td></tr></tbody></table><footer><p class="tftnote" id="tn0010" role="doc-footnote" epub:type="footnote"><sup><a href="#ctn0010">∗</a></sup> <a id="fntpara0010"/>The first number is the chromosome; p is the short arm of the chromosome, and q is the long arm of the chromosome. The second number is the region (band) of the chromosome.</p></footer></div><div class="text" id="p0390">In many cases, it is believed that these tumors arise because of inherited or acquired abnormalities in certain genes called <b>suppressor genes.</b> In normal persons, these suppressor genes regulate growth, promote differentiation, and suppress oncogenes from causing cancer. Loss of a normal suppressor gene takes the brake off the process of cell division and leads to cancer. Examples of suppressor genes are the <b>retinoblastoma (Rb) type 1 gene <i>(RB1)</i></b> and the <i><b>TP53</b></i> gene, which leads to brain tumors or breast cancer.</div><div class="text" id="p0395">Because inherited changes can be detected by analyzing DNA in any tissue of the body, not simply cancerous cells, blood cells from a cancer patient or family members are tested to determine whether a person has inherited the cancer-causing gene. This is known as <b>genetic screening.</b> Affected patients and family members may be watched carefully to detect tumors at an early stage or elect to have prophylactic removal of organs or tissue that may become cancerous. <a href="#t0015" id="Bt0015">Table 19-2</a> lists several hereditary cancers and the name of the responsible gene.</div></section></section><section><a id="s0045"/><h2 class="h1hd" id="cesectitle0055">Classification of Cancerous Tumors</h2><div class="textfl" id="p0400">Almost one half of all cancer deaths are caused by malignancies that originate in lung, breast, or colon; however, in all there are more than 100 distinct types of cancer, each having a unique set of symptoms and requiring a specific type of therapy. It is possible to divide these types of cancer into three broad groups on the basis of <b>histogenesis</b>—that is, by identifying the particular type of tissue <b>(hist/o)</b> from which the tumor cells arise (-<b>genesis</b>). These major groups are <b>carcinomas, sarcomas,</b> and <b>mixed-tissue tumors.</b><span role="doc-pagebreak" epub:type="pagebreak" aria-label="752" id="pagebreak_752"/><a id="pg752"/></div><section><a id="s0050"/><h3 class="h2hd" id="cesectitle0060">Carcinomas</h3><div class="textfl" id="p0405"><b>Carcinomas,</b> the largest group, are solid tumors that are derived from epithelial tissue that lines external and internal body surfaces, including skin, glands, and digestive, urinary, and reproductive organs. Approximately 90% of all malignancies are carcinomas.</div><div class="text" id="p0410"><a href="#t0020" id="Bt0020">Table 19-3</a> gives examples of specific carcinomas and the epithelial tissue from which they derive. Benign tumors of epithelial origin are usually designated by the term <b>adenoma,</b> which indicates that the tumor is of epithelial or glandular (<b>aden/o</b>) origin. For example, a gastric adenoma is a benign tumor of the glandular epithelial cells lining the stomach. Malignant tumors of epithelial origin are named by using the term <b>carcinoma</b> and adding the type of tissue in which the tumor occurs. Thus, a <b>gastric adenocarcinoma</b> is a cancerous tumor arising from glandular cells lining the stomach.<span role="doc-pagebreak" epub:type="pagebreak" aria-label="753" id="pagebreak_753"/><a id="pg753"/></div><div class="pageavoid"><p class="tnum"><a href="#Bt0020">TABLE 19-3</a></p><div class="big_device"><table id="t0020" class="tbody"><caption class="ttitle"><a id="tspara0020"/>CARCINOMAS AND THE EPITHELIAL TISSUES FROM WHICH THEY DERIVE</caption><thead><tr><th scope="col" class="tcolhd1">TYPE OF EPITHELIAL TISSUE</th><th scope="col" class="tcolhd1">MALIGNANT TUMOR (CARCINOMAS)</th></tr></thead><tbody><tr><th scope="row" class="tb"><b>Gastrointestinal tract</b></th><td class="tb"/></tr><tr><th scope="row" class="tb"> Colon</th><td class="tb">Adeno<b>carcinoma</b> of the colon</td></tr><tr><th scope="row" class="tb"> Esophagus</th><td class="tb">Esophageal <b>carcinoma</b></td></tr><tr><th scope="row" class="tb"> Liver</th><td class="tb">Hepatocellular <b>carcinoma</b> (hepatoma)</td></tr><tr><th scope="row" class="tb"> Stomach</th><td class="tb">Gastric adeno<b>carcinoma</b></td></tr><tr><th scope="row" class="tb"><b>Glandular tissue</b></th><td class="tb"/></tr><tr><th scope="row" class="tb"> Adrenal glands</th><td class="tb"><b>Carcinoma</b> of the adrenals (adrenocortical <b>carcinoma</b>)</td></tr><tr><th scope="row" class="tb"> Breast</th><td class="tb"><b>Carcinoma</b> of the breast</td></tr><tr><th scope="row" class="tb"> Pancreas</th><td class="tb"><b>Carcinoma</b> of the pancreas (pancreatic adeno<b>carcinoma</b>)</td></tr><tr><th scope="row" class="tb"> Prostate</th><td class="tb"><b>Carcinoma</b> of the prostate</td></tr><tr><th scope="row" class="tb"> Salivary glands</th><td class="tb">Adenoid cystic <b>carcinoma</b></td></tr><tr><th scope="row" class="tb"> Thyroid</th><td class="tb"><b>Carcinoma</b> of the thyroid</td></tr><tr><th scope="row" class="tb"><b>Kidney and bladder</b></th><td class="tb"/></tr><tr><td class="tb"/><td class="tb">Renal cell <b>carcinoma</b> (hypernephroma)</td></tr><tr><td class="tb"/><td class="tb">Transitional cell <b>carcinoma</b> of the bladder</td></tr><tr><th scope="row" class="tb"><b>Lung</b></th><td class="tb"/></tr><tr><td class="tb" rowspan="4"/><td class="tb">Adeno<b>carcinoma</b> (bronchioloalveolar)</td></tr><tr><td class="tb">Large cell <b>carcinoma</b></td></tr><tr><td class="tb">Small cell <b>carcinoma</b></td></tr><tr><td class="tb">Squamous cell <b>carcinoma</b> (epidermoid)</td></tr><tr><th scope="row" class="tb"><b>Reproductive organs</b></th><td class="tb"/></tr><tr><td class="tb" rowspan="6"/><td class="tb">Adeno<b>carcinoma</b> of the uterus</td></tr><tr><td class="tb">Squamous cell <b>carcinoma</b> of the penis</td></tr><tr><td class="tb">Chorio<b>carcinoma</b> of the uterus or testes</td></tr><tr><td class="tb">Cystadeno<b>carcinoma</b> (mucinous or serous) of the ovaries</td></tr><tr><td class="tb">Seminoma and embryonal cell <b>carcinoma</b> (testes)</td></tr><tr><td class="tb">Squamous cell (epidermoid) <b>carcinoma</b> of the vagina or cervix</td></tr><tr><th scope="row" class="tb"><b>Skin</b></th><td class="tb"/></tr><tr><th scope="row" class="tb"> Basal cell layer</th><td class="tb">Basal cell <b>carcinoma</b></td></tr><tr><th scope="row" class="tb"> Melanocyte</th><td class="tb">Malignant melanoma</td></tr><tr><th scope="row" class="tb"> Squamous cell layer</th><td class="tb">Squamous cell <b>carcinoma</b></td></tr></tbody></table></div>

</div></section><section><a id="s0055"/><h3 class="h2hd" id="cesectitle0065">Sarcomas</h3><div class="textfl" id="p0415"><b>Sarcomas</b> also are malignant tumors but are less common than carcinomas. They derive from connective tissues in the body, such as bone, fat, muscle, cartilage, and bone marrow and from cells of the lymphatic system. Often, the term <b>mesenchymal tissue</b> is used to describe embryonic connective tissue from which sarcomas are derived. The middle, or mesodermal, layer of the embryo gives rise to the connective tissues of the body as well as to blood and lymphatic vessels.</div><div class="text" id="p0420"><a href="#t0025" id="Bt0025">Table 19-4</a> gives examples of specific types of sarcomas and the connective tissues from which they derive. Benign tumors of connective tissue origin are named by adding the suffix <b>-oma</b> to the type of tissue in which the tumor occurs. For example, a benign tumor of bone is called an <b>osteoma.</b> Malignant tumors of connective tissue origin are frequently named using the term <b>sarcoma</b> (<b>sarc/o</b> = flesh). For example, an <b>osteosarcoma</b> is a malignant tumor of bone.<span role="doc-pagebreak" epub:type="pagebreak" aria-label="754" id="pagebreak_754"/><a id="pg754"/></div><div class="pageavoid"><p class="tnum"><a href="#Bt0025">TABLE 19-4</a></p><div class="big_device"><table id="t0025" class="tbody"><caption class="ttitle"><a id="tspara0025"/>SARCOMAS AND THE CONNECTIVE TISSUES FROM WHICH THEY DERIVE</caption><thead><tr><th scope="col" class="tcolhd1">TYPE OF CONNECTIVE TISSUE</th><th scope="col" class="tcolhd1">MALIGNANT TUMOR (SARCOMA)</th></tr></thead><tbody><tr><th scope="row" class="tb"><b>Bone</b></th><td class="tb"><div class="tb1">Osteo<b>sarcoma</b> (osteogenic sarcoma)</div><div class="tb1">Ewing <b>sarcoma</b></div></td></tr><tr><td class="tb" colspan="2"><b>Muscle</b></td></tr><tr><th scope="row" class="tb"> Smooth (visceral) muscle</th><td class="tb">Leiomyo<b>sarcoma</b></td></tr><tr><th scope="row" class="tb"> Striated (skeletal) muscle</th><td class="tb">Rhabdomyo<b>sarcoma</b></td></tr><tr><th scope="row" class="tb"><b>Cartilage</b></th><td class="tb">Chondro<b>sarcoma</b></td></tr><tr><th scope="row" class="tb"><b>Fat</b></th><td class="tb">Lipo<b>sarcoma</b></td></tr><tr><th scope="row" class="tb"><b>Fibrous tissue</b></th><td class="tb">Fibro<b>sarcoma</b></td></tr><tr><th scope="row" class="tb"><b>Blood vessel tissue</b></th><td class="tb">Angio<b>sarcoma</b></td></tr><tr><td class="tb" colspan="2"><b>Blood-forming tissue</b></td></tr><tr><th scope="row" class="tb"> All leukocytes</th><td class="tb">Leukemias</td></tr><tr><th scope="row" class="tb" rowspan="2"> Lymphocytes</th><td class="tb">Lymphomas</td></tr><tr><td class="tb"><ul id="olist0010"><li class="tunnumlist" id="p0065">Hodgkin lymphoma</li><li class="tunnumlist" id="p0070">Non-Hodgkin lymphomas</li><li class="tnumlist" id="p0075">1. follicular</li><li class="tnumlist" id="p0080">2. diffuse large cell</li><li class="tnumlist" id="p0085">3. Burkitt</li><li class="tnumlist" id="p0090">4. anaplastic large cell</li></ul></td></tr><tr><th scope="row" class="tb"> Plasma cells (bone marrow)</th><td class="tb">Multiple myeloma</td></tr><tr><td class="tb" colspan="2"><b>Nerve tissue</b></td></tr><tr><th scope="row" class="tb"> Embryonic nerve tissue</th><td class="tb">Neuroblastoma</td></tr><tr><th scope="row" class="tb"> Glial tissue</th><td class="tb"><div class="tb1">Astrocytoma (tumor of glial cells called astrocytes)</div><div class="tb1">Glioblastoma multiforme</div></td></tr><tr><th scope="row" class="tb"> Nerve cells of the gastrointestinal tract</th><td class="tb">Gastrointestinal stromal tumor (GIST)</td></tr></tbody></table></div>

</div>

<div class="pageavoid"><p class="tnum"><a href="#Bt0030">TABLE 19-5</a></p><table id="t0030" class="tbody"><caption class="ttitle"><a id="tspara0030"/>MIXED-TISSUE TUMORS</caption><thead><tr><th scope="col" class="tcolhd1">TYPE OF TISSUE</th><th scope="col" class="tcolhd1">MALIGNANT TUMOR</th></tr></thead><tbody><tr><th scope="row" class="tb"><b>Kidney</b></th><td class="tb">Wilms tumor (embryonal adenosarcoma)</td></tr><tr><th scope="row" class="tb"><b>Ovaries and testes</b></th><td class="tb"><div class="tb1">Teratoma (tumor composed of bone, muscle, skin, gland cells, cartilage, etc.)</div><div class="tb1">Germ cell tumor</div></td></tr></tbody></table></div><div class="text" id="p0425">In addition to the solid tumors of connective tissue origin, sarcomas include tumors arising from blood-forming tissue. <b>Leukemias</b> are tumors derived from bone marrow. <b>Lymphomas</b>, such as Hodgkin, Burkitt, follicular types, and <b>multiple myeloma,</b> are derived from immune cells of the lymphatic system. Glial cells within the brain and other cells of the nervous system give rise to malignancies such as <b>gliomas</b> and <b>neuroblastomas</b>.</div></section><section><a id="s0060"/><h3 class="h2hd" id="cesectitle0070">Mixed-Tissue Tumors</h3><div class="textfl" id="p0430">Mixed-tissue tumors are derived from tissue that is capable of differentiating into both epithelial and connective tissue. These uncommon tumors are thus composed of several different types of cells. Examples of mixed-tissue tumors (<a href="#t0030" id="Bt0030">Table 19-5</a>) are found in the kidney, ovaries, and testes.</div></section></section><section><a id="s0065"/><h2 class="h1hd" id="cesectitle0075">Pathologic Descriptions</h2><div class="textfl" id="p0435">The following terms are used to describe the appearance of a malignant tumor on either gross (visual) or microscopic examination.</div><section><a id="s0070"/><h3 class="h2hd" id="cesectitle0080">Gross Descriptions</h3><div id="p0440"/><div><div class="pageavoid"><div class="big_device"><table id="t0050" class="tbody"><tbody><tr><th scope="row" class="tb"><b>cystic</b></th><td class="tb"><div class="tb1"><b>Forming large open spaces filled with fluid.</b></div><div class="tb1"><b>Mucinous</b> tumors are filled with mucus (thick, sticky fluid), and <b>serous</b> tumors are filled with a thin, watery fluid resembling serum. The most common site of cystic tumors is in ovaries (<a href="#f0035" id="Bf0035">Figure 19-6A</a>).</div></td></tr><tr><td class="tb_ralign" colspan="2">Table Continued</td></tr></tbody></table><a id="sf0035"/><div class="pageavoid"><figure class="fig" id="f0035"><img src="../../IMAGES/B9780443107795000191/main.assets/f19-06-9780443107795.jpg" alt="A) An excised cystic ovary filled with fluid and blood-filled sacs kept on a piece of a cloth. B) Red and fleshy tumors on a black background."/><figcaption class='figleg'><a id="cap0035"/><a id="fspara0035"/><span class="fignum"><a href="#Bf0035">Figure 19-6</a></span> <b>A, Cystic ovarian adenocarcinoma.</b> Note that the tumor has formed fluid-filled cysts and blood-filled sacs. <b>B, Medullary carcinoma</b> of the thyroid. Tumor shows a solid pattern of growth. <span class="figcredit"><b>A,</b> Courtesy Dr. Annekathryn Goodman, Massachusetts General Hospital, Boston. <b>B,</b> from Kumar V, Abbas A, Aster J: <i>Robbins &amp; Cotran Pathologic Basis of Disease,</i> ed 8, Philadelphia, 2010, Elsevier/Saunders.</span></figcaption></figure></div>

</div>

<div><span role="doc-pagebreak" epub:type="pagebreak" aria-label="755" id="pagebreak_755"/></div><div class="big_device"><table class="tbody"><tbody><tr><th scope="row" class="tb"><b>fungating</b></th><td class="tb"><div class="tb1"><b>Mushrooming pattern of growth in which tumor cells pile one on top of another and project from a tissue surface.</b></div><div class="tb1">Tumors found in the colon are often of this type.</div></td></tr><tr><th scope="row" class="tb"><b>inflammatory</b></th><td class="tb"><div class="tb1"><b>Having the features of inflammation—that is, redness, swelling, and heat.</b></div><div class="tb1">Inflammatory changes result from tumor blockage of the lymphatic drainage of the skin, as in breast cancer.</div></td></tr><tr><th scope="row" class="tb"><b>medullary</b></th><td class="tb"><div class="tb1"><b>Large, soft, fleshy tumors.</b></div><div class="tb1">Thyroid and breast tumors may be medullary (<a href="#f0035">Figure 19-6B</a>).</div></td></tr><tr><th scope="row" class="tb"><b>necrotic</b></th><td class="tb"><div class="tb1"><b>Containing dead tissue.</b></div><div class="tb1">Any type of tumor can outgrow its blood supply with resulting cell death and necrosis of part or all of the tumor.</div></td></tr><tr><th scope="row" class="tb"><b>polypoid</b></th><td class="tb"><div class="tb1"><b>Growths that form projections extending outward from a base.</b></div><div class="tb1"><b>Sessile</b> polypoid tumors extend from a broad base, and <b>pedunculated</b> polypoid tumors extend from a stem or stalk. Both benign and malignant tumors of the colon may grow as polyps. Benign polyps of the colon have a significant risk of becoming malignant over time and should be removed to prevent cancer (<a href="#f0040" id="Bf0040">Figure 19-7A</a>).</div></td></tr><tr><th scope="row" class="tb"><b>ulcerating</b></th><td class="tb"><div class="tb1"><b>Characterized by an open, exposed surface resulting from the death of overlying tissue.</b></div><div class="tb1">Ulcerating tumors often are found in the stomach, breast, colon, and skin (<a href="#f0040">Figure 19-7B</a>).</div></td></tr><tr><th scope="row" class="tb"><b>verrucous</b></th><td class="tb"><div class="tb1"><b>Resembling a wart-like growth.</b></div><div class="tb1">Tumors of the gingiva (gum) frequently are verrucous.</div></td></tr></tbody></table></div>

</div></div><div class="textfl"/></section><section><a id="s0075"/><h3 class="h2hd" id="cesectitle0085">Microscopic Descriptions</h3><div id="p0445"/><div><div class="pageavoid"><div class="big_device"><table id="t0055" class="tbody"><tbody><tr><th scope="row" class="tb"><b>alveolar</b></th><td class="tb"><b>Tumor cells form patterns resembling small sacs;</b> commonly found in tumors of muscle, bone, fat, and cartilage.</td></tr><tr><th scope="row" class="tb"><b>carcinoma in situ</b></th><td class="tb"><b>Referring to localized tumor cells that have not invaded adjacent structures.</b> (Latin <i>in situ</i> means in place.) Cancer of the cervix may begin as carcinoma in situ.</td></tr><tr><td class="tb_ralign" colspan="2">Table Continued</td></tr></tbody></table><a id="sf0040"/><div class="pageavoid"><figure class="fig" id="f0040"><img src="../../IMAGES/B9780443107795000191/main.assets/f19-07-9780443107795.jpg" alt="A) Excised colon shows multiple red polyps present on the surface of colon on a black background. B) Excised section of stomach shows a gray colored ulcer on the surface."/><figcaption class='figleg'><a id="cap0040"/><a id="fspara0040"/><span class="fignum"><a href="#Bf0040">Figure 19-7</a></span> <b>A, Adenomatous polyposis of the colon.</b> These innumerable polypoid adenomas have a strong tendency for progression to colon adenocarcinoma. <b>B, Gastric (stomach) carcinoma presenting as a large, irregular ulcer.</b> <span class="figcredit"><b>A,</b> from Kumar V, Abbas A, Aster J: <i>Robbins &amp; Cotran Pathologic Basis of Disease,</i> ed 8, Philadelphia, 2010, Elsevier/Saunders. <b>B,</b> from Kumar V et al: <i>Robbins Basic Pathology,</i> ed 8, Philadelphia, 2007, Elsevier/Saunders.</span></figcaption></figure></div>

</div>

<div><span role="doc-pagebreak" epub:type="pagebreak" aria-label="756" id="pagebreak_756"/></div><div class="big_device"><table class="tbody"><tbody><tr><th scope="row" class="tb"><b>diffuse</b></th><td class="tb"><b>Spreading evenly throughout the affected tissue.</b> Malignant lymphomas may display diffuse involvement of lymph nodes.</td></tr><tr><th scope="row" class="tb"><b>dysplastic</b></th><td class="tb"><b>Containing abnormal-appearing cells that are not clearly cancerous.</b> Dysplastic nevi (moles on skin) are an example. They are often forerunners of skin cancers.</td></tr><tr><th scope="row" class="tb"><b>epidermoid</b></th><td class="tb"><b>Resembling squamous epithelial cells (thin, plate-like);</b> often found on the surface of the skin and lining of the respiratory and digestive tracts.</td></tr><tr><th scope="row" class="tb"><b>follicular</b></th><td class="tb"><b>Small, round gland-type clusters.</b> Thyroid gland cancer and lymphomas are examples (<a href="#f0045" id="Bf0045">Figure 19-8A</a>).</td></tr><tr><th scope="row" class="tb"><b>papillary</b></th><td class="tb"><b>Forming small, finger-like or nipple-like projections of cells.</b> Bladder and thyroid cancers are examples (<a href="#f0045">Figure 19-8B</a>).</td></tr><tr><th scope="row" class="tb"><b>pleomorphic</b></th><td class="tb"><b>Composed of a variety of types of cells.</b> Mixed-cell tumors are examples.</td></tr><tr><th scope="row" class="tb"><b>scirrhous</b></th><td class="tb"><b>Densely packed</b> (scirrhous means hard) <b>tumors, due to dense bands of fibrous tissue;</b> commonly found in breast or stomach cancers.</td></tr><tr><th scope="row" class="tb"><b>undifferentiated</b></th><td class="tb"><b>Lacking any microscopic structures typical of normal mature cells.</b></td></tr></tbody></table><a id="sf0045"/><div class="pageavoid"><figure class="fig" id="f0045"><img src="../../IMAGES/B9780443107795000191/main.assets/f19-08-9780443107795.jpg" alt="A) A micrograph shows white dots representing small glandular sacs. B) A micrograph shows three arrows at bottom-right pointing at three small, nipple-like projections of cells."/><figcaption class='figleg'><a id="cap0045"/><a id="fspara0045"/><span class="fignum"><a href="#Bf0045">Figure 19-8</a></span> A, Follicular non-Hodgkin lymphoma involving a lymph node. B, Papillary carcinoma of the thyroid. <span class="figcredit">From Kumar V, Abbas A, Aster J: <i>Robbins &amp; Cotran Pathologic Basis of Disease,</i> ed 8, Philadelphia, 2010, Elsevier/Saunders.</span></figcaption></figure></div>

</div>

</div></div><div class="textfl"><span role="doc-pagebreak" epub:type="pagebreak" aria-label="757" id="pagebreak_757"/><a id="pg757"/></div></section></section><section><a id="s0080"/><h2 class="h1hd" id="cesectitle0090">Grading and Staging Systems</h2><div class="textfl" id="p0450">In grading and staging systems, doctors classify tumors on the basis of <b>microscopic appearance (grade)</b> and the <b>extent of spread (stage).</b> These two properties influence the diagnosis, treatment, and prognosis for cancer patients.</div><section><a id="s0085"/><h3 class="h2hd" id="cesectitle0095">Grading</h3><div class="textfl" id="p0455">When <b>grading</b> a tumor, the pathologist is concerned with the microscopic appearance of the tumor cells, specifically with their degree of maturity and differentiation. Often, three or four grades are used. <b>Grade I</b> tumors are very well differentiated, so that they closely resemble normal cells. <b>Grade IV</b> tumors are so undifferentiated or anaplastic that even recognition of the tumor’s tissue of origin may be difficult. <b>Grades II</b> and <b>III</b> are intermediate in appearance, moderately or poorly differentiated, as opposed to well differentiated (grade I) and undifferentiated (grade IV).</div><div class="text" id="p0460">Grading often is of value in determining the prognosis for certain types of cancers, such as cancer of the urinary bladder, prostate gland, and ovary and brain tumors. Patients with grade I tumors have a high survival rate, and patients with grade II, III, and IV tumors have an increasingly poorer survival rate. Grading also is used in evaluating cells obtained from body fluids in preventive screening tests, such as <b>Papanicolaou (Pap) smears</b> of the uterine cervix.</div></section><section><a id="s0090"/><h3 class="h2hd" id="cesectitle0100">Staging</h3><div class="textfl" id="p0465">The <b>staging</b> of cancerous tumors is based on the extent of spread of the tumor. It relies on careful definition of the size and possible metastatic spread of the tumor, using computed tomography (CT), combination positron emission tomography with CT (PET-CT), magnetic resonance imaging (MRI) scans, and radionuclide (radioactive) bone scans. See <a href="#f0075" id="Bf0075">Figure 19-14</a>, <a href="#pg774">page 774</a>, for a PET-CT scan showing lymph node metastases. An example of a staging system is the <b>tumor-node-metastasis (TNM) International Staging System.</b> It has been applied to many malignancies, such as lung and breast cancer.</div><div class="text" id="p0470">Notations in a staging system are:</div><div><ul id="ulist0095"><li class="unnumlist" id="p0475"><a id="u0250"/><b>T</b> = <b>tumor</b> (size and degree of local extension)</li><li class="unnumlist" id="p0480"><a id="u0255"/><b>N</b> = <b>nodes</b> (number of regional lymph nodes invaded by tumor cells)</li><li class="unnumlist" id="p0485"><a id="u0260"/><b>M</b> = <b>metastases</b> (spread of tumor cells to distant sites)</li></ul></div><div class="text" id="p0490">Stages I-IV (1-4) represent categories of tumor progression. Thus, stage I includes small tumors that have not spread to lymph nodes or distant sites (T1, N0, M0). Stage II may be designated as T2, N1, M0. Stage IV is any T, any N, and distant metastases.<span role="doc-pagebreak" epub:type="pagebreak" aria-label="758" id="pagebreak_758"/><a id="pg758"/></div></section></section><section><a id="s0095"/><h2 class="h1hd" id="cesectitle0105">Cancer Treatment</h2><div class="textfl" id="p0495">Major approaches to cancer treatment are <b>surgery, radiation therapy, chemotherapy</b> (including <b>hormonal therapy), molecularly targeted therapy,</b> and <b>immunotherapy.</b> Each <b>modality</b> (method) may be used alone, but often they are used together in combined-modality regimens to improve the overall treatment result.</div><section><a id="s0100"/><h3 class="h2hd" id="cesectitle0110">Surgery</h3><div class="textfl" id="p0500">In many patients with cancer, the tumor is discovered before it has spread, and it may be cured by surgical excision. Some common cancers in which surgery may be curative are those of the stomach, breast, colon, lung, and uterus (endometrium). In other patients who have metastases, surgical removal of the primary tumor may be necessary to prevent local spread or complications, even in the presence of distant disease. A <b>debulking procedure</b> can be used to remove as much of the primary tumor mass as possible to improve results of irradiation or drug therapy. After removal of the primary tumor, the patient often receives <b>adjuvant</b> (assisting) radiation therapy and/or chemotherapy to prevent recurrence at local and distant sites.</div><div class="text" id="p0505">The following is a list of terms that describe surgical procedures used in diagnosing and treating cancer.</div><div><div class="pageavoid"><table id="t0060" class="tbody"><tbody><tr><th scope="row" class="tb"><b>cauterization</b></th><td class="tb">Destruction of tissue by burning. Examples are electrocauterization (using a needle or snare heated by electric current), laser, dry ice, and chemicals.</td></tr><tr><th scope="row" class="tb"><b>core needle biopsy</b></th><td class="tb">Placement of a large-bore needle that extracts a core of tissue.</td></tr><tr><th scope="row" class="tb"><b>cryosurgery</b></th><td class="tb">Use of subfreezing temperature to destroy tissue.</td></tr><tr><th scope="row" class="tb"><b>en bloc resection</b></th><td class="tb">Tumor is removed along with surrounding tissue containing lymph nodes or areas of tumor spread. Mastectomy, colectomy, and gastrectomy are examples.</td></tr><tr><th scope="row" class="tb"><b>excisional biopsy</b></th><td class="tb">Removal of tumor and a margin of normal tissue. This procedure provides a specimen for diagnosis and may be curative for small noninvasive tumors.</td></tr><tr><th scope="row" class="tb"><b>exenteration</b></th><td class="tb">Wide resection involving removal of the tumor, its organ of origin, and all surrounding tissue in the body space. Pelvic exenteration with removal of the uterus, ovaries, bladder, and segments of the large bowel may be performed to treat large primary tumors of the uterus.</td></tr><tr><th scope="row" class="tb"><b>fine needle aspiration</b></th><td class="tb">Placement of a very thin needle inside the tumor mass and extraction of cells for microscopic evaluation.</td></tr><tr><th scope="row" class="tb"><b>fulguration</b></th><td class="tb">Destruction of tissue by electric sparks generated by a high-frequency current.</td></tr><tr><th scope="row" class="tb"><b>incisional biopsy</b></th><td class="tb">Piece of tumor is removed for examination to establish a diagnosis. A more extensive surgical procedure or other forms of treatment, such as chemotherapy or radiation therapy, are then used to treat the bulk of the tumor.</td></tr></tbody></table></div></div></section><section><a id="s0105"/><h3 class="h2hd" id="cesectitle0115">Radiation Therapy (Radiation Oncology)</h3><div class="textfl" id="p0510"><b>Radiation therapy (RT)</b> employs high-energy beams to destroy tumors. The goal of radiation therapy is to deliver a maximal dose of ionizing radiation consisting of particles and rays of energy to the tumor tissue and a minimal dose to the surrounding normal tissue. High-dose <b>irradiation</b> (exposure of tissue to radiation) destroys tumor cells and produces damage to DNA. Newer techniques of irradiation use high-energy beams composed of <b>protons</b> (subatomic particles) to improve the uniformity of dose and to limit damage to normal tissues.<span role="doc-pagebreak" epub:type="pagebreak" aria-label="759" id="pagebreak_759"/><a id="pg759"/></div><div class="text" id="p0515">Terms used in the field of radiation therapy for cancer are as follows:</div><div><div class="pageavoid"><div class="big_device"><table id="t0065" class="tbody"><tbody><tr><th scope="row" class="tb"><b>brachytherapy</b></th><td class="tb">Small, sealed containers or seeds of radioactive material are inserted directly into the tumor (interstitial therapy) or into a cavity of the tumor (intracavitary therapy). An implant may be temporary (tumors of the head and neck or gynecologic malignancies) or permanent (prostate gland implants called “seeds”).</td></tr><tr><th scope="row" class="tb"><b>electron beams</b></th><td class="tb">Low-energy beams for treatment of skin or surface tumors.</td></tr><tr><th scope="row" class="tb"><b>external beam irradiation (teletherapy)</b></th><td class="tb">Radiation therapy applied to a tumor from a distant source (linear accelerator).</td></tr><tr><th scope="row" class="tb"><b>fractionation</b></th><td class="tb">Method of dividing radiation into small, repeated doses rather than fewer large doses. Fractionation allows larger total doses to be given while causing less damage to normal tissue. Two fractionation treatment schedules are <b>hyperfractionation</b> (giving small doses more often to improve the likelihood of better cancer control) and <b>hypofractionation</b> (giving larger doses less often, as used in palliative care to alleviate symptoms of advanced disease).</td></tr><tr><th scope="row" class="tb"><b>gray (Gy)</b></th><td class="tb">Unit of absorbed radiation dose. Historically, the unit in use was <b>rad</b> (100 rad equal 1 Gy).</td></tr><tr><th scope="row" class="tb"><b>linear accelerator</b></th><td class="tb">Large electronic device that produces high-energy x-ray (or photon) beams for the treatment of deep-seated tumors (<a href="#f0050" id="Bf0050">Figure 19-9</a>). <b>Intraoperative radiation therapy (IORT)</b> is direct application of radiation during surgery using a linear accelerator in the operating room.</td></tr><tr><th scope="row" class="tb"><b>photon therapy</b></th><td class="tb">Radiation therapy using x-rays or gamma rays. A linear accelerator produces photon beams to treat tumors. See <b><i>In Person: Radiotherapy,</i></b> <a href="#pg776">page 776</a>.</td></tr><tr><td class="tb_ralign" colspan="2">Table Continued</td></tr></tbody></table><a id="sf0050"/><div class="pageavoid"><figure class="fig" id="f0050"><img src="../../IMAGES/B9780443107795000191/main.assets/f19-09-9780443107795.jpg" alt="An assistant stands next to a patient lying on stomach under a linear accelerator."/><figcaption class='figleg'><a id="cap0050"/><a id="fspara0050"/><span class="fignum"><a href="#Bf0050">Figure 19-9</a></span> <b>Linear accelerator.</b> Radiation therapy (photon therapy) delivered to a patient positioned under a linear accelerator. <b>Intensity-modulated radiation therapy (IMRT)</b> is an advanced mode of high-precision radiotherapy that uses computer-controlled linear accelerators to deliver precise radiation doses to a malignant tumor. This is a type of <b>conformal radiation therapy</b> that uses computer technology to create a three-dimensional image of a tumor so that rotating beams can shape exactly to the contour of the tumor. <span class="figcredit">Courtesy Arthur Brimberg, MD, Riverhill Radiation Oncology, Yonkers, New York.</span></figcaption></figure></div>

</div>

<div><span role="doc-pagebreak" epub:type="pagebreak" aria-label="760" id="pagebreak_760"/></div><div class="big_device"><table class="tbody"><tbody><tr><th scope="row" class="tb"><b>proton therapy</b></th><td class="tb">Small subatomic positively charged particles (protons) produced by a cyclotron deposit all the energy at a focused finite point. This reduces the dose affecting normal surrounding tissues by at least 50% (<a href="#f0055" id="Bf0055">Figure 19-10A</a>).</td></tr><tr><th scope="row" class="tb"><b>radiation fields</b></th><td class="tb">Dimensions of an irradiated area used to treat a tumor from a specific angle. See <a href="#f0060" id="Bf0060">Figure 19-11</a>.</td></tr><tr><th scope="row" class="tb"><b>radiocurable tumor</b></th><td class="tb">Tumor that can be completely eradicated by radiation therapy. Usually, this is a localized tumor with no evidence of metastasis. Lymphomas, Hodgkin lymphoma, and seminomas of the testes are examples.</td></tr><tr><th scope="row" class="tb"><b>radioresistant tumor</b></th><td class="tb">Tumor that requires large doses of radiation to produce death of the cells. Melanoma and renal carcinoma are among the most radioresistant tumors.</td></tr><tr><th scope="row" class="tb"><b>radiosensitive tumor</b></th><td class="tb">Tumor in which irradiation can cause the death of cells without serious damage to surrounding tissue (morbidity). Tumors of hematopoietic (blood-forming) and lymphatic origins are radiosensitive.</td></tr><tr><th scope="row" class="tb"><b>radiosensitizers</b></th><td class="tb">Drugs that increase the sensitivity of tumors to x-rays. Many cancer chemotherapy drugs, especially 5-fluorouracil and cisplatin, sensitize tumors and normal tissue to radiation, thereby improving the outcome of treatment.</td></tr><tr><th scope="row" class="tb"><b>simulation</b></th><td class="tb">Imaging study performed before radiation therapy using CT scan and/or MRI to map the treatment area. Simulation is required in the treatment planning phase for all patients undergoing radiotherapy.</td></tr><tr><th scope="row" class="tb"><b>stereotactic radiosurgery (SRS)</b></th><td class="tb">Single large dose of radiation is delivered under precise, stereotactic 3D (three-dimensional) guidance. This is performed at multiple angles to destroy vascular abnormalities and small tumors in the brain or other sites (see <a href="#f0055">Figure 19-10B</a>).The <b>CyberKnife system</b> is a noninvasive example of stereotactic radiosurgery using precise beams of gamma rays to treat tumors throughout the body. <b>Gamma Knife</b> is another example of SRS for treatment of head and neck tumors.</td></tr></tbody></table></div>

</div></div><div class="text" id="p0520"><span role="doc-pagebreak" epub:type="pagebreak" aria-label="761" id="pagebreak_761"/><a id="pg761"/></div><div class="pageavoid"><figure class="fig" id="f0055"><img src="../../IMAGES/B9780443107795000191/main.assets/f19-10-9780443107795.jpg" alt="image" aria-describedby="LD011"/><figcaption class='figleg'><a id="cap0055"/><a id="fspara0055"/><span class="fignum"><a href="#Bf0055">FIGURE 19-10</a></span> <b>A, Proton therapy machine.</b> Proton beam radiation therapy is useful in treating a variety of cancers, including tumors of the head and neck, brain, eye, and prostate. The beam can rotate to different positions around the patient. <b>B, Proton stereotactic radiosurgery.</b> A model poses to show how a proton beam device is brought near a patient in preparation for stereotactic radiosurgery. <span class="figcredit">Courtesy Radiation Oncology Department, Massachusetts General Hospital, Boston.</span></figcaption></figure><p class="sr-only" id="LD011">A) A patient in supine position lies in a proton therapy machine with beam directed towards head. B) Close-up shows a model in supine position with beam directed on left eye, with brace covering mouth.</p></div><div class="pageavoid"><figure class="fig" id="f0060"><img src="../../IMAGES/B9780443107795000191/main.assets/f19-11-9780443107795.jpg" alt="A to C depict three scans depicting tumor in frontal lobe from three different views."/><figcaption class='figleg'><a id="cap0060"/><a id="fspara0060"/><span class="fignum"><a href="#Bf0060">FIGURE 19-11</a></span> <b>Radiation fields.</b> Three-color radiation dose distribution image showing radiation fields used to treat a brain tumor. There is always some overlap with surrounding normal tissue. <span class="figcredit">Courtesy of Radiation Oncology Department, Massachusetts General Hospital, Boston.</span></figcaption></figure></div><div class="text" id="p0525">Radiotherapy, although it may be either <b>palliative</b> (relieving symptoms) or curative, can produce undesirable side effects to any normal body tissues that are caught in the field of irradiation. Some complications due to irradiation of normal tissue surrounding the tumor and in the path of the beam of photons may be reversible with time, and recovery takes place soon after radiotherapy is completed. Side effects may be acute (days to weeks after first dose), subacute (several weeks or months later), or late (months to years later). Radiation side effects are listed in <a href="#t0035" id="Bt0035">Table 19-6</a>.<span role="doc-pagebreak" epub:type="pagebreak" aria-label="762" id="pagebreak_762"/><a id="pg762"/></div><div class="pageavoid"><p class="tnum"><a href="#Bt0035">TABLE 19-6</a></p><div class="big_device"><table id="t0035" class="tbody"><caption class="ttitle"><a id="tspara0035"/>RADIOTHERAPY SIDE EFFECTS</caption><tbody><tr><th scope="row" class="tb"><b>Acute</b></th><td class="tb"/></tr><tr><th scope="row" class="tb"><ol id="ulist0025"><li class="tbulllist" id="p0095">• <b>mucositis</b></li></ol></th><td class="tb">inflammation and ulceration of mucous membranes (mouth, pharynx, vagina, bladder, large or small intestine)</td></tr><tr><th scope="row" class="tb"><ol id="ulist0030"><li class="tbulllist" id="p0100">• <b>myelosuppression</b></li></ol></th><td class="tb">bone marrow depression (anemia, leukopenia, and thrombocytopenia)</td></tr><tr><th scope="row" class="tb"><ol id="ulist0035"><li class="tbulllist" id="p0105">• <b>nausea and vomiting</b></li></ol></th><td class="tb">uneasiness of the stomach and emptying of its contents—more common with irradiation of the brain and gastrointestinal tract</td></tr><tr><th scope="row" class="tb"><ol id="ulist0040"><li class="tbulllist" id="p0110">• <b>xerostomia</b></li></ol></th><td class="tb">dryness of the mouth—with salivary gland irradiation</td></tr><tr><th scope="row" class="tb"><b>Subacute</b></th><td class="tb"/></tr><tr><th scope="row" class="tb"><ol id="ulist0045"><li class="tbulllist" id="p0115">• <b>alopecia</b></li></ol></th><td class="tb">baldness (permanent or temporary)</td></tr><tr><th scope="row" class="tb"><ol id="ulist0050"><li class="tbulllist" id="p0120">• <b>cystitis</b></li></ol></th><td class="tb">inflammation of the urinary bladder</td></tr><tr><th scope="row" class="tb"><ol id="ulist0055"><li class="tbulllist" id="p0125">• <b>desquamation</b></li></ol></th><td class="tb">loss of skin over an irradiated area (breast cancer)</td></tr><tr><th scope="row" class="tb"><ol id="ulist0060"><li class="tbulllist" id="p0130">• <b>pneumonitis</b></li></ol></th><td class="tb">inflammation of the lungs</td></tr><tr><th scope="row" class="tb"><ol id="ulist0065"><li class="tbulllist" id="p0135">• <b>proctitis</b></li></ol></th><td class="tb">inflammation of the rectum and anus</td></tr><tr><th scope="row" class="tb"><b>Late</b></th><td class="tb"/></tr><tr><th scope="row" class="tb"><ol id="ulist0070"><li class="tbulllist" id="p0140">• <b>fibrosis</b></li></ol></th><td class="tb">increase of connective tissue (scarring of skin, lungs, kidneys)</td></tr><tr><th scope="row" class="tb"><ol id="ulist0075"><li class="tbulllist" id="p0145">• <b>secondary tumors</b></li></ol></th><td class="tb">new types of tumors in separate sites (leukemias and solid tumors such as carcinomas and sarcomas)</td></tr><tr><th scope="row" class="tb"><ol id="ulist0080"><li class="tbulllist" id="p0150">• <b>infertility</b></li></ol></th><td class="tb">loss of reproductive function</td></tr></tbody></table></div>

</div></section><section><a id="s0110"/><h3 class="h2hd" id="cesectitle0120">Chemotherapy</h3><div class="textfl" id="p0530"><b>Cancer chemotherapy</b> is the treatment of cancer using chemicals (drugs). It is the standard treatment for many types of cancer, and is curative in a number of them, such as testicular cancer, acute lymphocytic leukemia (children), and Hodgkin lymphoma, and large cell lymphomas. Chemotherapy may be used alone or in combination with surgery and irradiation to improve cure rates.</div><div class="text" id="p0535">Drugs cause tumor cells to die by damaging their DNA. Tumor cells with damaged DNA undergo apoptosis (self-destruction). This means that they have less capacity to repair their DNA and, in general, are less able to survive DNA damage caused by drugs and radiation.</div><div class="text" id="p0540">The ideal is to administer drugs that kill large numbers of tumor cells without harming normal cells. However, rapidly dividing normal cells, such as in the bone marrow and gastrointestinal lining, can suffer considerable damage from chemotherapeutic drugs. Research physicians measure drug levels and their rates of disappearance from the bloodstream and tissues. They use information from animal experiments and <b>clinical trials</b> <span class="icon1"><img src="../../IMAGES/B9780443107795000191/main.assets/icon01-9780443107795.jpg" alt="icon"/></span> to design better routes and schedules of administration to achieve the greatest tumor kill with the least toxicity (harm) to normal cells.</div><div class="text" id="p0545"><b>Combination chemotherapy</b> is the use of two or more drugs together to kill tumors. Drugs are given according to a written <b>protocol,</b> or plan, that details the route, schedule, and frequency of doses. Usually, drug therapy is continued until the patient achieves a complete <b>remission</b> (absence of all signs of disease). <b>Adjuvant chemotherapy</b> is the administration of drug treatment <i>after</i> surgery to kill any residual cancer cells. <b>Neoadjuvant chemotherapy</b> is administrated <i>before</i> surgery to reduce the size of a tumor, such as in breast or head and neck cancer. Neoadjuvant drug treatment allows for a lesser surgery and improvement of outcome.</div><div><aside aria-labelledby="b0010" epub:type="sidebar">

<div class="boxg1" id="b0010"><p/><div class="b1title" epub:type="title" id="title0015"><span class="icon1"><img src="../../IMAGES/B9780443107795000191/main.assets/icon02-9780443107795.jpg" alt="icon"/></span>Clinical Trials</div><div class="b1textfl" id="bpar0010">Clinical trials are research studies designed to find treatments that work better than the standard therapies for patients. The studies follow a predefined protocol and are divided into four phases:</div><div><ul id="ulist0100"><li class="b1unnumlist" id="bpar0015"><a id="u0265"/><b>Phase I:</b> The experimental drug or treatment is tested in a small group of people (20–50) for the first time to evaluate its safety. Phase I trials also determine a safe dosage range and schedule of administration (daily, weekly, or every 3 weeks, oral or intravenous, and to obtain early evidence of usefulness.</li><li class="b1unnumlist" id="bpar0020"><a id="u0270"/><b>Phase II:</b> Experimental treatment is given to a larger group of subjects (100–200) with a specific type of cancer to identify tumor response rate and define safety risks.</li><li class="b1unnumlist" id="bpar0025"><a id="u0275"/><b>Phase III:</b> A larger and more definitive trial is conducted in which hundreds or thousands of subjects take part. Patients are randomly assigned to the new treatment or to a standard, established treatment. The effectiveness and overall risk-versus-benefit ratio for the experimental treatment are compared with the results of those for standard treatment. Based on these results, a new drug may be approved by the FDA (U.S. Food and Drug Administration).</li><li class="b1unnumlist" id="bpar0030"><a id="u0280"/><b>Phase IV:</b> Large studies are conducted after the FDA has granted its initial approval of a new treatment for marketing. These trials are designed to monitor safety in large populations and identify new indications and new drug combinations beyond those already approved.</li></ul></div></div></aside></div><div class="textfl"><span role="doc-pagebreak" epub:type="pagebreak" aria-label="763" id="pagebreak_763"/><a id="pg763"/></div><div class="text" id="p0550">The following are categories of cancer chemotherapeutic agents. Each works by disrupting cell function so that cancer cells die. At the same time, normal cells may be damaged as well. In each category, side effects such as alopecia, nausea, vomiting, and myelosuppression (suppression of bone marrow) can occur.</div><div><ul class="ce_list" id="olist0020"><li class="numlist" id="p0555"><a id="o0050"/>1. <b>Alkylating agents.</b> These drugs create chemical bonds with DNA, leading to crosslinks and breaks in DNA. These breaks interfere with cell division. <b>Cyclophosphamide (Cytoxan)</b> is an example.</li><li class="numlist" id="p0560"><a id="o0055"/>2. <b>Antibiotics.</b> These drugs are produced by bacteria or fungi and inhibit cell division by causing breaks in DNA strands. <b>Doxorubicin (Adriamycin)</b> is an example.</li><li class="numlist" id="p0565"><a id="o0060"/>3. <b>Antimetabolites.</b> These drugs block synthesis of DNA components (nucleotides) and prevent cells from dividing. <b>Methotrexate</b> and <b>5-fluorouracil (5-FU)</b> are examples.</li><li class="numlist" id="p0570"><a id="o0065"/>4. <b>Antimitotics.</b> These chemicals block the function of a protein that is necessary for mitosis (cell division). Antimitotic drugs are derived from bacteria, fungi or plants, or from small sea animals found on coral reefs. <b>Paclitaxel (Taxol)</b> is an example.</li></ul></div><div class="text" id="p0575">A separate class of drugs called <b>hormonal agents</b> is also used to treat cancerous tumors. These drugs block hormone receptors on cells so that growth is inhibited. An example is <b>tamoxifen (Novadex)</b>, which blocks an <b>estrogen receptor</b> on breast cancer cells. Aromatase inhibitors, such as <b>anastrozole (Arimidex)</b>, prevent the conversion of androgen to estrogen and starve breast tumors of their estrogen supply in women who have gone through menopause (age greater than 50).</div><div class="text" id="p0580"><a href="#f0065" id="Bf0065">Figure 19-12</a> illustrates the mechanisms of action for the various types of cancer chemotherapeutic and hormonal drugs. Often, drugs are administered in combination, according to carefully planned <b>protocols</b> (regimens). For your reference, see <a href="#t0040" id="Bt0040">Table 19-7</a>, which lists specific chemotherapeutic and hormonal drugs and the type of cancer they treat.<span role="doc-pagebreak" epub:type="pagebreak" aria-label="764" id="pagebreak_764"/><a id="pg764"/></div><div class="pageavoid"><figure class="fig" id="f0065"><img src="../../IMAGES/B9780443107795000191/main.assets/f19-12-9780443107795.jpg" alt="image" aria-describedby="LD013"/><figcaption class='figleg'><a id="cap0065"/><a id="fspara0065"/><span class="fignum"><a href="#Bf0065">FIGURE 19-12</a></span> Mechanisms of action of cancer chemotherapeutic and hormonal agents.</figcaption></figure><p class="sr-only" id="LD013">Five mechanisms of actions are as follows: Antimetabolites: Block synthesis of DNA nucleotides. Antibiotics: Cause strands of DNA to break. Antimitotic: Block function of microtubules necessary for mitosis. Hormonal agents: Block hormone receptors so growth is inhibited. Alkylating agents: Cause crosslinks and strand breaks in DNA.</p></div><div class="pageavoid"><p class="tnum"><a href="#Bt0040">TABLE 19-7</a></p><div class="big_device"><table id="t0040" class="tbody"><caption class="ttitle"><a id="tspara0040"/>SELECTED CANCER CHEMOTHERAPEUTIC AND HORMONAL AGENTS AND THE CANCERS THEY TREAT</caption><thead><tr><th scope="col" class="tcolhd1" colspan="2">CHEMOTHERAPEUTIC AGENT</th><th scope="col" class="tcolhd1">TYPE OF CANCER</th></tr></thead><tbody><tr><td class="tb" colspan="3"><b>Alkylating Agents</b></td></tr><tr><th scope="row" class="tb" colspan="2">Cytoxan (cyclophosphamide)</th><td class="tb">Lymphoma</td></tr><tr><th scope="row" class="tb" colspan="2">Platinol (cisplatin<a href="#tbl19_1fnlowast" role="doc-noteref" epub:type="noteref" id="ctbl19_1fnlowast">∗</a>)</th><td class="tb">Testicular, ovarian, lung</td></tr><tr><td class="tb" colspan="3"><b>Antibiotics</b></td></tr><tr><th scope="row" class="tb" colspan="2">Adriamycin (doxorubicin)</th><td class="tb">Breast</td></tr><tr><th scope="row" class="tb" colspan="2">Blenoxane (bleomycin)</th><td class="tb">Testicular, Hodgkin lymphoma</td></tr><tr><th scope="row" class="tb" colspan="2">Onivyde (irinotecan)</th><td class="tb">Colorectal</td></tr><tr><td class="tb" colspan="3"><b>Antimetabolites</b></td></tr><tr><th scope="row" class="tb" colspan="2">Alimta (pemetrexed)</th><td class="tb">Lung</td></tr><tr><th scope="row" class="tb" colspan="2">Ara-C (cytarabine)</th><td class="tb">AML</td></tr><tr><th scope="row" class="tb" colspan="2">Folex (methotrexate, MXT)</th><td class="tb">Acute lymphoid leukemia (ALL)</td></tr><tr><td class="tb" colspan="3"><b>Antimitotics</b></td></tr><tr><th scope="row" class="tb" colspan="2">Oncovin (vincristine)</th><td class="tb">Lymphoma</td></tr><tr><th scope="row" class="tb" colspan="2">Taxol (paclitaxel)</th><td class="tb">Breast, ovarian, lung</td></tr><tr><th scope="row" class="tb" colspan="2"><b>HORMONAL AGENT</b></th><td class="tb"><b>TYPE OF CANCER</b></td></tr><tr><td class="tb" colspan="3"><b>Hormones and Hormone Antagonists</b></td></tr><tr><th scope="row" class="tb">Arimidex (anastrozole)</th><td class="tb" colspan="2">Breast</td></tr><tr><th scope="row" class="tb">Lupron (leuprolide)</th><td class="tb" colspan="2">Prostate</td></tr><tr><th scope="row" class="tb" colspan="2">Nolvadex (tamoxifen)</th><td class="tb">Breast</td></tr><tr><th scope="row" class="tb" colspan="2">Zytiga (abiraterone)</th><td class="tb">Prostate</td></tr></tbody></table></div>

<footer><p class="tftnote">Note: Generic names are in parentheses. Often drugs are given in combinations according to carefully planned regimens called <b>protocols.</b></p><p class="tftnote" id="tbl19_1fnlowast" role="doc-footnote" epub:type="footnote"><sup><a href="#ctbl19_1fnlowast">∗</a></sup> <a id="fntpara0015"/>Acts in a similar manner to alkylating agents</p></footer></div></section><section><a id="s0115"/><h3 class="h2hd" id="cesectitle0125">Molecularly Targeted Therapy</h3><div class="textfl" id="p0585">Molecularly targeted cancer therapy uses drugs to attack specific oncogenic mutations (targets) that drive cancer cell growth. When these targets are blocked by drugs, the cancer cell dies. Some of the targets are absolutely unique to tumor cells and not found in normal tissues. Thus, in contrast with chemotherapy, blocking these targets will have little or no effect on normal cells. Chemotherapeutic drugs normally are delivered by intravenous infusion, whereas molecularly targeted drugs <span class="icon1"><img src="../../IMAGES/B9780443107795000191/main.assets/icon01-9780443107795.jpg" alt="icon"/></span> often are mostly given in pill form.</div><div><aside aria-labelledby="b0015" epub:type="sidebar">

<div class="boxg1" id="b0015"><p/><div class="b1title" epub:type="title" id="title0020"><span class="icon1"><img src="../../IMAGES/B9780443107795000191/main.assets/icon02-9780443107795.jpg" alt="icon"/></span>Molecularly Targeted Therapy <b>Drugs</b> (notice that these drug names end in -ib)</div><div id="bpar0035"/><div><ul id="ulist0105"><li class="b1unnumlist" id="bpar0040"><a id="u0285"/><b>Gleevec (imatin<span class="underline">ib</span>)</b>—used in chronic myeloid leukemia</li><li class="b1unnumlist" id="bpar0045"><a id="u0290"/><b>Ibrance (palbocicl<span class="underline">ib</span>)</b>—used in breast cancer</li><li class="b1unnumlist" id="bpar0050"><a id="u0295"/><b>Imbruvica (ibrutin<span class="underline">ib</span>)</b>—used in chronic lymphoid leukemia, lymphoma</li><li class="b1unnumlist" id="bpar0055"><a id="u0300"/><b>Sutent (sunitin<span class="underline">ib</span>)</b>—used in renal cell carcinoma and hepatocelluar carcinoma</li><li class="b1unnumlist" id="bpar0060"><a id="u0305"/><b>Tagrisso (osimertin<span class="underline">ib</span>)</b>—used in lung cancer</li></ul></div></div></aside></div><div class="textfl"><span role="doc-pagebreak" epub:type="pagebreak" aria-label="765" id="pagebreak_765"/><a id="pg765"/></div></section><section><a id="s0120"/><h3 class="h2hd" id="cesectitle0130">Immunotherapy</h3><div class="textfl" id="p0590">Immunotherapy is the use of immune cells (lymphocytes) or antibodies to kill tumors. It is now possible to remove a patient’s own T cell lymphocytes and, in the laboratory, introduce new receptors, <b>CARs (chimeric antigen receptors),</b> on their cell surface. These CAR receptors are designed to bind to the CD19 protein found on the surface of all B-cell tumors. The engineered <b>CAR-T cells</b> can then be infused into the patient, where they attack and destroy B-cell tumors, including acute lymphoid leukemia (ALL), chronic lymphoid leukemia (CLL), and lymphomas.</div><div class="text" id="p0595">Other immunotherapies depend on laboratory engineered antibodies, called <b>monoclonal antibodies</b>. These monoclonal antibodies can kill tumors by blocking growth receptors on their cell surface. One of the most effective of these therapeutic antibodies is <b>Herceptin,</b> which inhibits the growth of breast cancer cells. Herceptin blocks HER2 growth receptors on breast cancer cells. Thus, if a patient presents with a HER2 breast cancer, the patient’s tumor will respond to treatment with Herceptin.</div><div class="text" id="p0600">A new way of using monoclonal antibodies is to attach a potent (toxic) drug to the antibody. The antibody will carry the drug specifically to tumor cells and release the toxic drug at that site, sparing normal tissue. These drugs are <b>antibody drug conjugates (ADCs).</b></div><div class="text" id="p0605">In another example of immunotherapy, monoclonal antibodies are used to activate T cell lymphocytes. Normal T cell lymphocytes are capable of recognizing and killing tumor cells, but in most cancer patients this response is ineffective due to a built-in brake called a checkpoint on the T cell surface. Monoclonal antibodies can block this checkpoint brake and allow the normal T cell population to expand and destroy the tumor. These antibodies, called <b>checkpoint inhibitors,</b> can treat melanoma, lymphoma, and lung, kidney, bladder, and colon cancers. See <a href="#t0045" id="Bt0045">Table 19-8</a> for examples of monoclonal antibodies and the cancers they treat.<span role="doc-pagebreak" epub:type="pagebreak" aria-label="766" id="pagebreak_766"/><a id="pg766"/></div><div class="pageavoid"><p class="tnum"><a href="#Bt0045">TABLE 19-8</a></p><table id="t0045" class="tbody"><caption class="ttitle"><a id="tspara0050"/>MONOCLONAL ANTIBODIES<a href="#tbl19_8fnlowast" role="doc-noteref" epub:type="noteref" id="ctbl19_8fnlowast">∗</a> AND CANCERS THEY TREAT</caption><thead><tr><th scope="col" class="tcolhd1">MONOCLONAL ANTIBODIES</th><th scope="col" class="tcolhd1">CANCERS THEY TREAT</th></tr></thead><tbody><tr><th scope="row" class="tb"><b>Adcetris (brentuxi<span class="underline">mab</span> vedotin)</b></th><td class="tb">Hodgkin lymphoma</td></tr><tr><th scope="row" class="tb"><b>Avastin (bevacizu<span class="underline">mab</span>)</b></th><td class="tb">colorectal cancer, lung cancer, brain tumors</td></tr><tr><th scope="row" class="tb"><b>Enhertu (fam-trastuzu<span class="underline">mab</span> deruxtecan)</b></th><td class="tb">breast cancer</td></tr><tr><th scope="row" class="tb"><b>Erbitux (cetuxi<span class="underline">mab</span>)</b></th><td class="tb">colorectal cancer, head and neck cancer</td></tr><tr><th scope="row" class="tb"><b>Herceptin (trastuzu<span class="underline">mab</span>)</b></th><td class="tb">breast cancer, gastric cancer</td></tr><tr><th scope="row" class="tb"><b>Keytruda (pembrolizu<span class="underline">mab</span>)</b></th><td class="tb">melanoma, lung, colon, and bladder cancers</td></tr><tr><th scope="row" class="tb"><b>Opdivo (nivolu<span class="underline">mab</span>)</b></th><td class="tb">melanoma, lung cancer, kidney cancer</td></tr><tr><th scope="row" class="tb"><b>Rituxan (rituxi<span class="underline">mab</span>)</b></th><td class="tb">CLL and lymphomas</td></tr></tbody></table><footer><p class="tftnote" id="tbl19_8fnlowast" role="doc-footnote" epub:type="footnote"><sup><a href="#ctbl19_8fnlowast">∗</a></sup> <a id="fntpara0020"/>Notice the common -mab ending in naming monoclonal antibodies.</p></footer></div><div><aside aria-labelledby="b0020" epub:type="sidebar">

<div class="boxg1" id="b0020"><p/><div class="b1title" epub:type="title" id="title0025"><span class="icon1"><img src="../../IMAGES/B9780443107795000191/main.assets/icon03-9780443107795.jpg" alt="icon"/></span>Vocabulary</div><div class="b1textfl" id="bpar0065">This list reviews many of the new terms introduced in the text. Short definitions reinforce your understanding of the terms. Refer to the Pronunciation of Terms section, <a href="#pg788">page 788</a>, for help with unfamiliar or difficult words.</div><div><div class="pageavoid"><div class="big_device"><table id="t0070" class="tbody"><tbody><tr><th scope="row" class="tb"><b>adjuvant chemotherapy</b></th><td class="tb">Drugs are given after primary therapy (surgery or radiation). Adjuvant means to assist.</td></tr><tr><th scope="row" class="tb"><b>alkylating agents</b></th><td class="tb">Chemotherapeutic synthetic drugs that cause crosslinks and breaks in DNA to stop cells from dividing.</td></tr><tr><th scope="row" class="tb"><b>anaplasia</b></th><td class="tb">Loss of differentiation of cells; reversion to a more primitive cell type.</td></tr><tr><th scope="row" class="tb"><b>antibiotics</b></th><td class="tb">Chemotherapeutic drugs found in bacteria and fungi, which cause breaks in DNA strands to inhibit cell division.</td></tr><tr><th scope="row" class="tb"><b>antimetabolites</b></th><td class="tb">Chemotherapeutic agents that block the synthesis of DNA components (nucleotides) and prevent cells from dividing.</td></tr><tr><th scope="row" class="tb"><b>antimitotics</b></th><td class="tb">Chemotherapeutic chemicals that block the function of a protein necessary for mitosis.</td></tr><tr><th scope="row" class="tb"><b>apoptosis</b></th><td class="tb">Programmed cell death. (Apo- means off, away; -ptosis means to fall.) Normal cells undergo apoptosis when damaged or aging. If cancer cells lose the ability to undergo apoptosis, they survive indefinitely.</td></tr><tr><th scope="row" class="tb"><b>benign tumor</b></th><td class="tb">Noncancerous growth (neoplasm).</td></tr><tr><th scope="row" class="tb"><b>brachytherapy</b></th><td class="tb">Radiotherapy that uses insertion of sealed containers into body cavities or radioactive seeds directly into the tumor.</td></tr><tr><th scope="row" class="tb"><b>carcinogens</b></th><td class="tb">Agents that cause cancer: chemicals and drugs, radiation, and viruses.</td></tr><tr><th scope="row" class="tb"><b>carcinoma</b></th><td class="tb">Cancerous tumor made up of cells of epithelial origin.</td></tr><tr><th scope="row" class="tb"><b>chemotherapy</b></th><td class="tb">Treatment with drugs that kill tumor cells.</td></tr><tr><th scope="row" class="tb"><b>combination chemotherapy</b></th><td class="tb">Use of several chemotherapeutic agents to treat tumors.</td></tr><tr><th scope="row" class="tb"><b>dedifferentiation</b></th><td class="tb">Loss of differentiation of cells; reversion to a more primitive, embryonic cell type; anaplasia or undifferentiation.</td></tr><tr><th scope="row" class="tb"><b>deoxyribonucleic acid (DNA)</b></th><td class="tb">Genetic material within the nucleus of a cell; controls cell division and protein synthesis.</td></tr><tr><th scope="row" class="tb"><b>differentiation</b></th><td class="tb">Specialization of cells.</td></tr><tr><th scope="row" class="tb"><b>electron beams</b></th><td class="tb">Low-energy beams of radiation for treatment of skin or surface tumors.</td></tr><tr><th scope="row" class="tb"><b>encapsulated</b></th><td class="tb">Surrounded by a capsule; benign tumors are encapsulated.</td></tr><tr><th scope="row" class="tb"><b>external beam irradiation</b></th><td class="tb">Radiation is applied to a tumor from a source outside the body.</td></tr><tr><th scope="row" class="tb"><b>fractionation</b></th><td class="tb">Giving radiation in small, repeated doses.</td></tr><tr><th scope="row" class="tb"><b>genetic screening</b></th><td class="tb">Patients and family members are tested to determine whether they have inherited a cancer-causing gene.</td></tr><tr><th scope="row" class="tb"><b>grading of tumors</b></th><td class="tb">Evaluating the degree of maturity of tumor cells or degree of differentiation.</td></tr><tr><td class="tb_ralign" colspan="2">Table Continued</td></tr></tbody></table></div>

<div><span role="doc-pagebreak" epub:type="pagebreak" aria-label="767" id="pagebreak_767"/></div><div class="big_device"><table class="tbody"><tbody><tr><th scope="row" class="tb"><b>gray (Gy)</b></th><td class="tb">Unit of absorbed radiation dose.</td></tr><tr><th scope="row" class="tb"><b>gross description of tumors</b></th><td class="tb">Visual appearance of tumors to the naked eye: cystic, fungating, inflammatory, medullary, necrotic, polypoid, ulcerating, or verrucous.</td></tr><tr><th scope="row" class="tb"><b>immunotherapy</b></th><td class="tb">Cancer treatment using immune cells and antibodies to kill tumor cells; <b>CAR-T cell therapy</b> and <b>checkpoint inhibitors</b> are examples.</td></tr><tr><th scope="row" class="tb"><b>infiltrative</b></th><td class="tb">Extending beyond normal tissue boundaries into adjacent tissues.</td></tr><tr><th scope="row" class="tb"><b>invasive</b></th><td class="tb">Having the ability to enter and destroy surrounding tissue.</td></tr><tr><th scope="row" class="tb"><b>irradiation</b></th><td class="tb">Exposure to any form of radiant energy such as light, heat, or x-rays.</td></tr><tr><th scope="row" class="tb"><b>linear accelerator</b></th><td class="tb">Large electronic device that produces high-energy x-ray beams for treatment of deep-seated tumors.</td></tr><tr><th scope="row" class="tb"><b>malignant tumor</b></th><td class="tb">Tumor having the characteristics of continuous growth, invasiveness, and metastasis.</td></tr><tr><th scope="row" class="tb"><b>mesenchymal</b></th><td class="tb">Embryonic connective tissue (mes = middle, enchym/o = to pour). This is the tissue from which connective tissues (bone, muscle, fat, cartilage, and blood cells) arise.</td></tr><tr><th scope="row" class="tb"><b>metastasis</b></th><td class="tb">Spread of a malignant tumor to a secondary site; literally, beyond (meta-) control (-stasis).</td></tr><tr><th scope="row" class="tb"><b>microscopic description of tumors</b></th><td class="tb">Appearance of tumors when viewed under a microscope: alveolar, carcinoma in situ, diffuse, dysplastic, epidermoid, follicular, papillary, pleomorphic, scirrhous, or undifferentiated.</td></tr><tr><th scope="row" class="tb"><b>mitosis</b></th><td class="tb">Replication of cells; a stage in a cell’s life cycle involving the production of two identical cells from a parent cell.</td></tr><tr><th scope="row" class="tb"><b>mixed-tissue tumors</b></th><td class="tb">Tumors composed of different types of tissue (epithelial as well as connective tissue).</td></tr><tr><th scope="row" class="tb"><b>modality</b></th><td class="tb">Method of treatment, such as surgery, chemotherapy, or irradiation.</td></tr><tr><th scope="row" class="tb"><b>molecularly targeted therapy</b></th><td class="tb">Use of drugs to attack specific targets (mutations) that drive cancer cell growth.</td></tr><tr><th scope="row" class="tb"><b>monoclonal antibodies</b></th><td class="tb">These are antibodies created in a laboratory by special reproductive (cloning) techniques. They are designed to attack specific cancer cells directly or to activate T cells (or other effector cells) to kill the tumor.</td></tr><tr><th scope="row" class="tb"><b>morbidity</b></th><td class="tb">Condition of being unwell or deficient in normal function.</td></tr><tr><th scope="row" class="tb"><b>mucinous</b></th><td class="tb">Containing mucus (a thick whitish secretion).</td></tr><tr><th scope="row" class="tb"><b>mutation</b></th><td class="tb">Change in the genetic material (DNA) of a cell; may be caused by chemicals, radiation, or viruses or may occur spontaneously.</td></tr><tr><th scope="row" class="tb"><b>neoadjuvant chemotherapy</b></th><td class="tb">Drugs are given before primary therapy (surgery or radiation) to reduce the size of a tumor.</td></tr><tr><th scope="row" class="tb"><b>neoplasm</b></th><td class="tb">New growth; benign or malignant tumor.</td></tr><tr><th scope="row" class="tb"><b>nucleotide</b></th><td class="tb">Component of DNA (gene) including sugar, phosphate, and a base. The arrangement of nucleotides on a gene is the genetic code.</td></tr><tr><th scope="row" class="tb"><b>oncogene</b></th><td class="tb">Region of DNA (gene) in tumor cells that causes cancer. Oncogenes are designated by a three-letter name, such as <i>abl</i>, <i>erb</i>, <i>jun</i>, <i>myc</i>, <i>ras</i>, and <i>src</i>.</td></tr><tr><td class="tb_ralign" colspan="2">Table Continued</td></tr></tbody></table></div>

<div><span role="doc-pagebreak" epub:type="pagebreak" aria-label="768" id="pagebreak_768"/></div><div class="big_device"><table class="tbody"><tbody><tr><th scope="row" class="tb"><b>palliative</b></th><td class="tb">Relieving but not curing symptoms.</td></tr><tr><th scope="row" class="tb"><b>pedunculated</b></th><td class="tb">Possessing a stem or stalk (peduncle); characteristic of some polypoid tumors.</td></tr><tr><th scope="row" class="tb"><b>photon therapy</b></th><td class="tb">Radiation therapy using energy in the form of x-rays or gamma rays.</td></tr><tr><th scope="row" class="tb"><b>protocol</b></th><td class="tb">Detailed plan for treatment of an illness.</td></tr><tr><th scope="row" class="tb"><b>proton therapy</b></th><td class="tb">Subatomic positively charged particles (protons) produced by a cyclotron deposit a dose of radiation at a tightly focused point in the body.</td></tr><tr><th scope="row" class="tb"><b>radiation</b></th><td class="tb">Energy carried by a stream of particles.</td></tr><tr><th scope="row" class="tb"><b>radiation field</b></th><td class="tb">Area of the body undergoing irradiation.</td></tr><tr><th scope="row" class="tb"><b>radiation therapy</b></th><td class="tb">Treatment of tumors using doses of radiation; radiation oncology; radiotherapy.</td></tr><tr><th scope="row" class="tb"><b>radiocurable tumor</b></th><td class="tb">Tumor that is completely destroyed by radiation therapy. Early Hodgkin lymphoma is an example.</td></tr><tr><th scope="row" class="tb"><b>radioresistant tumor</b></th><td class="tb">Tumor that survives large doses of radiation.</td></tr><tr><th scope="row" class="tb"><b>radiosensitive tumor</b></th><td class="tb">Tumor for which radiation can cause the death of cells without serious damage to surrounding tissue.</td></tr><tr><th scope="row" class="tb"><b>radiosensitizers</b></th><td class="tb">Drugs that increase the sensitivity of tumors to x-rays.</td></tr><tr><th scope="row" class="tb"><b>radiotherapy</b></th><td class="tb">Treatment of tumors using doses of radiation; radiation therapy; radiation oncology.</td></tr><tr><th scope="row" class="tb"><b>relapse</b></th><td class="tb">Recurrence of tumor after treatment.</td></tr><tr><th scope="row" class="tb"><b>remission</b></th><td class="tb">Absence of signs and symptoms of disease (tumor).</td></tr><tr><th scope="row" class="tb"><b>ribonucleic acid (RNA)</b></th><td class="tb">Cellular substance that represents a copy of DNA and directs the formation of new protein inside cells.</td></tr><tr><th scope="row" class="tb"><b>sarcoma</b></th><td class="tb">Cancerous tumor derived from connective or flesh tissue.</td></tr><tr><th scope="row" class="tb"><b>serous</b></th><td class="tb">Having the appearance of a thin, watery fluid (serum).</td></tr><tr><th scope="row" class="tb"><b>sessile</b></th><td class="tb">Having no stem; characteristic of some polypoid tumors.</td></tr><tr><th scope="row" class="tb"><b>simulation</b></th><td class="tb">Study using CT scan or MRI to map the area to receive treatment before radiotherapy is given.</td></tr><tr><th scope="row" class="tb"><b>solid tumor</b></th><td class="tb">Tumor composed of a mass of cells.</td></tr><tr><th scope="row" class="tb"><b>staging of tumors</b></th><td class="tb">System of evaluating the extent of spread of tumors. An example is the TNM (tumor-node-metastasis) system.</td></tr><tr><th scope="row" class="tb"><b>stereotactic radiosurgery</b></th><td class="tb">Technique in which a single large dose of radiation is delivered under precise 3D guidance. The aim is to destroy small tumors, usually at a single site in the body.</td></tr><tr><th scope="row" class="tb"><b>surgical procedures to treat cancer</b></th><td class="tb">Methods of removing cancerous tissue: cryosurgery, cauterization, en bloc resection, excisional biopsy, exenteration, fulguration, incisional biopsy.</td></tr><tr><th scope="row" class="tb"><b>viral oncogenes</b></th><td class="tb">Pieces of DNA from viruses that, when mutated, cause normal cells to become malignant.</td></tr><tr><th scope="row" class="tb"><b>virus</b></th><td class="tb">Infectious agent that reproduces by entering a host cell and using the host’s genetic material to make copies of itself.</td></tr></tbody></table></div>

</div></div></div></aside></div><div class="textfl"><span role="doc-pagebreak" epub:type="pagebreak" aria-label="769" id="pagebreak_769"/><a id="pg769"/></div><div><aside aria-labelledby="b0025" epub:type="sidebar">

<div class="boxg1" id="b0025"><p/><div class="b1title" epub:type="title" id="title0030"><span class="icon1"><img src="../../IMAGES/B9780443107795000191/main.assets/icon04-9780443107795.jpg" alt="icon"/></span>Terminology</div><div class="b1textfl" id="bpar0070">Write the meanings of the medical terms in the spaces provided.</div><section><a id="boxsec0015"/><div class="b3_1hd" id="cesectitle0135">Combining Forms</div><div id="bpar0075"/><div><div class="pageavoid"><div class="big_device"><table id="t0075" class="tbody"><thead><tr><th scope="col" class="tcolhd1">COMBINING FORM</th><th scope="col" class="tcolhd1">MEANING</th><th scope="col" class="tcolhd1">TERMINOLOGY</th><th scope="col" class="tcolhd1">MEANING</th></tr></thead><tbody><tr><th scope="row" class="tb"><b>alveol/o</b></th><td class="tb">small sac</td><td class="tb" colspan="2"><div class="tb1"><span class="underline">alveol</span>ar ________________________________________</div><div class="tb1"><i>Microscopic description of tumor cell arrangement (found in connective tissue tumors).</i></div></td></tr><tr><th scope="row" class="tb"><b>cac/o</b></th><td class="tb">bad</td><td class="tb" colspan="2"><div class="tb1"><span class="underline">cac</span>hexia ________________________________________</div><div class="tb1"><i>General ill health and malnutrition (wasting of muscle and emaciation) associated with chronic, severe disease (-hexia means state or condition).</i></div></td></tr><tr><th scope="row" class="tb"><b>carcin/o</b></th><td class="tb">cancer, cancerous</td><td class="tb" colspan="2"><div class="tb1"><span class="underline">carcin</span>oma in situ _________________________________</div><div class="tb1"><i>Localized cancer; confined to the site of origin.</i></div></td></tr><tr><th scope="row" class="tb"><b>cauter/o</b></th><td class="tb">burn, heat</td><td class="tb" colspan="2">electro<span class="underline">cauter</span>ization _______________________________</td></tr><tr><th scope="row" class="tb"><b>chem/o</b></th><td class="tb">chemical, drug</td><td class="tb" colspan="2"><span class="underline">chem</span>otherapy ___________________________________</td></tr><tr><th scope="row" class="tb"><b>cry/o</b></th><td class="tb">cold</td><td class="tb" colspan="2"><span class="underline">cry</span>osurgery _____________________________________</td></tr><tr><th scope="row" class="tb"><b>cyst/o</b></th><td class="tb">sac of fluid</td><td class="tb" colspan="2"><span class="underline">cyst</span>ic tumor _____________________________________</td></tr><tr><th scope="row" class="tb"><b>fibr/o</b></th><td class="tb">fibers</td><td class="tb" colspan="2"><span class="underline">fibr</span>osarcoma ____________________________________</td></tr><tr><th scope="row" class="tb"><b>follicul/o</b></th><td class="tb">small glandular sacs</td><td class="tb" colspan="2"><div class="tb1"><span class="underline">follicul</span>ar _______________________________________</div><div class="tb1"><i>Microscopic description in glandular tumors.</i></div></td></tr><tr><th scope="row" class="tb"><b>fung/i</b></th><td class="tb">fungus, mushroom</td><td class="tb" colspan="2"><span class="underline">fung</span>ating tumor __________________________________</td></tr><tr><th scope="row" class="tb"><b>medull/o</b></th><td class="tb">soft, inner part</td><td class="tb" colspan="2"><span class="underline">medull</span>ary tumor _________________________________</td></tr><tr><th scope="row" class="tb"><b>mucos/o</b></th><td class="tb">mucous membrane</td><td class="tb" colspan="2"><span class="underline">mucos</span>itis _______________________________________</td></tr><tr><th scope="row" class="tb"><b>mut/a</b></th><td class="tb">genetic change</td><td class="tb" colspan="2"><div class="tb1"><span class="underline">mut</span>ation _______________________________________</div><div class="tb1"><i>-tion means process.</i></div></td></tr><tr><th scope="row" class="tb"><b>mutagen/o</b></th><td class="tb">causing genetic change</td><td class="tb" colspan="2"><span class="underline">mutagen</span>ic ______________________________________</td></tr><tr><th scope="row" class="tb"><b>necr/o</b></th><td class="tb">death</td><td class="tb" colspan="2"><span class="underline">necr</span>otic tumor ___________________________________</td></tr><tr><th scope="row" class="tb"><b>neur/o</b></th><td class="tb">nerve</td><td class="tb" colspan="2"><div class="tb1"><span class="underline">neuro</span>fibromatosis ________________________________</div><div class="tb1"><i>Fibromas are tumors of fibrous connective tissue. Tumors begin in supporting cells of nerves and the myelin sheath around nerve cells. Most tumors are benign, but some may become cancerous. It is a genetic disorder occurring in 1 in 3000 births, but some cases arise via spontaneous mutation.</i></div></td></tr><tr><td class="tb_ralign" colspan="4">Table Continued</td></tr></tbody></table></div>

<div><span role="doc-pagebreak" epub:type="pagebreak" aria-label="770" id="pagebreak_770"/></div><div class="big_device"><table class="tbody"><thead><tr><th scope="col" class="tcolhd1">COMBINING FORM</th><th scope="col" class="tcolhd1">MEANING</th><th scope="col" class="tcolhd1">TERMINOLOGY</th><th scope="col" class="tcolhd1">MEANING</th></tr></thead><tbody><tr><th scope="row" class="tb"><b>onc/o</b></th><td class="tb">tumor</td><td class="tb" colspan="2"><span class="underline">onc</span>ology _______________________________________</td></tr><tr><th scope="row" class="tb"><b>papill/o</b></th><td class="tb">nipple-like</td><td class="tb" colspan="2"><div class="tb1"><span class="underline">papill</span>ary <span class="icon1"><img src="../../IMAGES/B9780443107795000191/main.assets/icon01-9780443107795.jpg" alt="icon"/></span> ________________________________________</div><div class="tb1"><i>A microscopic description of tumor cell growth.</i></div></td></tr><tr><th scope="row" class="tb"><b>plas/o</b></th><td class="tb">formation</td><td class="tb" colspan="2"><div class="tb1">dys<span class="underline">plas</span>tic _______________________________________</div><div class="tb1"><i>Microscopic description of cells that are highly abnormal but not clearly cancerous. The suffix -tic means pertaining to.</i></div></td></tr><tr><th scope="row" class="tb"><b>ple/o</b></th><td class="tb">many, more</td><td class="tb" colspan="2"><div class="tb1"><span class="underline">ple</span>omorphic _____________________________________</div><div class="tb1"><i>Microscopic description of tumors that are composed of a variety of cells.</i></div></td></tr><tr><th scope="row" class="tb"><b>polyp/o</b></th><td class="tb">polyp</td><td class="tb" colspan="2"><div class="tb1"><span class="underline">polyp</span>oid tumor __________________________________</div><div class="tb1"><i>The suffix -oid means resembling.</i></div></td></tr><tr><th scope="row" class="tb"><b>prot/o</b></th><td class="tb">first</td><td class="tb" colspan="2"><div class="tb1"><span class="underline">prot</span>ocol ________________________________________</div><div class="tb1"><i>The ending -col, from Latin</i> kolla, <i>means glued page. A protocol is a written plan detailing the procedures to be followed in research or treatment.</i></div></td></tr><tr><th scope="row" class="tb"><b>radi/o</b></th><td class="tb">rays</td><td class="tb" colspan="2"><div class="tb1"><span class="underline">radi</span>ation _______________________________________</div><div class="tb1"><i>Use of radioactive substances in the diagnosis and treatment of disease. <b>Irradiation</b> is exposure to any form of radiation (ionizing, heat, light, or x-rays).</i></div></td></tr><tr><th scope="row" class="tb"><b>sarc/o</b></th><td class="tb">flesh, connective tissue</td><td class="tb" colspan="2">osteo<span class="underline">sarc</span>oma ____________________________________</td></tr><tr><th scope="row" class="tb"><b>scirrh/o</b></th><td class="tb">hard</td><td class="tb" colspan="2"><div class="tb1"><span class="underline">scirrh</span>ous _______________________________________</div><div class="tb1"><i>Microscopic description of densely packed, fibrous tumor cell composition.</i></div></td></tr><tr><th scope="row" class="tb"><b>xer/o</b></th><td class="tb">dry</td><td class="tb" colspan="2"><span class="underline">xer</span>ostomia ______________________________________</td></tr></tbody></table></div>

</div></div><div><aside aria-labelledby="b0030" epub:type="sidebar">

<div class="boxg1" id="b0030"><p/><div class="b1title" epub:type="title" id="title0035"><span class="icon1"><img src="../../IMAGES/B9780443107795000191/main.assets/icon02-9780443107795.jpg" alt="icon"/></span>Papillary Thyroid Cancer</div><div class="b1textfl" id="bpar0080">This is the most common type of thyroid cancer, affecting 80% of thyroid cancer patients. See <a href="#f0070" id="Bf0070">Figure 19-13</a>. Follicular, medullary, and anaplastic cancers of the thyroid gland are less common. Treatment may not be needed for small papillary cancers since they have low risk of spreading. Surgical treatment depends on the size, type, and stage of the cancer and includes thyroidectomy, thyroid lobectomy, and lymph node dissection (removal). Thyroid hormone therapy is used to replace thyroid hormones after surgery.</div></div></aside></div><div class="b1textfl"><span role="doc-pagebreak" epub:type="pagebreak" aria-label="771" id="pagebreak_771"/><a id="pg771"/></div><div class="pageavoid"><figure class="fig" id="f0070"><img src="../../IMAGES/B9780443107795000191/main.assets/f19-13-9780443107795.jpg" alt="Closeup of neck of a patient shows enlarged thyroid along with an enlargement at the right lateral side of the neck." class="box_img"/><figcaption class='figleg'><a id="cap0070"/><a id="fspara0070"/><span class="fignum"><a href="#Bf0070">FIGURE 19-13</a></span> <b>Papillary thyroid cancer.</b> A 30-year-old patient with papillary thyroid cancer along with lymph node metastases. <span class="figcredit">Copyright Dr. Chintamani, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.</span></figcaption></figure></div></section><section><a id="boxsec0020"/><div class="b3_1hd" id="cesectitle0140">Suffixes</div><div id="bpar0085"/><div><div class="pageavoid"><div class="big_device"><table id="t0080" class="tbody"><thead><tr><th scope="col" class="tcolhd1">SUFFIX</th><th scope="col" class="tcolhd1">MEANING</th><th scope="col" class="tcolhd1">TERMINOLOGY</th><th scope="col" class="tcolhd1">MEANING</th></tr></thead><tbody><tr><th scope="row" class="tb"><b>-blastoma</b></th><td class="tb">immature tumor</td><td class="tb" colspan="2"><div class="tb1">retino<span class="underline">blastoma</span> ___________________________________</div><div class="tb1"><i>Childhood cancer arising from immature cells in the retina (posterior, light-sensitive area of the eye).</i></div><div class="tb1">neuro<span class="underline">blastoma</span> ___________________________________</div><div class="tb1"><i>This sarcoma of nervous system origin affects infants and children up to the age of 10 years, usually arising in immature tissues of the autonomic nervous system or adrenal medulla.</i></div></td></tr><tr><th scope="row" class="tb"><b>-genesis</b></th><td class="tb">formation</td><td class="tb" colspan="2">carcino<span class="underline">genesis</span> ___________________________________</td></tr><tr><th scope="row" class="tb"><b>-oma</b></th><td class="tb">mass, tumor</td><td class="tb" colspan="2">adenocarcin<span class="underline">oma</span> __________________________________</td></tr><tr><th scope="row" class="tb"><b>-plasia</b></th><td class="tb">formation, growth</td><td class="tb" colspan="2">hyper<span class="underline">plasia</span> ______________________________________</td></tr><tr><th scope="row" class="tb"><b>-plasm</b></th><td class="tb">formation, growth</td><td class="tb" colspan="2">neo<span class="underline">plasm</span> _______________________________________</td></tr><tr><th scope="row" class="tb"><b>-suppression</b></th><td class="tb">to stop</td><td class="tb" colspan="2">myelo<span class="underline">suppression</span> ________________________________</td></tr><tr><th scope="row" class="tb"><b>-therapy</b></th><td class="tb">treatment</td><td class="tb" colspan="2"><div class="tb1">radio<span class="underline">therapy</span> ____________________________________</div><div class="tb1"><i>Ionizing radiation is used to treat malignancies.</i></div></td></tr></tbody></table></div>

</div></div></section><section><a id="boxsec0025"/><div class="b3_1hd" id="cesectitle0145">Prefixes</div><div id="bpar0090"/><div><div class="pageavoid"><div class="big_device"><table id="t0085" class="tbody"><thead><tr><th scope="col" class="tcolhd1">PREFIX</th><th scope="col" class="tcolhd1">MEANING</th><th scope="col" class="tcolhd1">TERMINOLOGY</th><th scope="col" class="tcolhd1">MEANING</th></tr></thead><tbody><tr><th scope="row" class="tb"><b>ana-</b></th><td class="tb">backward</td><td class="tb" colspan="2"><span class="underline">ana</span>plasia _______________________________________</td></tr><tr><th scope="row" class="tb"><b>apo-</b></th><td class="tb">off, away</td><td class="tb" colspan="2"><span class="underline">apo</span>ptosis _______________________________________</td></tr><tr><th scope="row" class="tb"><b>brachy-</b></th><td class="tb">short (distance)</td><td class="tb" colspan="2"><div class="tb1"><span class="underline">brachy</span>therapy ___________________________________</div><div class="tb1"><i>Radiation delivered in close range to tumor site.</i></div></td></tr><tr><th scope="row" class="tb"><b>epi-</b></th><td class="tb">upon</td><td class="tb" colspan="2"><div class="tb1"><span class="underline">epi</span>dermoid _____________________________________</div><div class="tb1"><i>Microscopic description of tumor cells that resemble epidermal tissue.</i></div></td></tr><tr><th scope="row" class="tb"><b>meta-</b></th><td class="tb">beyond; change</td><td class="tb" colspan="2"><span class="underline">meta</span>stasis ______________________________________</td></tr><tr><th scope="row" class="tb"><b>neo-</b></th><td class="tb">new</td><td class="tb" colspan="2"><div class="tb1"><span class="underline">neo</span>adjuvant _____________________________________</div><div class="tb1"><i>Adjuvant means to assist or aid.</i> <span class="icon1"><img src="../../IMAGES/B9780443107795000191/main.assets/icon01-9780443107795.jpg" alt="icon"/></span></div></td></tr><tr><th scope="row" class="tb"><b>tele-</b></th><td class="tb">far</td><td class="tb" colspan="2"><div class="tb1"><span class="underline">tele</span>therapy ______________________________________</div><div class="tb1"><i>Also called <b>external beam radiotherapy.</b></i></div></td></tr></tbody></table></div>

</div></div></section></div></aside></div><div><aside aria-labelledby="b0035" epub:type="sidebar">

<div class="boxg1" id="b0035"><p/><div class="b1title" epub:type="title" id="title0040"><span class="icon1"><img src="../../IMAGES/B9780443107795000191/main.assets/icon02-9780443107795.jpg" alt="icon"/></span>Neoadjuvant and Adjuvant</div><div class="b1textfl" id="bpar0095">Don’t confuse these terms. <b>Neoadjuvant drug therapy</b> is delivered <b>before</b> primary treatment, as a first step to shrink a tumor. <b>Adjuvant drug therapy</b> is given <b>after</b> primary treatment to kill possible hidden tumor cells.</div></div></aside></div><div class="textfl"><span role="doc-pagebreak" epub:type="pagebreak" aria-label="772" id="pagebreak_772"/><a id="pg772"/></div></section></section><section><a id="s0125"/><h2 class="h1hd" id="cesectitle0150">Laboratory Tests</h2><div id="p0610"/><div><div class="pageavoid"><div class="big_device"><table id="t0090" class="tbody"><tbody><tr><th scope="row" class="tb"><b>cytogenetic analysis</b></th><td class="tb" colspan="3"><div class="tb1"><b>Chromosomes of normal or tumor cells are examined for breaks, translocations, or deletions of DNA.</b></div><div class="tb1">The results of cytogenetic analysis can help confirm the diagnosis of a particular form of leukemia or other cancer.</div></td></tr><tr><th scope="row" class="tb"><b>immunohistochemistry</b></th><td class="tb" colspan="3"><div class="tb1"><b>Localization of antigens or proteins in tissues using labeled (colored or fluorescent) antibodies.</b></div><div class="tb1">This technique allows for evaluation of the presence and amount of specific molecules in normal and tumor cells.</div></td></tr><tr><th scope="row" class="tb" rowspan="11"><b>protein marker tests</b></th><td class="tb" colspan="3"><div class="tb1"><b>Measure the level of proteins in the blood or on the surface of tumor cells.</b></div><div class="tb1">These tests diagnose cancer or detect its recurrence after treatment. Examples are:</div></td></tr><tr><th scope="row" class="tb"><b>Protein</b></th><td class="tb"><b>Where Measured</b></td><td class="tb"><b>Type of Cancer</b></td></tr><tr><th scope="row" class="tb"><b>acid phosphatase</b></th><td class="tb">blood</td><td class="tb">prostate</td></tr><tr><th scope="row" class="tb"><b>alpha-fetoprotein (AFP)</b></th><td class="tb">blood</td><td class="tb">liver, testicular</td></tr><tr><th scope="row" class="tb"><b>beta-hCG (human chorionic gonadotropin)</b></th><td class="tb">blood</td><td class="tb">choriocarcinoma, testicular</td></tr><tr><th scope="row" class="tb"><b>CA-125</b></th><td class="tb">blood</td><td class="tb">ovarian</td></tr><tr><th scope="row" class="tb"><b>CEA (carcinoembryonic antigen)</b></th><td class="tb">blood</td><td class="tb">colorectal, GI</td></tr><tr><th scope="row" class="tb"><b>estrogen receptor</b></th><td class="tb">tumor cells</td><td class="tb">breast</td></tr><tr><th scope="row" class="tb"><b>PSA (prostate-specific antigen)</b></th><td class="tb">blood</td><td class="tb">prostate</td></tr><tr><th scope="row" class="tb"><b>15.3 and 29.7</b></th><td class="tb">blood</td><td class="tb">breast</td></tr><tr><th scope="row" class="tb"><b>19.9</b></th><td class="tb">blood</td><td class="tb">pancreatic</td></tr></tbody></table></div>

</div></div></section><section><a id="s0130"/><h2 class="h1hd" id="cesectitle0155">Clinical Procedures</h2><div class="textfl" id="p0615">The following specialized procedures are used to detect or treat malignancies. X-rays, CT scans, MRI, and ultrasound imaging (described throughout the text and specifically in <a href="../B9780443107795000208/CH0020_793-822_B9780443107795000208.xhtml">Chapter 20</a>) also are important diagnostic procedures in oncology.</div><div><div class="pageavoid"><div class="big_device"><table id="t0095" class="tbody"><tbody><tr><th scope="row" class="tb"><b>bone marrow biopsy</b></th><td class="tb"><b>Aspiration of bone marrow cells and removal of a core of bone marrow tissue that will be examined under a microscope for evidence of malignancy.</b></td></tr><tr><th scope="row" class="tb"><b>bone marrow or stem cell transplantation</b></th><td class="tb"><div class="tb1"><b>Bone marrow or stem cells are infused intravenously into a patient.</b></div><div class="tb1">In <b>autologous marrow transplantation,</b> marrow previously obtained from the patient and stored is reinfused after high-dose chemotherapy. In <b>allogeneic marrow transplantation</b> (all/o = other), marrow is obtained from a living donor. In <b>peripheral blood stem cell transplantation,</b> immature blood cells (stem cells) are selected and harvested from the blood instead of from the bone marrow. After undergoing chemotherapy, the patient gets a reinfusion of the stem cells to repopulate the bone marrow.</div></td></tr><tr><td class="tb_ralign" colspan="2">Table Continued</td></tr></tbody></table></div>

<div><span role="doc-pagebreak" epub:type="pagebreak" aria-label="773" id="pagebreak_773"/></div><div class="big_device"><table class="tbody"><tbody><tr><th scope="row" class="tb"><b>core needle biopsy</b></th><td class="tb"><div class="tb1"><b>Insertion of a large-bore needle into tissue to remove a core of cells for microscopic examination.</b></div><div class="tb1">A needle (aspiration) biopsy is the insertion of a fine needle and aspiration (extraction) of a sample from a fluid-filled cavity or solid mass of tumor.</div></td></tr><tr><th scope="row" class="tb"><b>exfoliative cytology</b></th><td class="tb"><div class="tb1"><b>Cells are scraped from the region of suspected disease and examined under a microscope.</b></div><div class="tb1">The Pap test (smear) to detect carcinoma of the cervix and vagina is an example.</div></td></tr><tr><th scope="row" class="tb"><b>fiberoptic colonoscopy</b></th><td class="tb"><div class="tb1"><b>Visual examination of the colon using a fiberoptic instrument.</b></div><div class="tb1">This is an important screening procedure using an endoscope to detect cancer and remove premalignant polyps.</div></td></tr><tr><th scope="row" class="tb"><b>laparoscopy</b></th><td class="tb"><div class="tb1"><b>Visual examination of the abdominal cavity using small incisions and a laparoscope.</b></div><div class="tb1">Also known as peritoneoscopy.</div></td></tr><tr><th scope="row" class="tb"><b>liquid biopsy</b></th><td class="tb"><div class="tb1"><b>Blood test to look for cancer cells or for pieces of DNA from cancer cells.</b></div><div class="tb1">A liquid biopsy may be used to detect cancer at an early stage or to find out how well treatment is working. There are significant differences between a liquid biopsy and a solid tissue biopsy. <span class="icon1"><img src="../../IMAGES/B9780443107795000191/main.assets/icon01-9780443107795.jpg" alt="icon"/></span></div></td></tr><tr><th scope="row" class="tb"><b>mammography</b></th><td class="tb"><b>X-ray examination of the breast to detect breast cancer.</b></td></tr><tr><td class="tb_ralign" colspan="2">Table Continued</td></tr></tbody></table></div>

<div><span role="doc-pagebreak" epub:type="pagebreak" aria-label="774" id="pagebreak_774"/></div><div class="big_device"><table class="tbody"><tbody><tr><th scope="row" class="tb"><b>PET-CT scan</b></th><td class="tb"><div class="tb1"><b>Diagnostic procedure combining CT (computed tomography) and PET (positron emission tomography).</b></div><div class="tb1">The combination provides a more complete picture of a tumor’s location, growth, and spread than either done independently. See <a href="#f0075">Figure 19-14</a>. PET-CT uses a combination of two machines: one to examine chemical reactions (PET scan) and the other to examine physical structures (CT scan). A <b>PET-MRI scan</b> incorporates magnetic resonance imaging (especially good for soft tissues) and positron emission tomography to reveal sites of tumor growth.</div></td></tr><tr><th scope="row" class="tb"><b>radionuclide scans</b></th><td class="tb"><div class="tb1"><b>Radioactive substances (radionuclides) are injected intravenously, and scans (images) of organs are obtained.</b></div><div class="tb1">These tests detect tumor and metastases. Examples of radionuclides are gallium-67 (whole-body scan), rose Bengal (liver), and technetium-99m (liver and spleen).</div></td></tr></tbody></table></div>

</div></div><div class="textfl"><a id="pg774"/></div><div><aside aria-labelledby="b0040" epub:type="sidebar">

<div class="boxg1" id="b0040"><p/><div class="b1title" epub:type="title" id="title0045"><span class="icon1"><img src="../../IMAGES/B9780443107795000191/main.assets/icon02-9780443107795.jpg" alt="icon"/></span>LIQUID BIOPSY vs TISSUE BIOPSY</div><div id="bpar0100"/><div><div class="pageavoid"><div class="big_device"><table id="t0100" class="tbody"><thead><tr><th scope="col" class="tcolhd1">LIQUID BIOPSY</th><th scope="col" class="tcolhd1">TISSUE BIOPSY</th></tr></thead><tbody><tr><th scope="row" class="tb"><b>Noninvasive blood test</b></th><td class="tb"><b>Invasive excision of tissue</b></td></tr><tr><th scope="row" class="tb"><ol id="ulist0110"><li class="tbulllist" id="bpar0105">• Easily obtained and repeated</li><li class="tbulllist" id="bpar0110">• Minimal pain/risk</li></ol></th><td class="tb"><ol id="ulist0115"><li class="tbulllist" id="bpar0115">• Not easily obtained and repeated
<ol id="ulist0120"><li class="tbulllist1" id="bpar0120">• Some pain/risk</li></ol></li></ol></td></tr><tr><th scope="row" class="tb"><b>Sampling of tumor components</b></th><td class="tb"><b>Microscopic analysis of tumor cells</b></td></tr><tr><th scope="row" class="tb"><ol id="ulist0125"><li class="tbulllist" id="bpar0125">• Circulating tumor cells (<b>CTC</b>)
<ol id="ulist0130"><li class="tbulllist1" id="bpar0130">• Circulating tumor DNA (<b>ctDNA</b>)
<ul id="ulist0135"><li class="tunnumlist2" id="bpar0135">Pieces of tumor DNA floating in</li><li class="tunnumlist2" id="bpar0140">blood plasma</li><li class="tunnumlist2" id="bpar0145">Example is <b>Guardant360 CDx</b></li></ul></li></ol></li></ol></th><td class="tb"/></tr><tr><th scope="row" class="tb"><b>Use</b></th><td class="tb"><b>Use</b></td></tr><tr><th scope="row" class="tb"><ol id="ulist0140"><li class="tbulllist" id="bpar0150">• Diagnose presence of tumor</li><li class="tbulllist" id="bpar0155">• Determine molecular targets for therapy</li><li class="tbulllist" id="bpar0160">• Detect relapse of tumor during therapy</li><li class="tbulllist" id="bpar0165">• Monitor evidence of metastatic disease</li></ol></th><td class="tb"><ol id="ulist0145"><li class="tbulllist" id="bpar0170">• Diagnosis from tumor cell sample</li><li class="tbulllist" id="bpar0175">• Determine molecular targets from analysis of genetic mutations in tumor cells</li><li class="tbulllist" id="bpar0180">• Detect relapse of tumor during therapy</li></ol></td></tr></tbody></table></div>

</div></div></div></aside></div><div class="textfl"><span role="doc-pagebreak" epub:type="pagebreak" aria-label="775" id="pagebreak_775"/><a id="pg775"/></div><div class="pageavoid"><figure class="fig" id="f0075"><img src="../../IMAGES/B9780443107795000191/main.assets/f19-14-9780443107795.jpg" alt="A whole body scan shows three orange spots under left armpit."/><figcaption class='figleg'><a id="cap0075"/><a id="fspara0075"/><span class="fignum"><a href="#Bf0075">FIGURE 19-14</a></span> <b>PET-CT scan.</b> The PET-CT scan shown captures three areas of increased radioactivity, seen in the lymph nodes of the left axilla (armpit). By overlaying PET and CT images, physicians can identify spread of malignancy or metastasis. Brain and heart activity are normal. <span class="figcredit">Courtesy Massachusetts General Hospital, Boston, Massachusetts.</span></figcaption></figure></div><div><aside aria-labelledby="b0045" epub:type="sidebar">

<div class="boxg1" id="b0045"><p/><div class="b1title" epub:type="title" id="title0050"><span class="icon1"><img src="../../IMAGES/B9780443107795000191/main.assets/icon07-9780443107795.jpg" alt="icon"/></span>Abbreviations</div><div id="bpar0185"/><div><div class="pageavoid"><table id="t0105" class="tbody"><tbody><tr><th scope="row" class="tb"><b>ADCs</b></th><td class="tb">antibody drug conjugates</td></tr><tr><th scope="row" class="tb"><b>AFP</b></th><td class="tb">alpha-fetoprotein</td></tr><tr><th scope="row" class="tb"><b>bcr</b></th><td class="tb">breakpoint cluster region (<i>bcr-abl</i> oncogene is a part of the Philadelphia chromosome associated with chronic myeloid leukemia)</td></tr><tr><th scope="row" class="tb"><b>BMT</b></th><td class="tb">bone marrow transplantation</td></tr><tr><th scope="row" class="tb"><b>bx</b></th><td class="tb">biopsy</td></tr><tr><th scope="row" class="tb"><b>CA</b></th><td class="tb">cancer</td></tr><tr><th scope="row" class="tb"><b>CAR-T cell</b></th><td class="tb">chimeric antigen receptor T cell</td></tr><tr><th scope="row" class="tb"><b>CEA</b></th><td class="tb">carcinoembryonic antigen</td></tr><tr><th scope="row" class="tb"><b>cGy</b></th><td class="tb">centigray (one hundredth of a gray) or rad</td></tr><tr><th scope="row" class="tb"><b>chemo</b></th><td class="tb">chemotherapy</td></tr><tr><th scope="row" class="tb"><b>CR</b></th><td class="tb">complete response—disappearance of all tumor</td></tr><tr><th scope="row" class="tb"><b>CSF</b></th><td class="tb">colony-stimulating factor—examples: G-CSF (granulocyte colony-stimulating factor) and GM-CSF (granulocyte-macrophage colony-stimulating factor)</td></tr><tr><th scope="row" class="tb"><b>CTC</b></th><td class="tb">circulating tumor cells</td></tr><tr><th scope="row" class="tb"><b>ctDNA</b></th><td class="tb">circulating tumor DNA</td></tr><tr><th scope="row" class="tb"><b>DNA</b></th><td class="tb">deoxyribonucleic acid</td></tr><tr><th scope="row" class="tb"><b>EGFR</b></th><td class="tb">epidermal growth factor receptor</td></tr><tr><th scope="row" class="tb"><b>ER</b></th><td class="tb">estrogen receptor</td></tr><tr><th scope="row" class="tb"><b>FNA</b></th><td class="tb">fine needle aspiration</td></tr><tr><th scope="row" class="tb"><b>5-FU</b></th><td class="tb">5-fluorouracil</td></tr><tr><th scope="row" class="tb"><b>GIST</b></th><td class="tb">gastrointestinal stromal tumor</td></tr><tr><th scope="row" class="tb"><b>Gy</b></th><td class="tb">gray—unit of absorbed radiation dose</td></tr><tr><th scope="row" class="tb"><b>H&amp;E</b></th><td class="tb">hematoxylin and eosin—dye combination used to stain cells</td></tr><tr><th scope="row" class="tb"><b>HER2</b></th><td class="tb">human epidermal growth factor receptor 2—growth factor gene activated in cells of certain types of breast cancer</td></tr><tr><th scope="row" class="tb"><b>IGRT</b></th><td class="tb">intensity-modulated gated radiation therapy—use of imaging mechanism attached to linear accelerator is added to IMRT to gate (track) a tumor moving during respiration</td></tr><tr><th scope="row" class="tb"><b>IHC</b></th><td class="tb">immunohistochemistry</td></tr><tr><th scope="row" class="tb"><b>IMRT</b></th><td class="tb">intensity-modulated radiation therapy—high doses of radiation are delivered directly to cancer cells in a targeted way, more precisely than in conventional radiotherapy</td></tr><tr><th scope="row" class="tb"><b>IO</b></th><td class="tb">immuno-oncology</td></tr><tr><th scope="row" class="tb"><b>IORT</b></th><td class="tb">intraoperative radiation therapy</td></tr><tr><th scope="row" class="tb"><b>mets</b></th><td class="tb">metastases</td></tr><tr><th scope="row" class="tb"><b>mAb (MAB)</b></th><td class="tb">monoclonal antibody; -mab indicates that a drug is a monoclonal antibody</td></tr><tr><th scope="row" class="tb"><b>NED</b></th><td class="tb">no evidence of disease</td></tr><tr><th scope="row" class="tb"><b>NF</b></th><td class="tb">neurofibromatosis</td></tr><tr><th scope="row" class="tb"><b>NHL</b></th><td class="tb">non-Hodgkin lymphoma</td></tr><tr><th scope="row" class="tb"><b>NSCLC</b></th><td class="tb">non–small cell lung cancer</td></tr><tr><th scope="row" class="tb"><b>Pap smear</b></th><td class="tb">Papanicolaou smear</td></tr><tr><th scope="row" class="tb"><b>PD</b></th><td class="tb">progressive disease</td></tr><tr><th scope="row" class="tb"><b>PET</b></th><td class="tb">positron emission tomography—radioactive forms of glucose tracer is used to find tumor location</td></tr><tr><th scope="row" class="tb"><b>PET-CT</b></th><td class="tb">combination of positron emission tomography plus computed tomography to locate areas of tumor growth</td></tr><tr><th scope="row" class="tb"><b>PET-MRI</b></th><td class="tb">combination of positron emission tomography plus magnetic resonance imaging to locate areas of tumor growth</td></tr><tr><th scope="row" class="tb"><b>PR</b></th><td class="tb">partial response</td></tr><tr><th scope="row" class="tb"><b>prot.</b></th><td class="tb">protocol</td></tr><tr><th scope="row" class="tb"><b>PSA</b></th><td class="tb">prostate-specific antigen</td></tr><tr><th scope="row" class="tb"><b>PSCT</b></th><td class="tb">peripheral stem cell transplantation</td></tr><tr><th scope="row" class="tb"><b>PSRS</b></th><td class="tb">proton stereotactic radiosurgery</td></tr><tr><th scope="row" class="tb"><b>RNA</b></th><td class="tb">ribonucleic acid</td></tr><tr><th scope="row" class="tb"><b>RT</b></th><td class="tb">radiation therapy</td></tr><tr><th scope="row" class="tb"><b>SD</b></th><td class="tb">stable disease—tumor does not shrink but does not grow</td></tr><tr><th scope="row" class="tb"><b>SRS</b></th><td class="tb">stereotactic radiosurgery</td></tr><tr><th scope="row" class="tb"><b>TNM</b></th><td class="tb">tumor-node-metastasis</td></tr><tr><th scope="row" class="tb"><b>VEGF</b></th><td class="tb">vascular endothelial growth factor</td></tr><tr><th scope="row" class="tb"><b>RT, XRT</b></th><td class="tb">radiation therapy</td></tr></tbody></table></div></div></div></aside></div><div class="textfl"><span role="doc-pagebreak" epub:type="pagebreak" aria-label="776" id="pagebreak_776"/><a id="pg776"/></div><div><aside aria-labelledby="b0050" epub:type="sidebar">

<div class="boxg1" id="b0050"><p/><div class="b1title" epub:type="title" id="title0055"><span class="icon1"><img src="../../IMAGES/B9780443107795000191/main.assets/icon09-9780443107795.jpg" alt="icon"/></span>In Person</div><div class="b1subt" role="doc-subtitle" epub:type="subtitle" id="subtitle0010">Radiotherapy</div><div id="bpar0190"/><div><div class="pageavoid"><figure class="fig" id="f0085"><img src="../../IMAGES/B9780443107795000191/main.assets/u19-01-9780443107795.jpg" alt="A photograph of Mary Braun." class="box_img"/><figcaption class='figleg'></figcaption></figure></div></div><div class="b1text" id="bpar0195"><i>This first-person narrative is by a woman who experienced radiation therapy for breast cancer.</i></div><div class="b1text" id="bpar0200">My life changed forever when I got that phone call that no one wants to hear: “Your biopsy is malignant.” So after they tell you that you have cancer, you are scared to death, begin to contemplate your mortality, and wonder how to break the news to your husband, children, loved ones, and friends. You settle down and marshal up your strength to fight this beast that attacks too many of us.</div><div class="b1text" id="bpar0205">After my biopsy, I met with a team that included my surgeon, my radiation oncologist, and my medical oncologist. It was decided that the best course of action was to perform a lumpectomy to remove the malignant tissue in my breast. At the same time, I would also have a sentinel node biopsy to check for lymphatic invasion. Surgery would be followed by a course of radiation therapy and then a 5-year regimen of the drug tamoxifen.</div><div class="b1text" id="bpar0210">Approximately 3 weeks after the surgery, I met with my radiation oncologist. She explained all the benefits and risks associated with radiation. At my first radiotherapy appointment, technicians created a mold to hold my breast in the exact position for treatment. I was marked on both sides of my body with indelible ink to place the mold correctly each visit. I also received a small permanent tattoo on the middle of my breastbone that enabled the machine to correctly target the beams.</div><div class="b1text" id="bpar0215">On my first day of treatment, as I walked into the radiation room, I noticed hundreds of molds for other patients stacked up against the wall. The technicians positioned me into my mold and calibrated the machine against the markings on my body. When all the bodily GPS settings were in sync, they scurried out of the room to stand behind the giant lead walls (the cowards). A giant circular radiation machine began to move closer, gyrating slowly back and forth until it was properly fixed. A pulse of light shot out and a humming sound began. The machine gradually rotated, sending radiation to my breast. The entire treatment session lasted less than 10 minutes.</div><div class="b1text" id="bpar0220">My side effects of radiation included fatigue and skin irritation from folliculitis (inflammation of hair follicles). Even after my treatments ended, side effects (blisters and even bleeding) continued. Time, however, brought healing.</div><div class="b1text" id="bpar0225">I am amazed at what my journey revealed. Most of all, it taught me about how wonderful friends can be, how much of a difference support groups can make, and why dedicated medical professionals deserve so much thanks and praise. A very lovely woman I met along the way shared some wisdom that I will pass along to all of you reading my story. She said, “At first cancer is your whole world, then it becomes a room, then it becomes a drawer in that room, and then it becomes a box in the drawer.” I still take that box out once in a while, but not as often.</div><div class="b1text" id="bpar0230"><i>Mary Braun is Vice President, Investments at Chapin Davis, Baltimore, Maryland.</i></div></div></aside></div><div class="textfl"><span role="doc-pagebreak" epub:type="pagebreak" aria-label="777" id="pagebreak_777"/><a id="pg777"/></div><div><aside aria-labelledby="b0055" epub:type="sidebar">

<div class="boxg1" id="b0055"><p/><div class="b1title" epub:type="title" id="title0060"><span class="icon1"><img src="../../IMAGES/B9780443107795000191/main.assets/icon08-9780443107795.jpg" alt="icon"/></span>Practical Applications</div><div class="b1textfl" id="bpar0235">Answers to questions are on <a href="#pg787">page 787</a>.</div><section><a id="boxsec5025"/><div class="b3_1hd" id="cesectitle0160">FYI: Other Malignant Tumors</div><div class="b1textfl" id="bpar0240">A number of malignant tumors do not contain the combining form carcin/o or sarc/o in their names:</div><div><div class="pageavoid"><table id="t0110" class="tbody"><thead><tr><th scope="col" class="tcolhd1">Malignant Tumor</th><th scope="col" class="tcolhd1">Description</th></tr></thead><tbody><tr><th scope="row" class="tb">glioma</th><td class="tb">primary brain tumor</td></tr><tr><th scope="row" class="tb">hepatoma</th><td class="tb">liver tumor (hepatocellular carcinoma)</td></tr><tr><th scope="row" class="tb">hypernephroma</th><td class="tb">kidney tumor</td></tr><tr><th scope="row" class="tb">lymphoma</th><td class="tb">lymph node tumor</td></tr><tr><th scope="row" class="tb">melanoma</th><td class="tb">tumor of pigmented skin cells</td></tr><tr><th scope="row" class="tb">mesothelioma</th><td class="tb">tumor of cells within the pleura</td></tr><tr><th scope="row" class="tb">multiple myeloma</th><td class="tb">bone marrow cell tumor</td></tr><tr><th scope="row" class="tb">thymoma</th><td class="tb">thymus gland tumor</td></tr></tbody></table></div></div><section><a id="boxsec0030"/><div class="b3_3hd" id="cesectitle0165">Questions about FYI: Other Malignant Tumors</div><div id="bpar0245"/><div><ul class="ce_list" id="olist0025"><li class="b1numlist" id="bpar0250"><a id="o0070"/>1. Which tumor develops from a dysplastic nevus? ______________________</li><li class="b1numlist" id="bpar0255"><a id="o0075"/>2. Which tumor arises from an organ located within the mediastinum? ______________________</li><li class="b1numlist" id="bpar0260"><a id="o0080"/>3. Which tumor arises from an organ in the RUQ of the abdomen? ______________________</li><li class="b1numlist" id="bpar0265"><a id="o0085"/>4. Which tumor has types called astrocytoma, ependymoma, glioblastoma multiforme? ______________________</li><li class="b1numlist" id="bpar0270"><a id="o0090"/>5. Which tumor is also known as a renal cell carcinoma? ______________________</li><li class="b1numlist" id="bpar0275"><a id="o0095"/>6. Which type of cancer contains large numbers of plasma cells (bone marrow antibody-producing cells)? _____________________</li><li class="b1numlist" id="bpar0280"><a id="o0100"/>7. Which tumor arises from membrane cells surrounding the lungs? ______________________</li><li class="b1numlist" id="bpar0285"><a id="o0105"/>8. Which tumor is derived from B cell lymphocytes? ______________________</li></ul></div><div class="b1textfl"><span role="doc-pagebreak" epub:type="pagebreak" aria-label="778" id="pagebreak_778"/><a id="pg778"/></div></section></section><section><a id="boxsec0035"/><div class="b3_1hd" id="cesectitle0170">Case Study: Suspected Breast Cancer</div><div class="b1textfl" id="bpar0290">A 52-year-old married woman presented to her physician with a painless mass in her left breast. During breast examination a 1.0-cm, firm, nontender mass was palpated in the upper outer quadrant located at the 2 o’clock position, 3 cm from the areola. The mass was not fixed to the skin, and there was no cutaneous erythema or edema. No axillary or supraclavicular lymphadenopathy was noted.</div><div class="b1text" id="bpar0295">An excisional biopsy of the mass was performed. The pathology report described a gross specimen of fatty breast tissue. Microscopic evaluation of the nodule revealed an invasive ductal carcinoma. The margins of the lumpectomy specimen were free of tumor. Sentinel node [first lymph node where cancer cells are likely to spread] biopsy revealed no tumor involvement.</div><div class="b1text" id="bpar0300">A portion of the specimen was sent for estrogen receptor assay and proved to be positive. The patient was informed of the diagnosis and underwent additional studies, including chest x-ray, liver chemistries, CBC, and bone scan; all results were negative.</div><div class="b1text" id="bpar0305">The patient’s tumor was staged as a T1N0M0, stage I carcinoma of the left breast. She was referred to a radiation oncologist for radiation therapy to the lumpectomy site. After completion of radiotherapy, she was treated with tamoxifen. Prognosis is excellent for cure.</div><section><a id="boxsec0040"/><div class="b3_3hd" id="cesectitle0175">Questions about the Case Study</div><div id="bpar0310"/><div><ul class="ce_list" id="olist0030"><li class="b1numlist" id="bpar0315"><a id="o0110"/>1. Where was the primary breast lesion located?</li><li class="b1numlist"><ul class="ce_list" id="olist0035"><li class="b1numlist1" id="bpar0320"><a id="o0115"/>a. Under the pigmented area of the breast</li><li class="b1numlist1" id="bpar0325"><a id="o0120"/>b. About an inch and a half above and to the left of the nipple and pigmented area</li><li class="b1numlist1" id="bpar0330"><a id="o0125"/>c. Near the axilla and under the shoulder blade</li></ul></li><li class="b1numlist" id="bpar0335"><a id="o0130"/>2. Other associated findings were</li><li class="b1numlist"><ul class="ce_list" id="olist0040"><li class="b1numlist1" id="bpar0340"><a id="o0135"/>a. Redness and swelling</li><li class="b1numlist1" id="bpar0345"><a id="o0140"/>b. Enlarged lymph nodes under the armpit</li><li class="b1numlist1" id="bpar0350"><a id="o0145"/>c. None of the above</li></ul></li><li class="b1numlist" id="bpar0355"><a id="o0150"/>3. What procedure gave evidence that the tumor had not yet metastasized?</li><li class="b1numlist"><ul class="ce_list" id="olist0045"><li class="b1numlist1" id="bpar0360"><a id="o0155"/>a. Estrogen receptor assay</li><li class="b1numlist1" id="bpar0365"><a id="o0160"/>b. Excisional biopsy of the mass</li><li class="b1numlist1" id="bpar0370"><a id="o0165"/>c. Sentinel node biopsy</li></ul></li><li class="b1numlist" id="bpar0375"><a id="o0170"/>4. What additional therapy was undertaken?</li><li class="b1numlist"><ul class="ce_list" id="olist0050"><li class="b1numlist1" id="bpar0380"><a id="o0175"/>a. Cytotoxic chemotherapy</li><li class="b1numlist1" id="bpar0385"><a id="o0180"/>b. Radiation to the breast</li><li class="b1numlist1" id="bpar0390"><a id="o0185"/>c. Radiation to the breast and then treatment with an estrogen blocker</li></ul></li><li class="b1numlist" id="bpar0395"><a id="o0190"/>5. Tamoxifen was prescribed because</li><li class="b1numlist"><ul class="ce_list" id="olist0055"><li class="b1numlist1" id="bpar0400"><a id="o0195"/>a. The tumor was found to be nonresponsive to estrogen.</li><li class="b1numlist1" id="bpar0405"><a id="o0200"/>b. The tumor had an estrogen receptor, and tamoxifen is an antiestrogen.</li><li class="b1numlist1" id="bpar0410"><a id="o0205"/>c. The tumor was at an advanced stage.</li></ul></li></ul></div><div class="b1textfl"><span role="doc-pagebreak" epub:type="pagebreak" aria-label="779" id="pagebreak_779"/><a id="pg779"/></div></section></section><section><a id="boxsec0045"/><div class="b3_1hd" id="cesectitle0180">Short Histories</div><div class="b1textfl" id="bpar0415">As you read these actual patient histories, congratulate yourself on your understanding of medical terms!</div><div><ul class="ce_list" id="olist0060"><li class="b1numlist" id="bpar0420"><a id="o0210"/>1. A 28-year-old man feels a hard, nontender mass in his right testicle. He goes to his doctor, who checks his serum human chorionic gonadotropin and alpha-fetoprotein levels and finds both to be quite elevated. The tentative diagnosis is a germ cell tumor of the testis. A CT scan of the abdomen reveals extensive lymphadenopathy along the aorta. A chest CT shows nodes in both lungs suggestive of tumor. An orchiectomy confirms the diagnosis of testicular cancer. He is given four cycles of chemotherapy with vinblastine, cisplatin, and bleomycin, and his serum AFP and HCG markers return to normal. His CT scans reveal no evidence of residual tumor.</li><li class="b1numlist" id="bpar0425"><a id="o0215"/>2. A 42-year-old woman notices repeated episodes of red blood in her stool with each bowel movement. A colonoscopy reveals a 4-cm mass arising from the wall of the rectum. A biopsy demonstrates a rectal adenocarcinoma. An abdominal CT shows two large metastases in the liver and enlarged lymph nodes. She first receives four cycles of 5-fluorouracil and oxaliplatin, which cause the liver lesions to shrink significantly and the lymph nodes to regress. The remaining liver lesions are surgically resected. Radiation therapy is then administered to shrink the rectal tumor and lymph nodes. A small residual tumor is resected. The lymph nodes are removed and contain no tumor.</li><li class="b1numlist" id="bpar0430"><a id="o0220"/>3. A 62-year-old man has a routine PSA blood sample drawn. PSA is elevated at 5.8 (normal is less than 4.0). A transrectal biopsy of the prostate reveals a Gleason grade 6 adenocarcinoma in 4 of 12 biopsy pieces. He chooses to be treated with brachytherapy. Treatment causes dysuria, cystitis, and proctitis, but these symptoms disappear 6 weeks after therapy ends, and his PSA is now undetectable.</li></ul></div></section></div></aside></div></section></section><div id="em0010"><div id="exmq0010"><div class="qtitle" id="cesectitle0185"><span class="icon1"><img src="../../IMAGES/B9780443107795000191/main.assets/icon10-9780443107795.jpg" alt="image"/></span>Exercises</div><div class="textfl" id="p0620">Remember to check your answers carefully with those given in the Answers to Exercises, <a href="#pg786">page 786</a>.<div id="olist0065"><div class="question" id="p0625"><a id="o0225"/><b>A Identify the following characteristics of malignant tumors based on their definitions as given below. Word parts are given as clues.</b><div id="olist0070"><div class="question2" id="p0630"><a id="o0230"/>1. loss of differentiation of cells and reversion to a more primitive cell type: ana ______________________</div><div class="question2" id="p0635"><a id="o0235"/>2. extending beyond the normal tissue boundaries: in ______________________</div><div class="question2" id="p0640"><a id="o0240"/>3. having the ability to enter and destroy surrounding tissue: in ______________________</div><div class="question2" id="p0645"><a id="o0245"/>4. spreading to a secondary site: meta ______________________</div></div><a id="pg780"/><span role="doc-pagebreak" epub:type="pagebreak" aria-label="780" id="pagebreak_780"/></div><div class="question" id="p0650"><a id="o0250"/><b>B Match the terms or abbreviations with the definitions/descriptions that follow.</b><div id="olist0075"><div class="question2" id="p0655"><a id="u0390"/>chemical carcinogen</div><div class="question2" id="p0660"><a id="u0395"/>DNA</div><div class="question2" id="p0665"><a id="u0400"/>mitosis</div><div class="question2" id="p0670"><a id="u0405"/>mutation</div><div class="question2" id="p0675"><a id="u0410"/>nucleotide</div><div class="question2" id="p0680"><a id="u0415"/>oncogene</div><div class="question2" id="p0685"><a id="u0420"/>radiation</div><div class="question2" id="p0690"><a id="u0425"/>RNA</div><div class="question2" id="p0695"><a id="u0430"/>virus</div><div class="question2" id="p0700"><a id="o0255"/>1. replication of cells; two identical cells are produced from a parent cell _________________________</div><div class="question2" id="p0705"><a id="o0260"/>2. change in the genetic material of a cell _________________________</div><div class="question2" id="p0710"><a id="o0265"/>3. genetic material within the nucleus that controls replication and protein synthesis _________________________</div><div class="question2" id="p0715"><a id="o0270"/>4. cellular substance (ribonucleic acid) that is important in protein synthesis _________________________</div><div class="question2" id="p0720"><a id="o0275"/>5. energy carried by a stream of particles _________________________</div><div class="question2" id="p0725"><a id="o0280"/>6. infectious agent that reproduces by entering a host cell and using the host’s genetic material to make copies of itself _________________________</div><div class="question2" id="p0730"><a id="o0285"/>7. region of genetic material found in tumor cells and in viruses that causes cancer _________________________</div><div class="question2" id="p0735"><a id="o0290"/>8. an agent (hydrocarbon, insecticide, hormone) that causes cancer _________________________</div><div class="question2" id="p0740"><a id="o0295"/>9. unit (component) of DNA composed of a sugar, phosphate, and base _______________________________</div></div></div><div class="question" id="p0745"><a id="o0300"/><b>C Give the meanings of the following terms.</b><div id="olist0080"><div class="question2" id="p0750"><a id="o0305"/>1. solid tumor ____________________________________________________________________</div><div class="question2" id="p0755"><a id="o0310"/>2. adenoma ______________________________________________________________________</div><div class="question2" id="p0760"><a id="o0315"/>3. adenocarcinoma _________________________________________________________________</div><div class="question2" id="p0765"><a id="o0320"/>4. osteoma _______________________________________________________________________</div><div class="question2" id="p0770"><a id="o0325"/>5. osteosarcoma _______________________________________________________________</div><div class="question2" id="p0775"><a id="o0330"/>6. mixed-tissue tumor _______________________________________________________________</div><div class="question2" id="p0780"><a id="o0335"/>7. neoplasm _______________________________________________________________________</div><div class="question2" id="p0785"><a id="o0340"/>8. neurofibromatosis ________________________________________________________________</div><div class="question2" id="p0790"><a id="o0345"/>9. benign _________________________________________________________________________</div><div class="question2a" id="p0795"><a id="o0350"/>10. differentiation __________________________________________________________________</div></div><a id="pg781"/><span role="doc-pagebreak" epub:type="pagebreak" aria-label="781" id="pagebreak_781"/></div><div class="question" id="p0800"><a id="o0355"/><b>D Name the terms that describe tumor growth as seen through a microscope. Definitions and word parts are given.</b><div id="olist0085"><div class="question2" id="p0805"><a id="o0360"/>1. small nipple-like projections: pap ________________________</div><div class="question2" id="p0810"><a id="o0365"/>2. abnormal formation of cells: dys ________________________</div><div class="question2" id="p0815"><a id="o0370"/>3. localized growth of cells: carcin ________________________</div><div class="question2" id="p0820"><a id="o0375"/>4. densely packed; containing fibrous tissue: ________________________ous</div><div class="question2" id="p0825"><a id="o0380"/>5. pattern resembling small, microscopic sacs: alv ________________________</div><div class="question2" id="p0830"><a id="o0385"/>6. small, round, gland-type clusters: foll ________________________</div><div class="question2" id="p0835"><a id="o0390"/>7. variety of cell types: pleo ________________________</div><div class="question2" id="p0840"><a id="o0395"/>8. lacking structures typical of mature cells: un ________________________</div><div class="question2" id="p0845"><a id="o0400"/>9. spreading evenly throughout the tissue: di ________________________</div><div class="question2a" id="p0850"><a id="o0405"/>10. resembling epithelial cells: epiderm ________________________</div></div></div><div class="question" id="p0855"><a id="o0410"/><b>E Match the gross descriptions of tumors with the descriptions/definitions that follow.</b><div id="olist0090"><div class="question2" id="p0860"><a id="u0435"/>cystic</div><div class="question2" id="p0865"><a id="u0440"/>fungating</div><div class="question2" id="p0870"><a id="u0445"/>inflammatory</div><div class="question2" id="p0875"><a id="u0450"/>medullary</div><div class="question2" id="p0880"><a id="u0455"/>necrotic</div><div class="question2" id="p0885"><a id="u0460"/>polypoid</div><div class="question2" id="p0890"><a id="u0465"/>ulcerating</div><div class="question2" id="p0895"><a id="u0470"/>verrucous</div><div class="question2" id="p0900"><a id="o0415"/>1. Containing dead tissue: ________________________</div><div class="question2" id="p0905"><a id="o0420"/>2. Mushrooming pattern of growth: tumor cells pile on top of each other: _______________________</div><div class="question2" id="p0910"><a id="o0425"/>3. Characterized by large, open, exposed surfaces: ________________________</div><div class="question2" id="p0915"><a id="o0430"/>4. Characterized by redness, swelling, and heat: ________________________</div><div class="question2" id="p0920"><a id="o0435"/>5. Growths are projections from a base; sessile and pedunculated tumors are examples: ________________________</div><div class="question2" id="p0925"><a id="o0440"/>6. Tumors form large, open spaces filled with fluid; serous and mucinous tumors are examples: ________________________</div><div class="question2" id="p0930"><a id="o0445"/>7. Tumors resemble wart-like growths: ________________________</div><div class="question2" id="p0935"><a id="o0450"/>8. Tumors are large, soft, and fleshy: ________________________</div></div><a id="pg782"/><span role="doc-pagebreak" epub:type="pagebreak" aria-label="782" id="pagebreak_782"/></div><div class="question" id="p0940"><a id="o0455"/><b>F Circle or supply the appropriate medical terms.</b><div id="olist0095"><div class="question2" id="p0945"><a id="o0460"/>1. A <b>(carcinoma/sarcoma)</b> is a cancerous tumor composed of cells of epithelial tissue. An example of such a cancerous tumor is a/an ____________________________________.</div><div class="question2" id="p0950"><a id="o0465"/>2. A <b>(carcinoma/sarcoma)</b> is a cancerous tumor composed of connective tissue. An example of such a cancerous tumor is a/an ______________________________________.</div><div class="question2" id="p0955"><a id="o0470"/>3. Retinoblastoma and adenomatous polyposis coli syndrome are examples of <b>(chemical carcinogens/inherited cancers).</b></div><div class="question2" id="p0960"><a id="o0475"/>4. The assessment of a tumor’s degree of maturity or microscopic differentiation is <b>(grading/staging)</b> of the tumor.</div><div class="question2" id="p0965"><a id="o0480"/>5. The assessment of a tumor’s extent of spread within the body is known as <b>(grading/staging).</b></div><div class="question2" id="p0970"><a id="o0485"/>6. In the TNM staging system, T stands for <b>(tissue/tumor)</b>, N stands for <b>(node/necrotic)</b>, and M stands for <b>(mitotic/metastasis).</b></div><div class="question2" id="p0975"><a id="o0490"/>7. Loss of differentiation of cells is called <b>(hyperplasia/anaplasia).</b></div><div class="question2" id="p0980"><a id="o0495"/>8. Programmed call death is known as <b>(apoptosis/carcinogenesis).</b></div></div></div><div class="question" id="p0985"><a id="o0500"/><b>G Match the surgical procedure in Column I with its meaning in Column II. Write the letter of the meaning in the space provided.</b><div>

<div class="pageavoid"><div class="big_device"><table id="t0115" class="tbody"><thead><tr><th class="tcolhd1">COLUMN I</th><td class="tcolhd1"/><th class="tcolhd1">COLUMN II</th></tr></thead><tbody><tr><td class="tb"><ul id="olist0100"><li class="tnumlist2" id="p0990">1. fulguration</li></ul></td><td class="tb">_______</td><td class="tb" rowspan="7"><ul id="olist0105"><li class="tnumlist2" id="p0995">A. Removal of tumor and a margin of normal tissue for diagnosis and possible cure of small tumors</li><li class="tnumlist2" id="p1000">B. Burning a lesion to destroy tumor cells</li><li class="tnumlist2" id="p1005">C. Wide resection involving removal of tumor, its organ of origin, and surrounding tissue in the body space</li><li class="tnumlist2" id="p1010">D. Destruction of tissue by electric sparks generated by a high-frequency current</li><li class="tnumlist2" id="p1015">E. Removal of entire tumor and regional lymph nodes</li><li class="tnumlist2" id="p1020">F. Freezing a lesion to kill tumor cells</li><li class="tnumlist2" id="p1025">G. Cutting into a tumor and removing a piece to establish a diagnosis</li></ul></td></tr><tr><td class="tb"><ul id="olist0110"><li class="tnumlist2" id="p1030">2. en bloc resection</li></ul></td><td class="tb">_______</td></tr><tr><td class="tb"><ul id="olist0115"><li class="tnumlist2" id="p1035">3. incisional biopsy</li></ul></td><td class="tb">_______</td></tr><tr><td class="tb"><ul id="olist0120"><li class="tnumlist2" id="p1040">4. excisional biopsy</li></ul></td><td class="tb">_______</td></tr><tr><td class="tb"><ul id="olist0125"><li class="tnumlist2" id="p1045">5. cryosurgery</li></ul></td><td class="tb">_______</td></tr><tr><td class="tb"><ul id="olist0130"><li class="tnumlist2" id="p1050">6. cauterization</li></ul></td><td class="tb">_______</td></tr><tr><td class="tb"><ul id="olist0135"><li class="tnumlist2" id="p1055">7. exenteration</li></ul></td><td class="tb">_______</td></tr></tbody></table></div>

</div>

</div></div><div class="question" id="p1060"><a id="o0575"/><b>H Supply medical terms to complete the following sentences.</b><div id="olist0140"><div class="question2" id="p1065"><a id="o0580"/>1. The method of treating cancer using high-energy radiation is __________________________.</div><div class="question2" id="p1070"><a id="o0585"/>2. If tumor tissue survives large doses of radiation, it is a/an __________________________ tumor.</div><div class="question2" id="p1075"><a id="o0590"/>3. If radiation can cause loss of tumor cells without serious damage to surrounding regions, the tumor is __________________________.</div><div class="question2" id="p1080"><a id="o0595"/>4. A tumor that is completely destroyed by RT is a/an __________________________ tumor.</div><div class="question2" id="p1085"><a id="o0600"/>5. The method of giving radiation in small, repeated doses is __________________________.</div><div class="question2" id="p1090"><a id="o0605"/>6. Drugs that increase the sensitivity of tumors to x-rays are __________________________.</div><div class="question2" id="p1095"><a id="o0610"/>7. Treatment of cancerous tumors with drugs is __________________________.</div><div class="question2" id="p1100"><a id="o0615"/>8. A condition of tumors of fibrous supportive nerve cells is _________________.<a id="pg783"/><span role="doc-pagebreak" epub:type="pagebreak" aria-label="783" id="pagebreak_783"/></div><div class="question2" id="p1105"><a id="o0620"/>9. The use of two or more drugs to kill tumor cells is __________________________.</div><div class="question2a" id="p1110"><a id="o0625"/>10. A large electronic device that produces high-energy x-ray or photon beams for treatment of deep-seated tumors is a/an __________________________.</div><div class="question2a" id="p1115"><a id="o0630"/>11. Alkylating agents, antimetabolites, hormones, antibiotics, and antimitotics all are types of __________________________ agents.</div><div class="question2a" id="p1120"><a id="o0635"/>12. Implantation of seeds of radioactive material directly into a tumor is ______________________.</div><div class="question2a" id="p1125"><a id="o0640"/>13. The unit of absorbed radiation dose is __________________________.</div><div class="question2a" id="p1130"><a id="o0645"/>14. Radiation applied to a tumor from a distant source is __________________________.</div><div class="question2a" id="p1135"><a id="o0650"/>15. Technique in which subatomic positively charged particles produced by a cyclotron deposit a dose of radiation at a tightly focused point is __________________________.</div><div class="question2a" id="p1140"><a id="o0655"/>16. The dimension of the area of the body that receives radiation is a/an ______________________.</div><div class="question2a" id="p1145"><a id="o0660"/>17. Study performed using CT or MRI to map the area to receive treatment before radiotherapy is given is __________________________.</div><div class="question2a" id="p1150"><a id="o0665"/>18. Technique in which a single large dose of radiation is delivered under precise 3D guidance to destroy vascular abnormalities and small brain tumors is __________________________.</div></div></div><div class="question" id="p1155"><a id="o0670"/><b>I Match the side effects of radiotherapy and chemotherapy with the descriptions/treatments that follow.</b><div id="olist0145"><div class="question2" id="p1160"><a id="u0475"/>alopecia</div><div class="question2" id="p1165"><a id="u0480"/>cystitis and proctitis</div><div class="question2" id="p1170"><a id="u0485"/>desquamation</div><div class="question2" id="p1175"><a id="u0490"/>fibrosis</div><div class="question2" id="p1180"><a id="u0495"/>infertility</div><div class="question2" id="p1185"><a id="u0500"/>myelosuppression</div><div class="question2" id="p1190"><a id="u0505"/>nausea</div><div class="question2" id="p1195"><a id="u0510"/>oral mucositis</div><div class="question2" id="p1200"><a id="u0515"/>pneumonitis</div><div class="question2" id="p1205"><a id="u0520"/>secondary tumors</div><div class="question2" id="p1210"><a id="u0525"/>xerostomia</div><div class="question2" id="p1215"><a id="o0675"/>1. Inflammation and ulceration of lining cells in the mouth caused by radiation to the jaw: _______________________</div><div class="question2" id="p1220"><a id="o0680"/>2. Radiation to the lungs causes inflammation of the lungs: ________________________</div><div class="question2" id="p1225"><a id="o0685"/>3. Chemotherapy for ovarian cancer causes loss of hair on the head: ________________________</div><div class="question2" id="p1230"><a id="o0690"/>4. Bone marrow depression with leukopenia, anemia, and thrombocytopenia: ________________________</div><div class="question2" id="p1235"><a id="o0695"/>5. Radiation to the lungs causes increase in connective tissue: ________________________</div><div class="question2" id="p1240"><a id="o0700"/>6. Radiation of salivary glands causes dryness of the mouth: ________________________</div><div class="question2" id="p1245"><a id="o0705"/>7. Chemotherapy may cause this sensation leading to vomiting: ________________________</div><div class="question2" id="p1250"><a id="o0710"/>8. New type of growths in separate sites from the primary tumor: ______________________</div><div class="question2" id="p1255"><a id="o0715"/>9. Loss of reproductive function: ________________________</div><div class="question2" id="p1260"><a id="o0720"/>10. Radiation effects on the urinary bladder and rectum: ________________________</div><div class="question2" id="p1265"><a id="o0725"/>11. Loss of skin over an irradiated area: ______________________________________</div></div><a id="pg784"/><span role="doc-pagebreak" epub:type="pagebreak" aria-label="784" id="pagebreak_784"/></div><div class="question" id="p1270"><a id="o0730"/><b>J Match the term in Column I with its meaning in Column II. Write the letter of the meaning in the space provided.</b></div><div id="p1275"><div>

<div class="pageavoid"><div class="big_device"><table id="t0120" class="tbody"><thead><tr><th class="tcolhd1">COLUMN I</th><td class="tcolhd1"/><th class="tcolhd1">COLUMN II</th></tr></thead><tbody><tr><td class="tb"><ul id="olist0150"><li class="tnumlist2" id="p1280">1. apoptosis</li></ul></td><td class="tb">_______</td><td class="tb"><ul id="olist0155"><li class="tnumlist2" id="p1285">A. Method of treatment</li></ul></td></tr><tr><td class="tb"><ul id="olist0160"><li class="tnumlist2" id="p1290">2. cachexia</li></ul></td><td class="tb">_______</td><td class="tb"><ul id="olist0165"><li class="tnumlist2" id="p1295">B. Report or plan of steps taken in an experiment or disease case</li></ul></td></tr><tr><td class="tb"><ul id="olist0170"><li class="tnumlist2" id="p1300">3. modality</li></ul></td><td class="tb">_______</td><td class="tb"><ul id="olist0175"><li class="tnumlist2" id="p1305">C. Absence of all signs of disease</li></ul></td></tr><tr><td class="tb"><ul id="olist0180"><li class="tnumlist2" id="p1310">4. morbidity</li></ul></td><td class="tb">_______</td><td class="tb"><ul id="olist0185"><li class="tnumlist2" id="p1315">D. Symptoms of disease return</li></ul></td></tr><tr><td class="tb"><ul id="olist0190"><li class="tnumlist2" id="p1320">5. palliative</li></ul></td><td class="tb">_______</td><td class="tb"><ul id="olist0195"><li class="tnumlist2" id="p1325">E. Conditions of damage (disease) to normal tissue</li></ul></td></tr><tr><td class="tb"><ul id="olist0200"><li class="tnumlist2" id="p1330">6. protocol</li></ul></td><td class="tb">_______</td><td class="tb"><ul id="olist0205"><li class="tnumlist2" id="p1335">F. Programmed cell death</li></ul></td></tr><tr><td class="tb"><ul id="olist0210"><li class="tnumlist2" id="p1340">7. relapse</li></ul><ul id="olist0215"><li class="tnumlist2" id="p1345">8. remission</li></ul></td><td class="tb">______________</td><td class="tb"><ul id="olist0220"><li class="tnumlist2" id="p1350">G. Malnutrition marked by weakness and emaciation; usually associated with later stages of cancer</li></ul></td></tr><tr><td class="tb"/><td class="tb"/><td class="tb"><ul id="olist0225"><li class="tnumlist2" id="p1355">H. Relieving but not curing symptoms of disease</li></ul></td></tr></tbody></table></div>

</div>

</div></div><div class="question" id="p1360"><a id="o0815"/><b>K Match the test or procedure with its description/definition.</b><div id="olist0230"><div class="question2" id="p1365"><a id="u0530"/>beta-hCG test</div><div class="question2" id="p1370"><a id="u0535"/>bone marrow biopsy</div><div class="question2" id="p1375"><a id="u0540"/>CA-125</div><div class="question2" id="p1380"><a id="u0545"/>CEA test</div><div class="question2" id="p1385"><a id="u0550"/>core needle biopsy</div><div class="question2" id="p1390"><a id="u0555"/>estrogen receptor assay</div><div class="question2" id="p1395"><a id="u0560"/>exfoliative cytology</div><div class="question2" id="p1400"><a id="u0565"/>laparoscopy</div><div class="question2" id="p1405"><a id="u0570"/>PSA test</div><div class="question2" id="p1410"><a id="u0575"/>stem cell transplant</div><div class="question2" id="p1415"><a id="o0820"/>1. test for the presence of a portion of human chorionic gonadotropin hormone (a marker for testicular cancer) ________________________</div><div class="question2" id="p1420"><a id="o0825"/>2. protein marker for ovarian cancer detected in the blood ________________________</div><div class="question2" id="p1425"><a id="o0830"/>3. visual examination of the abdominal cavity; peritoneoscopy ________________________</div><div class="question2" id="p1430"><a id="o0835"/>4. test for the presence of a hormone receptor on breast cancer cells ________________________</div><div class="question2" id="p1435"><a id="o0840"/>5. removal of bone marrow tissue for microscopic examination ________________________</div><div class="question2" id="p1440"><a id="o0845"/>6. obtaining a plug of tissue for microscopic examination ________________________</div><div class="question2" id="p1445"><a id="o0850"/>7. blood test for the presence of an antigen related to prostate cancer ________________________</div><div class="question2" id="p1450"><a id="o0855"/>8. blood test for carcinoembryonic antigen (marker for GI cancer) ________________________</div><div class="question2" id="p1455"><a id="o0860"/>9. cells are scraped off tissue and microscopically examined ________________________</div><div class="question2" id="p1460"><a id="o0865"/>10. an intravenous infusion of blood-forming cells ________________________</div></div></div><div class="question" id="p1465"><a id="u0580"/><b>L Complete the following sentences with terms related to cancer treatment:</b><div id="olist0235"><div class="question2" id="p1470"><a id="o0870"/>1. Assisting primary treatment with drug therapy is called: _____________chemotherapy.</div><div class="question2" id="p1475"><a id="o0875"/>2. Using drugs to reduce size of a tumor before surgery is: ____________chemotherapy.</div><div class="question2" id="p1480"><a id="o0880"/>3. Test to determine if a patient has an inherited cancer-causing gene is: genetic __________.</div><div class="question2" id="p1485"><a id="o0885"/>4. A treatment applied to a tumor from a source outside the body is: external beam _________.</div><div class="question2" id="p1490"><a id="o0890"/>5. A cancer treatment using antibodies (T cell lymphocytes) is called: ___________________.<a id="pg785"/><span role="doc-pagebreak" epub:type="pagebreak" aria-label="785" id="pagebreak_785"/></div><div class="question2" id="p1495"><a id="o0895"/>6. Drug treatment to attack specific mutations in cancer cells is: _________________ therapy.</div><div class="question2" id="p1500"><a id="o0900"/>7. A blood test to look for cancer cells or pieces of floating DNA is a __________biopsy.</div></div></div><div class="question" id="p1505"><a id="o0905"/><span class="icon1"><img src="../../IMAGES/B9780443107795000191/main.assets/icon16-9780443107795.jpg" alt="image"/></span> <b>M Circle the correct boldface terms to complete the sentences.</b><div id="olist0240"><div class="question2" id="p1510"><a id="o0910"/>1. Following a head CT scan, Pauline was diagnosed with a meningioma, which usually is a/an <b>(benign, anaplastic, necrotic</b>) tumor. The doctor explained that it was not malignant but that it should be removed because of the pressure it was causing on surrounding tissues.</div><div class="question2" id="p1515"><a id="o0915"/>2. Marlene underwent surgical resection of a breast mass. After surgery, Dr. Mendez recommended <b>(dedifferentiated, modality, adjuvant)</b> chemotherapy because the tumor had spread to a lymph node.</div><div class="question2" id="p1520"><a id="o0920"/>3. Sam had a lung cancer diagnosis with tumor spread to the liver. After testing the tumor cells for mutations, the oncologist recommended beginning <b>(irradiation, surgery, molecularly targeted drug therapy)</b>.</div><div class="question2" id="p1525"><a id="o0925"/>4. The polyp in Lisa’s colon was <i>not</i> pedunculated, and Dr. Sidney described it as flat and <b>(fungating, scirrhous, sessile)</b>.</div><div class="question2" id="p1530"><a id="o0930"/>5. Mr. Elder had difficulty urinating and had an elevated PSA blood level. Dr. Jones did a digital rectal exam and found a hard prostate mass. A needle <b>(laparoscopy, electrocauterization, biopsy)</b> demonstrated adenocarcinoma.</div><div class="question2" id="p1535"><a id="o0935"/>6. During the days following chemotherapy for breast cancer, Mrs. Yang experienced loss of appetite and fever. Blood tests revealed low levels of all blood cells, indicating chemotherapy-induced <b>(hematopoiesis, myeloma, myelosuppression)</b>.</div><div class="question2" id="p1540"><a id="o0940"/>7. One year after diagnosis and treatment for lung cancer, Mr. Smith underwent follow-up <b>(bone marrow biopsy, PET-CT scan, exfoliative cytology)</b>, which enabled doctors to <b>(restage, regrade)</b> the disease and give Mr. Smith the good news that the disease was in <b>(remission, relapse)</b>.</div><div class="question2" id="p1545"><a id="o0945"/>8. Because Mrs. Broom’s brain tumor recurred after surgery, doctors recommended <b>(CA-125, RT, PSA)</b>.</div><div class="question2" id="p1550"><a id="o0950"/>9. Mr. Jones has melanoma that will be treated with a type of immunotherapy called <b>(brachytherapy, radical mastectomy, checkpoint inhibitor)</b>.</div><div class="question2a" id="p1555"><a id="o0955"/>10. CAR-T cell therapy is indicated for <b>(auto accidents, relapsed ALL, fluid overload).</b> It is an an effective form of <b>(chemotherapy, radiotherapy, immunotherapy)</b>.</div></div></div></div><a id="pg786"/><span role="doc-pagebreak" epub:type="pagebreak" aria-label="786" id="pagebreak_786"/></div></div><div id="exma0010"><div class="anstitle" id="cesectitle0190">Answers to Exercises</div><a id="s0135"/><a id="cesectitle0195"/>A<div class="textfl" id="p1560"><div id="olist0245"><div class="answer" id="p1565"><a id="o0960"/>1. anaplasia</div><div class="answer" id="p1570"><a id="o0965"/>2. infiltrative</div><div class="answer" id="p1575"><a id="o0970"/>3. invasive</div><div class="answer" id="p1580"><a id="o0975"/>4. metastasis</div></div></div><a id="s0140"/><a id="cesectitle0200"/>B<div class="textfl" id="p1585"><div id="olist0250"><div class="answer" id="p1590"><a id="o0980"/>1. mitosis</div><div class="answer" id="p1595"><a id="o0985"/>2. mutation</div><div class="answer" id="p1600"><a id="o0990"/>3. DNA</div><div class="answer" id="p1605"><a id="o0995"/>4. RNA</div><div class="answer" id="p1610"><a id="o1000"/>5. radiation</div><div class="answer" id="p1615"><a id="o1005"/>6. virus</div><div class="answer" id="p1620"><a id="o1010"/>7. oncogene</div><div class="answer" id="p1625"><a id="o1015"/>8. chemical carcinogen</div><div class="answer" id="p1630"><a id="o1020"/>9. nucleotide</div></div></div><a id="s0145"/><a id="cesectitle0205"/>C<div class="textfl" id="p1635"><div id="olist0255"><div class="answer" id="p1640"><a id="o1025"/>1. tumor composed of a mass of cells</div><div class="answer" id="p1645"><a id="o1030"/>2. tumor of glandular tissue (benign)</div><div class="answer" id="p1650"><a id="o1035"/>3. cancerous (malignant) tumor of glandular tissue</div><div class="answer" id="p1655"><a id="o1040"/>4. tumor of bone (benign)</div><div class="answer" id="p1660"><a id="o1045"/>5. flesh (connective tissue) tumor of bone (malignant)</div><div class="answer" id="p1665"><a id="o1050"/>6. tumor composed of different types of tissue (both epithelial and connective tissues)</div><div class="answer" id="p1670"><a id="o1055"/>7. new formation (tumor)</div><div class="answer" id="p1675"><a id="o1060"/>8. tumors of fibrous supportive nerve tissue; often benign but may become malignant</div><div class="answer" id="p1680"><a id="o1065"/>9. noncancerous</div><div class="answera" id="p1685"><a id="o1070"/>10. specialization of cells</div></div></div><a id="s0150"/><a id="cesectitle0210"/>D<div class="textfl" id="p1690"><div id="olist0260"><div class="answer" id="p1695"><a id="o1075"/>1. papillary</div><div class="answer" id="p1700"><a id="o1080"/>2. dysplastic</div><div class="answer" id="p1705"><a id="o1085"/>3. carcinoma in situ</div><div class="answer" id="p1710"><a id="o1090"/>4. scirrhous</div><div class="answer" id="p1715"><a id="o1095"/>5. alveolar</div><div class="answer" id="p1720"><a id="o1100"/>6. follicular</div><div class="answer" id="p1725"><a id="o1105"/>7. pleomorphic</div><div class="answer" id="p1730"><a id="o1110"/>8. undifferentiated</div><div class="answer" id="p1735"><a id="o1115"/>9. diffuse</div><div class="answera" id="p1740"><a id="o1120"/>10. epidermoid</div></div></div><a id="s0155"/><a id="cesectitle0215"/>E<div class="textfl" id="p1745"><div id="olist0265"><div class="answer" id="p1750"><a id="o1125"/>1. necrotic</div><div class="answer" id="p1755"><a id="o1130"/>2. fungating</div><div class="answer" id="p1760"><a id="o1135"/>3. ulcerating</div><div class="answer" id="p1765"><a id="o1140"/>4. inflammatory</div><div class="answer" id="p1770"><a id="o1145"/>5. polypoid</div><div class="answer" id="p1775"><a id="o1150"/>6. cystic</div><div class="answer" id="p1780"><a id="o1155"/>7. verrucous</div><div class="answer" id="p1785"><a id="o1160"/>8. medullary</div></div></div><a id="s0160"/><a id="cesectitle0220"/>F<div class="textfl" id="p1790"><div id="olist0270"><div class="answer" id="p1795"><a id="o1165"/>1. carcinoma; thyroid adenocarcinoma, squamous cell carcinoma</div><div class="answer" id="p1800"><a id="o1170"/>2. sarcoma; liposarcoma, chondrosarcoma, osteogenic sarcoma</div><div class="answer" id="p1805"><a id="o1175"/>3. inherited cancers</div><div class="answer" id="p1810"><a id="o1180"/>4. grading</div><div class="answer" id="p1815"><a id="o1185"/>5. staging</div><div class="answer" id="p1820"><a id="o1190"/>6. tumor; node; metastasis</div><div class="answer" id="p1825"><a id="o1195"/>7. anaplasia</div><div class="answer" id="p1830"><a id="o1200"/>8. apoptosis</div></div></div><a id="s0165"/><a id="cesectitle0225"/>G<div class="textfl" id="p1835"><div id="olist0275"><div class="answer" id="p1840"><a id="o1205"/>1. D</div><div class="answer" id="p1845"><a id="o1210"/>2. E</div><div class="answer" id="p1850"><a id="o1215"/>3. G</div><div class="answer" id="p1855"><a id="o1220"/>4. A</div><div class="answer" id="p1860"><a id="o1225"/>5. F</div><div class="answer" id="p1865"><a id="o1230"/>6. B</div><div class="answer" id="p1870"><a id="o1235"/>7. C</div></div></div><a id="s0170"/><a id="cesectitle0230"/>H<div class="textfl" id="p1875"><div id="olist0280"><div class="answer" id="p1880"><a id="o1240"/>1. radiation therapy</div><div class="answer" id="p1885"><a id="o1245"/>2. radioresistant</div><div class="answer" id="p1890"><a id="o1250"/>3. radiosensitive</div><div class="answer" id="p1895"><a id="o1255"/>4. radiocurable</div><div class="answer" id="p1900"><a id="o1260"/>5. fractionation</div><div class="answer" id="p1905"><a id="o1265"/>6. radiosensitizers</div><div class="answer" id="p1910"><a id="o1270"/>7. chemotherapy</div><div class="answer" id="p1915"><a id="o1275"/>8. neurofibromatosis</div><div class="answer" id="p1920"><a id="o1280"/>9. combination chemotherapy</div><div class="answera" id="p1925"><a id="o1285"/>10. linear accelerator</div><div class="answera" id="p1930"><a id="o1290"/>11. chemotherapeutic agents</div><div class="answera" id="p1935"><a id="o1295"/>12. brachytherapy</div><div class="answera" id="p1940"><a id="o1300"/>13. gray</div><div class="answera" id="p1945"><a id="o1305"/>14. external beam radiation (teletherapy)</div><div class="answera" id="p1950"><a id="o1310"/>15. proton therapy</div><div class="answera" id="p1955"><a id="o1315"/>16. radiation field</div><div class="answera" id="p1960"><a id="o1320"/>17. simulation</div><div class="answera" id="p1965"><a id="o1325"/>18. stereotactic radiosurgery</div></div><a id="pg787"/><span role="doc-pagebreak" epub:type="pagebreak" aria-label="787" id="pagebreak_787"/></div><a id="s0175"/><a id="cesectitle0235"/>I<div class="textfl" id="p1970"><div id="olist0285"><div class="answer" id="p1975"><a id="o1330"/>1. oral mucositis</div><div class="answer" id="p1980"><a id="o1335"/>2. pneumonitis</div><div class="answer" id="p1985"><a id="o1340"/>3. alopecia</div><div class="answer" id="p1990"><a id="o1345"/>4. myelosuppression</div><div class="answer" id="p1995"><a id="o1350"/>5. fibrosis</div><div class="answer" id="p2000"><a id="o1355"/>6. xerostomia</div><div class="answer" id="p2005"><a id="o1360"/>7. nausea</div><div class="answer" id="p2010"><a id="o1365"/>8. secondary tumors</div><div class="answer" id="p2015"><a id="o1370"/>9. infertility</div><div class="answera" id="p2020"><a id="o1375"/>10.cystitis and proctitis</div><div class="answera" id="p2025"><a id="o1380"/>11. desquamation</div></div></div><a id="s0180"/><a id="cesectitle0240"/>J<div class="textfl" id="p2030"><div id="olist0290"><div class="answer" id="p2035"><a id="o1385"/>1. F</div><div class="answer" id="p2040"><a id="o1390"/>2. G</div><div class="answer" id="p2045"><a id="o1395"/>3. A</div><div class="answer" id="p2050"><a id="o1400"/>4. E</div><div class="answer" id="p2055"><a id="o1405"/>5. H</div><div class="answer" id="p2060"><a id="o1410"/>6. B</div><div class="answer" id="p2065"><a id="o1415"/>7. D</div><div class="answer" id="p2070"><a id="o1420"/>8. C</div></div></div><a id="s0185"/><a id="cesectitle0245"/>K<div class="textfl" id="p2075"><div id="olist0295"><div class="answer" id="p2080"><a id="o1425"/>1. beta-hCG test</div><div class="answer" id="p2085"><a id="o1430"/>2. CA-125</div><div class="answer" id="p2090"><a id="o1435"/>3. laparoscopy</div><div class="answer" id="p2095"><a id="o1440"/>4. estrogen receptor assay</div><div class="answer" id="p2100"><a id="o1445"/>5. bone marrow biopsy</div><div class="answer" id="p2105"><a id="o1450"/>6. core needle biopsy</div><div class="answer" id="p2110"><a id="o1455"/>7. PSA test</div><div class="answer" id="p2115"><a id="o1460"/>8. CEA test</div><div class="answer" id="p2120"><a id="o1465"/>9. exfoliative cytology</div><div class="answera" id="p2125"><a id="o1470"/>10. stem cell transplant</div></div></div><a id="s0190"/><a id="cesectitle0250"/>L<div class="textfl" id="p2130"><div id="olist0300"><div class="answer" id="p2135"><a id="o1475"/>1. adjuvant chemotherapy</div><div class="answer" id="p2140"><a id="o1480"/>2. neoadjuvant chemotherapy</div><div class="answer" id="p2145"><a id="o1485"/>3. genetic screening</div><div class="answer" id="p2150"><a id="o1490"/>4. external beam radiation</div><div class="answer" id="p2155"><a id="o1495"/>5. immunotherapy</div><div class="answer" id="p2160"><a id="o1500"/>6. molecularly targeted therapy</div><div class="answer" id="p2165"><a id="o1505"/>7. liquid biopsy</div></div></div><a id="s0195"/><a id="cesectitle0255"/>M<div class="textfl" id="p2170"><div id="olist0305"><div class="answer" id="p2175"><a id="o1510"/>1. benign</div><div class="answer" id="p2180"><a id="o1515"/>2. adjuvant</div><div class="answer" id="p2185"><a id="o1520"/>3. molecularly targeted drug therapy</div><div class="answer" id="p2190"><a id="o1525"/>4. sessile</div><div class="answer" id="p2195"><a id="o1530"/>5. biopsy</div><div class="answer" id="p2200"><a id="o1535"/>6. myelosuppression</div><div class="answer" id="p2205"><a id="o1540"/>7. PET-CT scan; restage; remission</div><div class="answer" id="p2210"><a id="o1545"/>8. RT</div><div class="answer" id="p2215"><a id="o1550"/>9. checkpoint inhibitor</div><div class="answera" id="p2220"><a id="o1555"/>10. relapsed ALL(acute lymphocytic leukemia)</div></div></div><a id="s0200"/><a id="cesectitle0260"/>Answers to Practical Applications<a id="s0205"/><a id="cesectitle0265"/>FYI: Other Malignant Tumors<div class="textfl" id="p2225"><div id="olist0310"><div class="answer" id="p2230"><a id="o1560"/>1. melanoma (a nevus is a benign pigmented lesion or mole)</div><div class="answer" id="p2235"><a id="o1565"/>2. thymoma</div><div class="answer" id="p2240"><a id="o1570"/>3. hepatoma</div><div class="answer" id="p2245"><a id="o1575"/>4. glioma</div><div class="answer" id="p2250"><a id="o1580"/>5. hypernephroma</div><div class="answer" id="p2255"><a id="o1585"/>6. multiple myeloma</div><div class="answer" id="p2260"><a id="o1590"/>7. mesothelioma</div><div class="answer" id="p2265"><a id="o1595"/>8. lymphoma (previously known as lymphosarcoma)</div></div></div><a id="s0210"/><a id="cesectitle0270"/>Case Study<div class="textfl" id="p2270"><div id="olist0315"><div class="answer" id="p2275"><a id="o1600"/>1. b</div><div class="answer" id="p2280"><a id="o1605"/>2. c</div><div class="answer" id="p2285"><a id="o1610"/>3. c</div><div class="answer" id="p2290"><a id="o1615"/>4. c</div><div class="answer" id="p2295"><a id="o1620"/>5. b</div></div><a id="pg788"/><span role="doc-pagebreak" epub:type="pagebreak" aria-label="788" id="pagebreak_788"/></div></div></div><section><div id="p2300"/><div><aside aria-labelledby="b0060" epub:type="sidebar">

<div class="boxg1" id="b0060"><p/><div class="b1title" epub:type="title" id="title0065"><span class="icon1"><img src="../../IMAGES/B9780443107795000191/main.assets/icon12-9780443107795.jpg" alt="icon"/></span>Pronunciation of Terms</div><div class="b1textfl" id="bpar0435">The terms you have learned in this chapter are presented here with their pronunciations. The meanings for all the terms are in the <b>Mini-Dictionary</b> beginning on page 897.</div><div><div class="pageavoid"><div class="big_device"><table id="t0125" class="tbody"><thead><tr><th scope="col" class="tcolhd1">TERM</th><th scope="col" class="tcolhd1">PRONUNCIATION</th></tr></thead><tbody><tr><th scope="row" class="tb"><b>adenocarcinoma</b></th><td class="tb">ah-deh-no-kar-sih-NO-mah</td></tr><tr><th scope="row" class="tb"><b>adjuvant chemotherapy</b></th><td class="tb">AD-ju-vantke-mo-THER-ah-pe</td></tr><tr><th scope="row" class="tb"><b>alkylating agents</b></th><td class="tb">AL-kih-la-tingA-jents</td></tr><tr><th scope="row" class="tb"><b>alopecia</b></th><td class="tb">al-o-PE-she-ah</td></tr><tr><th scope="row" class="tb"><b>alveolar</b></th><td class="tb">al-ve-O-lar</td></tr><tr><th scope="row" class="tb"><b>anaplasia</b></th><td class="tb">an-ah-PLA-ze-ah</td></tr><tr><th scope="row" class="tb"><b>antibiotics</b></th><td class="tb">an-tih-bi-OT-iks</td></tr><tr><th scope="row" class="tb"><b>antimetabolites</b></th><td class="tb">an-te-meh-TAB-o-lites</td></tr><tr><th scope="row" class="tb"><b>antimitotics</b></th><td class="tb">an-tih-mi-TOT-iks</td></tr><tr><th scope="row" class="tb"><b>apoptosis</b></th><td class="tb">a-pop-TO-sis</td></tr><tr><th scope="row" class="tb"><b>benign tumor</b></th><td class="tb">be-NINETU-mor</td></tr><tr><th scope="row" class="tb"><b>bone marrow biopsy</b></th><td class="tb">boneMAH-roBI-op-se</td></tr><tr><th scope="row" class="tb"><b>bone marrow transplantation</b></th><td class="tb">boneMAH-rotranz-plan-TA-shun</td></tr><tr><th scope="row" class="tb"><b>brachytherapy</b></th><td class="tb">bra-ke-THER-ah-pe</td></tr><tr><th scope="row" class="tb"><b>cachexia</b></th><td class="tb">kah-KEK-se-ah</td></tr><tr><th scope="row" class="tb"><b>carcinogens</b></th><td class="tb">kar-SIH-no-jenz</td></tr><tr><th scope="row" class="tb"><b>carcinoma</b></th><td class="tb">kar-sih-NO-mah</td></tr><tr><th scope="row" class="tb"><b>carcinoma in situ</b></th><td class="tb">kar-sih-NO-mahinSI-tu</td></tr><tr><th scope="row" class="tb"><b>cauterization</b></th><td class="tb">kaw-ter-ih-ZA-shun</td></tr><tr><th scope="row" class="tb"><b>chemotherapy</b></th><td class="tb">ke-mo-THER-ah-pe</td></tr><tr><th scope="row" class="tb"><b>combination chemotherapy</b></th><td class="tb">KOM-bih-NA-shunke-mo-THER-ah-pe</td></tr><tr><th scope="row" class="tb"><b>core needle biopsy</b></th><td class="tb">coreNE-delBI-op-se</td></tr><tr><th scope="row" class="tb"><b>cryosurgery</b></th><td class="tb">kri-o-SUR-jer-e</td></tr><tr><th scope="row" class="tb"><b>cystic tumor</b></th><td class="tb">SIS-tikTU-mor</td></tr><tr><th scope="row" class="tb"><b>cytogenetic analysis</b></th><td class="tb">si-to-jeh-NET-ikah-NAL-eh-sis</td></tr><tr><th scope="row" class="tb"><b>dedifferentiation</b></th><td class="tb">de-dif-er-en-she-A-shun</td></tr><tr><th scope="row" class="tb"><b>deoxyribonucleic acid</b></th><td class="tb">de-ox-e-ri-bo-nu-KLE-ikAS-id</td></tr><tr><th scope="row" class="tb"><b>differentiation</b></th><td class="tb">dif-er-en-she-A-shun</td></tr><tr><th scope="row" class="tb"><b>diffuse</b></th><td class="tb">di-FUS</td></tr><tr><th scope="row" class="tb"><b>dysplastic</b></th><td class="tb">dis-PLAS-tik</td></tr><tr><th scope="row" class="tb"><b>electrocauterization</b></th><td class="tb">eh-lek-tro-kaw-ter-eh-ZA-shun</td></tr><tr><th scope="row" class="tb"><b>electron beams</b></th><td class="tb">eh-LEK-tronbeemz</td></tr><tr><th scope="row" class="tb"><b>en bloc resection</b></th><td class="tb">enblokre-SEK-shun</td></tr><tr><th scope="row" class="tb"><b>encapsulated</b></th><td class="tb">en-KAP-su-la-ted</td></tr><tr><th scope="row" class="tb"><b>epidermoid</b></th><td class="tb">ep-ih-DER-moyd</td></tr><tr><th scope="row" class="tb"><b>excisional biopsy</b></th><td class="tb">ek-SIZH-un-alBI-op-se</td></tr><tr><th scope="row" class="tb"><b>exenteration</b></th><td class="tb">eks-en-teh-RA-shun</td></tr><tr><th scope="row" class="tb"><b>exfoliative cytology</b></th><td class="tb">eks-FO-le-a-tivsi-TOL-o-je</td></tr><tr><th scope="row" class="tb"><b>external beam radiation</b></th><td class="tb">eks-TER-nalbeamra-de-A-shun</td></tr><tr><th scope="row" class="tb"><b>fiberoptic colonoscopy</b></th><td class="tb">fi-ber-OP-tikko-lon-OS-ko-pe</td></tr><tr><th scope="row" class="tb"><b>fibrosarcoma</b></th><td class="tb">fi-bro-sar-KO-mah</td></tr><tr><th scope="row" class="tb"><b>fibrosis</b></th><td class="tb">fi-BRO-sis</td></tr><tr><th scope="row" class="tb"><b>fine needle aspiration</b></th><td class="tb">fineNE-dilas-peh-RA-shun</td></tr><tr><th scope="row" class="tb"><b>follicular</b></th><td class="tb">fo-LIK-u-lar</td></tr><tr><th scope="row" class="tb"><b>fractionation</b></th><td class="tb">frak-shah-NA-shun</td></tr><tr><th scope="row" class="tb"><b>fulguration</b></th><td class="tb">ful-gu-RA-shun</td></tr><tr><td class="tb_ralign" colspan="2">Table Continued</td></tr></tbody></table></div>

<div><span role="doc-pagebreak" epub:type="pagebreak" aria-label="789" id="pagebreak_789"/></div><div class="big_device"><table class="tbody"><thead><tr><th scope="col" class="tcolhd1">TERM</th><th scope="col" class="tcolhd1">PRONUNCIATION</th></tr></thead><tbody><tr><th scope="row" class="tb"><b>fungating tumor</b></th><td class="tb">fun-GA-tingTU-mor</td></tr><tr><th scope="row" class="tb"><b>genetic screening</b></th><td class="tb">jeh-NET-ikSCRE-ning</td></tr><tr><th scope="row" class="tb"><b>grading of tumors</b></th><td class="tb">GRA-dingofTU-morz</td></tr><tr><th scope="row" class="tb"><b>gray</b></th><td class="tb">gra</td></tr><tr><th scope="row" class="tb"><b>hyperplasia</b></th><td class="tb">hi-per-PLA-ze-ah</td></tr><tr><th scope="row" class="tb"><b>immunohistochemistry</b></th><td class="tb">im-u-no-his-to-KEM-is-tre</td></tr><tr><th scope="row" class="tb"><b>immunotherapy</b></th><td class="tb">im-u-no-THE-rah-pe</td></tr><tr><th scope="row" class="tb"><b>incisional biopsy</b></th><td class="tb">in-SIZH-un-alBI-op-se</td></tr><tr><th scope="row" class="tb"><b>infertility</b></th><td class="tb">in-fer-TIL-ih-te</td></tr><tr><th scope="row" class="tb"><b>infiltrative</b></th><td class="tb">IN-fil-tra-tiv</td></tr><tr><th scope="row" class="tb"><b>invasive</b></th><td class="tb">in-VA-siv</td></tr><tr><th scope="row" class="tb"><b>irradiation</b></th><td class="tb">ir-ra-de-A-shun</td></tr><tr><th scope="row" class="tb"><b>laparoscopy</b></th><td class="tb">lap-ah-ROS-ko-pe</td></tr><tr><th scope="row" class="tb"><b>linear accelerator</b></th><td class="tb">LIN-e-arak-SEL-eh-ra-tor</td></tr><tr><th scope="row" class="tb"><b>liquid biopsy</b></th><td class="tb">LIK-widBI-op-se</td></tr><tr><th scope="row" class="tb"><b>malignant tumor</b></th><td class="tb">mah-LIG-nantTU-mor</td></tr><tr><th scope="row" class="tb"><b>mammography</b></th><td class="tb">mah-MOG-rah-fe</td></tr><tr><th scope="row" class="tb"><b>medullary tumor</b></th><td class="tb">MED-u-lair-eTU-mor</td></tr><tr><th scope="row" class="tb"><b>mesenchymal</b></th><td class="tb">mez-en-KI-mal</td></tr><tr><th scope="row" class="tb"><b>metastasis</b></th><td class="tb">met-TAS-tah-sis</td></tr><tr><th scope="row" class="tb"><b>mitosis</b></th><td class="tb">mi-TO-sis</td></tr><tr><th scope="row" class="tb"><b>mixed tissue tumors</b></th><td class="tb">MIKSDTIH-shuTU-morz</td></tr><tr><th scope="row" class="tb"><b>modality</b></th><td class="tb">mo-DAL-ih-te</td></tr><tr><th scope="row" class="tb"><b>molecularly targeted therapy</b></th><td class="tb">mo-LEK-u-lar-leTAR-get-edTHER-ah-pe</td></tr><tr><th scope="row" class="tb"><b>monoclonal antibodies</b></th><td class="tb">mon-o-CLO-nalANT-ih-bod-eez</td></tr><tr><th scope="row" class="tb"><b>morbidity</b></th><td class="tb">mor-BID-ih-te</td></tr><tr><th scope="row" class="tb"><b>mucinous</b></th><td class="tb">MU-sin-us</td></tr><tr><th scope="row" class="tb"><b>mucositis</b></th><td class="tb">mu-ko-SI-tis</td></tr><tr><th scope="row" class="tb"><b>mutagenic</b></th><td class="tb">mu-tah-JEN-ik</td></tr><tr><th scope="row" class="tb"><b>mutation</b></th><td class="tb">mu-TA-shun</td></tr><tr><th scope="row" class="tb"><b>myelosuppression</b></th><td class="tb">mi-eh-lo-su-PRE-shun</td></tr><tr><th scope="row" class="tb"><b>necrotic tumor</b></th><td class="tb">neh-KROT-ikTU-mor</td></tr><tr><th scope="row" class="tb"><b>neoadjuvant chemotherapy</b></th><td class="tb">ne-o-AD-ju-vantke-mo-THER-ah-pe</td></tr><tr><th scope="row" class="tb"><b>neoplasm</b></th><td class="tb">NE-o-plazm</td></tr><tr><th scope="row" class="tb"><b>neuroblastoma</b></th><td class="tb">nu-ro-blas-TO-mah</td></tr><tr><th scope="row" class="tb"><b>neurofibromatosis</b></th><td class="tb">nu-ro-fi-bro-mah-TO-sis</td></tr><tr><th scope="row" class="tb"><b>nucleotide</b></th><td class="tb">NU-kle-o-tide</td></tr><tr><th scope="row" class="tb"><b>oncogene</b></th><td class="tb">ON-ko-jeen</td></tr><tr><th scope="row" class="tb"><b>oncology</b></th><td class="tb">on-KOL-o-je</td></tr><tr><th scope="row" class="tb"><b>osteosarcoma</b></th><td class="tb">os-te-o-sar-KO-mah</td></tr><tr><th scope="row" class="tb"><b>palliative</b></th><td class="tb">PAH-le-ah-tiv</td></tr><tr><th scope="row" class="tb"><b>papillary</b></th><td class="tb">PAP-ih-lair-e</td></tr><tr><th scope="row" class="tb"><b>pedunculated</b></th><td class="tb">peh-DUNG-ku-la-ted</td></tr><tr><th scope="row" class="tb"><b>PET/CT scan</b></th><td class="tb">PET-CTskan</td></tr><tr><th scope="row" class="tb"><b>photon therapy</b></th><td class="tb">FO-tonTHER-ah-pe</td></tr><tr><th scope="row" class="tb"><b>pleomorphic</b></th><td class="tb">ple-o-MOR-fik</td></tr><tr><th scope="row" class="tb"><b>pneumonitis</b></th><td class="tb">nu-mo-NI-tis</td></tr><tr><th scope="row" class="tb"><b>polypoid tumor</b></th><td class="tb">POL-ih-poydTU-mor</td></tr><tr><th scope="row" class="tb"><b>protein marker tests</b></th><td class="tb">PRO-teenMARK-ertests</td></tr><tr><th scope="row" class="tb"><b>protocol</b></th><td class="tb">PRO-to-kol</td></tr><tr><th scope="row" class="tb"><b>proton therapy</b></th><td class="tb">PRO-tonTHER-ah-pe</td></tr><tr><th scope="row" class="tb"><b>radiation</b></th><td class="tb">ra-de-A-shun</td></tr><tr><th scope="row" class="tb"><b>radiation fields</b></th><td class="tb">ra-de-A-shunfeeldz</td></tr><tr><th scope="row" class="tb"><b>radiocurable tumor</b></th><td class="tb">ra-de-o-KYUR-a-blTU-mor</td></tr><tr><th scope="row" class="tb"><b>radionuclide scans</b></th><td class="tb">ra-de-o-NU-klideskanz</td></tr><tr><th scope="row" class="tb"><b>radioresistant tumor</b></th><td class="tb">ra-de-o-re-ZIS-tantTU-mor</td></tr><tr><td class="tb_ralign" colspan="2">Table Continued</td></tr></tbody></table></div>

<div><span role="doc-pagebreak" epub:type="pagebreak" aria-label="790" id="pagebreak_790"/></div><div class="big_device"><table class="tbody"><thead><tr><th scope="col" class="tcolhd1">TERM</th><th scope="col" class="tcolhd1">PRONUNCIATION</th></tr></thead><tbody><tr><th scope="row" class="tb"><b>radiosensitive tumor</b></th><td class="tb">ra-de-o-SEN-sih-tivTU-mor</td></tr><tr><th scope="row" class="tb"><b>radiosensitizers</b></th><td class="tb">ra-de-o-SEN-sih-ti-zerz</td></tr><tr><th scope="row" class="tb"><b>radiotherapy</b></th><td class="tb">ra-de-o-THER-ah-pe</td></tr><tr><th scope="row" class="tb"><b>relapse</b></th><td class="tb">RE-laps</td></tr><tr><th scope="row" class="tb"><b>remission</b></th><td class="tb">re-MIH-shun</td></tr><tr><th scope="row" class="tb"><b>retinoblastoma</b></th><td class="tb">reh-tin-o-blas-TO-mah</td></tr><tr><th scope="row" class="tb"><b>ribonucleic acid</b></th><td class="tb">ri-bo-nu-KLE-ikAS-id</td></tr><tr><th scope="row" class="tb"><b>sarcoma</b></th><td class="tb">sar-KO-mah</td></tr><tr><th scope="row" class="tb"><b>scirrhous</b></th><td class="tb">SKIR-us</td></tr><tr><th scope="row" class="tb"><b>secondary tumors</b></th><td class="tb">SEK-on-dair-eTU-morz</td></tr><tr><th scope="row" class="tb"><b>serous</b></th><td class="tb">SER-us</td></tr><tr><th scope="row" class="tb"><b>sessile</b></th><td class="tb">SES-ile</td></tr><tr><th scope="row" class="tb"><b>simulation</b></th><td class="tb">sim-u-LA-shun</td></tr><tr><th scope="row" class="tb"><b>solid tumor</b></th><td class="tb">SOL-idTU-mor</td></tr><tr><th scope="row" class="tb"><b>staging of tumors</b></th><td class="tb">STA-jingofTU-morz</td></tr><tr><th scope="row" class="tb"><b>stem cell transplantation</b></th><td class="tb">stemseltranz-plan-TA-shun</td></tr><tr><th scope="row" class="tb"><b>stereotactic radiosurgery</b></th><td class="tb">steh-re-o-TAK-ticra-de-o-SUR-jeh-ry</td></tr><tr><th scope="row" class="tb"><b>teletherapy</b></th><td class="tb">tel-e-THER-ah-pe</td></tr><tr><th scope="row" class="tb"><b>ulcerating tumor</b></th><td class="tb">UL-ser-a-tingTU-mor</td></tr><tr><th scope="row" class="tb"><b>undifferentiated</b></th><td class="tb">un-dif-er-EN-she-a-ted</td></tr><tr><th scope="row" class="tb"><b>verrucous tumor</b></th><td class="tb">veh-RU-kusTU-mor</td></tr><tr><th scope="row" class="tb"><b>viral oncogenes</b></th><td class="tb">VI-ralONK-o-jenz</td></tr><tr><th scope="row" class="tb"><b>virus</b></th><td class="tb">VI-rus</td></tr><tr><th scope="row" class="tb"><b>xerostomia</b></th><td class="tb">zer-o-STO-me-ah</td></tr></tbody></table></div>

</div></div></div></aside></div><div class="textfl"><a id="pg791"/><span role="doc-pagebreak" epub:type="pagebreak" aria-label="791" id="pagebreak_791"/></div><div><aside aria-labelledby="b0065" epub:type="sidebar">

<div class="boxg1" id="b0065"><p/><div class="b1title" epub:type="title" id="title0070"><span class="icon1"><img src="../../IMAGES/B9780443107795000191/main.assets/icon13-9780443107795.jpg" alt="icon"/></span>Review Sheet</div><div class="b1textfl" id="bpar0440">Write the meanings of the combining forms in the spaces provided and test yourself. Check your answers with the information in the chapter or in the <b><i>Glossary (Medical Word Parts—English)</i></b> at the end of the book.</div><section><a id="boxsec5045"/><div class="b3_1hd" id="cesectitle0275">Combining Forms</div><div id="bpar0445"/><div><div class="pageavoid"><table id="t0130" class="tbody"><thead><tr><th scope="col" class="tcolhd1">COMBINING FORM</th><th scope="col" class="tcolhd1">MEANING</th></tr></thead><tbody><tr><th scope="row" class="tb">aden/o</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">alveol/o</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">cac/o</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">carcin/o</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">cauter/o</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">chem/o</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">cry/o</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">cyst/o</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">fibr/o</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">follicul/o</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">fung/i</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">medull/o</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">mucos/o</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">mut/a</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">mutagen/o</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">necr/o</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">neur/o</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">onc/o</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">papill/o</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">pharmac/o</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">plas/o</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">ple/o</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">polyp/o</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">radi/o</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">sarc/o</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">scirrh/o</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">xer/o</th><td class="tb">____________________</td></tr></tbody></table></div></div></section><section><a id="boxsec0050"/><div class="b3_1hd" id="cesectitle0280">Suffixes</div><div id="bpar0450"/><div><div class="pageavoid"><table id="t0135" class="tbody"><thead><tr><th scope="col" class="tcolhd1">SUFFIX</th><th scope="col" class="tcolhd1">MEANING</th></tr></thead><tbody><tr><th scope="row" class="tb">-ary</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">-blastoma</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">-oid</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">-oma</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">-plasia</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">-plasm</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">-ptosis</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">-stasis</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">-stomia</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">-suppression</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">-therapy</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">-tion</th><td class="tb">____________________</td></tr></tbody></table></div></div><div class="b1textfl"><a id="pg792"/></div><div><span role="doc-pagebreak" epub:type="pagebreak" aria-label="792" id="pagebreak_792"/></div></section><section><a id="boxsec0055"/><div class="b3_1hd" id="cesectitle0285">Prefixes</div><div id="bpar0455"/><div><div class="pageavoid"><table id="t0140" class="tbody"><thead><tr><th scope="col" class="tcolhd1">PREFIX</th><th scope="col" class="tcolhd1">MEANING</th></tr></thead><tbody><tr><th scope="row" class="tb">ana-</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">anti-</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">apo-</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">brachy-</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">dys-</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">epi-</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">hyper-</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">meta-</th><td class="tb">____________________</td></tr><tr><th scope="row" class="tb">tele-</th><td class="tb">____________________</td></tr></tbody></table></div></div><div class="b1text" id="bpar0460"><b>Write the terms used in cancer medicine next to their meanings below.</b></div><div id="bpar0465"/><div><ul class="ce_list" id="olist0320"><li class="b1unnumlist" id="bpar0470"><a id="u0585"/>adjuvant chemotherapy</li><li class="b1unnumlist" id="bpar0475"><a id="u0590"/>brachytherapy</li><li class="b1unnumlist" id="bpar0480"><a id="u0595"/>cachexia</li><li class="b1unnumlist" id="bpar0485"><a id="u0600"/>carcinoma</li><li class="b1unnumlist" id="bpar0490"><a id="u0605"/>carcinoma in situ</li><li class="b1unnumlist" id="bpar0495"><a id="u0610"/>exenteration</li><li class="b1unnumlist" id="bpar0500"><a id="u0615"/>external beam radiotherapy</li><li class="b1unnumlist" id="bpar0505"><a id="u0620"/>fine needle aspiration</li><li class="b1unnumlist" id="bpar0510"><a id="u0625"/>metastasis</li><li class="b1unnumlist" id="bpar0515"><a id="u0630"/>myelosuppression</li><li class="b1unnumlist" id="bpar0520"><a id="u0635"/>protein markers</li><li class="b1unnumlist" id="bpar0525"><a id="u0640"/>protocol</li><li class="b1unnumlist" id="bpar0530"><a id="u0645"/>sarcoma</li><li class="b1unnumlist" id="bpar0535"><a id="u0650"/>simulation</li><li class="b1numlist" id="bpar0540"><a id="o1625"/>1. Cancerous tumor composed of cells of epithelial origin _______________________</li><li class="b1numlist" id="bpar0545"><a id="o1630"/>2. Drug treatment given after primary treatment _______________________</li><li class="b1numlist" id="bpar0550"><a id="o1635"/>3. Detailed plan of treatment _______________________</li><li class="b1numlist" id="bpar0555"><a id="o1640"/>4. Study using CT scan or MRI to map the area to receive treatment before radiation therapy _______________________</li><li class="b1numlist" id="bpar0560"><a id="o1645"/>5. Wide and complete resection of tumor in a cavity of the body _______________________</li><li class="b1numlist" id="bpar0565"><a id="o1650"/>6. Cancerous tumor derived from connective (flesh) tissue _______________________</li><li class="b1numlist" id="bpar0570"><a id="o1655"/>7. Chemicals in the blood that measure the presence of tumor in the body _______________________</li><li class="b1numlist" id="bpar0575"><a id="o1660"/>8. General ill health and malnutrition associated with disease _______________________</li><li class="b1numlist" id="bpar0580"><a id="o1665"/>9. Teletherapy _______________________</li><li class="b1numlist" id="bpar0585"><a id="o1670"/>10. Insertion of radioactive seeds or sealed containers into tumor _______________________</li><li class="b1numlist" id="bpar0590"><a id="o1675"/>11. Malignancy that is localized and not invasive _______________________</li><li class="b1numlist" id="bpar0595"><a id="o1680"/>12. Cancerous tumor that has spread to lymph nodes and other organs _______________________</li><li class="b1numlist" id="bpar0600"><a id="o1685"/>13. Stopping the growth of cells in the bone marrow _______________________</li><li class="b1numlist" id="bpar0605"><a id="o1690"/>14. Extraction of cells for microscopic (biopsy) evaluation _______________________</li></ul></div></section></div></aside></div></section></section></body></html>